ESGAR

2019
Annual Meeting and Postgraduate Course

June 5-8 ROME LY

ITA

FINAL PROGRAMME

European Society of Gastrointestinal and Abdominal Radiology | www.esgar.org

ESGAR 2019 FINAL PROGRAMME

Important Addresses / CME / Contributing Societies / Patronage 2

Committees 3
Information from A – Z 4
Abstract Reviewing Panel 11
Poster Jury 12
Welcome Addresses 13
Honorary Fellows 16
Programme Overview 19
Wednesday, June 5 26
Thursday, June 6 28
Friday, June 7 37
Saturday, June 8 46
SIRM Programme 52
Poster Presentations – Educational 54
Poster Presentations – Scientific 64
Corporate Members 73
Industry Sponsored Symposia 75
Industry Satellite Workshops 87
Exhibitors and Sponsors 90
Floorplan Exhibition Area 91
Floorplan Meeting Halls 92

© European Society of Gastrointestinal and Abdominal Radiology

Date of publication: May 2019
ESGAR accepts no responsibility for errors or misprints.
IMPORTANT ADDRESSES

ORGANISING SECRETARIAT EXHIBITION MANAGEMENT CONFERENCE VENUE

Central ESGAR Office MAW Roma Convention Center

Esslinggasse 2/3 Medizinische Ausstellungs- und La Nuvola – ”The Cloud“
AT – 1010 Vienna Werbegesellschaft Viale Asia 40
Phone: +43 1 535 89 27 International Exhibitions & Advertising IT – 00144 Rome
Fax: +43 1 535 89 27 15 Freyung 6/3
E-Mail: office@esgar.org AT – 1010 Vienna
Phone: +43 1 536 63 73
www.esgar.org Fax: +43 1 535 60 16
E-Mail: maw@media.co.at

www.media.co.at

CME
The “ESGAR European Society of Gastrointestinal and Abdominal Radiology” (or) “ESGAR 2019 – 30th Annual Meeting and Postgraduate
Course” is accredited by the European Accreditation Council for Continuing Medical Education (EACCME) to provide the following CME
activity for medial specialists. The EACCME is an institution of the European Union of Medical Specialists (UEMS), www.uems.net.

The ESGAR Annual Meeting and Postgraduate Course, Rome, Italy, 05/06/2019 – 08/06/2019 has been accredited by the European
Accreditation Council for Continuing Medical Education (EACCME®) with 25 European CME credits (ECMEC®s). Each medial specialist
should claim only those hours of credits that he/she actually spent in the educational activity.

CONTRIBUTING SOCIETIES

PATRONAGE MEDIA PARTNER

2

ESGAR EXECUTIVE
COMMITTEE
PRESIDENT
S. Halligan, London/UK
PRESIDENT-ELECT
R.G.H. Beets-Tan, Amsterdam/NL
VICE PRESIDENT
A. Laghi, Rome/IT
SECRETARY/TREASURER
M. Zins, Paris/FR
PAST PRESIDENT
C. Matos, Lisbon/PT
EDUCATION COMMITTEE CHAIR
S. Jackson, Plymouth/UK
MEMBERSHIP COMMITTEE CHAIR
M.A. Bali, Brussels/BE
RESEARCH COMMITTEE CHAIR
J. Stoker, Amsterdam/NL
WORKSHOP COMMITTEE CHAIR
G. Brancatelli, Palermo/IT
MEETING PRESIDENT 2019
A. Laghi, Rome/IT
PRE-MEETING PRESIDENT
J. Stoker, Amsterdam/NL
MEMBERS AT LARGE
A. Ba-Ssalamah, Vienna/AT
V. Vilgrain, Clichy/FR
C.J. Zech, Basel/CH
ESGAR EXECUTIVE DIRECTOR
B. Lindlbauer, Vienna/AT
COMMITTEES
ESGAR 2019 MEETING ESGAR 2019 LOCAL
PRESIDENT ORGANISING COMMITTEE
Prof. Andrea Laghi G. Argento, Rome/IT
Full Professor of Radiology B. Beomonte Zobel, Rome/IT
Department of Surgical and Medical C. Bibbolino, Rome/IT
Sciences and Translational Medicine S. Canitano, Rieti/IT
“Sapienza” – University of Rome C. Catalano, Rome/IT
Chairman of Radiology Unit – Sant’Andrea M. Caterino, Rome/IT
University Hospital P. Cerro, Rome/IT
Via di Grottarossa 1035 R. Cianni, Rome/IT
IT – 00189 Rome P. D’Andrea, Belluno/IT
V. David, Rome/IT
M. Galluzzo, Rome/IT
ESGAR 2019 PROGRAMME A. Giovagnoni, Ancona/IT
M. Guazzaroni, Rome/IT
COMMITTEE
E. Iannicelli, Rome/IT
CHAIRS R. Manfredi, Rome/IT
M. Zins, Paris/FR A. Orlacchio, Rome/IT
C. Matos, Lisbon/PT E. Pofi, Rome/IT
M. Rossi, Rome/IT
MEMBERS P. Schiroso, Rome/IT
M.A. Bali, Brussels/BE F.M. Solivetti, Rome/IT
A. Ba-Ssalamah, Vienna/AT L. Tipaldi, Rome/IT
R.G.H. Beets-Tan, Amsterdam/NL
G. Brancatelli, Palermo/IT
H. Fenlon, Dublin/IE
S. Halligan, London/UK
S. Jackson, Plymouth/UK
A. Laghi, Rome/IT
J. Stoker, Amsterdam/NL
V. Vilgrain, Clichy/FR
C.J. Zech, Basel/CH
3
INFORMATION FROM A – Z

ABBREVIATIONS BOOK OF ABSTRACTS

The following abbreviations are used in the programme: The ESGAR 2019 Book of Abstracts includes submitted and
accepted oral presentations and is only available online. It can
ES Editorial Session be downloaded via the ESGAR App or your personal ESGAR
ET ESGAR Tutorial (former Workshop) Account (www.esgar.org). By using the ESGAR 2019 Interactive
HL Honorary Lecture Programme Planner, you can also create your own Book of
IGT Image Guided Therapy Abstracts (www.esgar.org/programmeplanner2019).
ISWS Industry Satellite Workshop
IWS Interventional Workshop
LS Lecture Session CASES OF THE DAY
PG Postgraduate Course Scientific Coordinator: A. Ba-Ssalamah, Vienna/AT
PO Poster Session
PS Plenary Session Different cases are displayed each day from Wednesday, June 5
RC Research Centre to Saturday, June 8, giving registrants the opportunity to take
SOE School of ESGAR part in the quiz and check the results on the following day.
SS Scientific Session The participants who solve the most cases correctly will be
SY Lunch Symposium announced in the ESGAR Newsletter.
TC Tricky Cases The cases are accessible via the computer terminals located in
USV Ultrasound Village the Electronic Poster Exhibition (Exhibition Area) as well as online
(www.esgar.org/programmeplanner2019).

APP
As in previous years, ESGAR provides an App for iPhone, iPad
and Android Systems. You can browse the programme by
day or by session type. You can have a look at all abstracts,
search for authors and save the pdf of the Final Programme
and Book of Abstracts on your device. Solving the Cases of the
Day, evaluation and CME acquisition are also possible via the
ESGAR App. Please note that the “City Guide” within the App is
automatically generated by Google Inc. ESGAR does not assume
any responsibility for the quality and accuracy of the information
provided.
BADGES
It is obligatory for all participants to wear their name badge visibly
throughout the meeting as it is the entrance ticket to all sessions
and the exhibition. The name badge is not transferable. In case of
badge loss, please contact the registration desk (Entrance Level
Foyer). ESGAR reserves the right to check your identification. You
may be asked at any time to present adequate proof of identity
by showing your passport, driver’s licence, national or military
identification or student ID, all with photograph and signature.
CLINICAL FILES
Friday, June 7 in Room Florence (17:00 – 18:00)
An experienced moderator presents four themed and challenging
multimodality cases to a radiology panel. Each case is chosen to
illustrate various diagnostic and therapeutic options available for
the clinical management of the patient. The interpretation session
is live as the panellists did not see the cases before the session.
The panellists describe the imaging findings. The moderator
guides the panellists with questions regarding differentials and
patient management. The aim of this session is to stress the
central role of clinical radiology in today’s patient management
and to show how experts deal with cases in real life.
CLOAKROOM
The coat check service is located on the left-hand side in the
Entrance Level Foyer.

4
CME ACCREDITATION & EVALUATION
ESGAR uses a digital CME acquisition system in order to provide
more flexibility to delegates in regard to evaluating sessions and
obtaining CME credits.
CME acquisition & Evaluation is possible via
• the official ESGAR 2019 App
• online via www.esgar.org/programmeplanner2019
• the CME & Evaluation Terminals (Entrance Level)
• the registration counters (Entrance Level) from Thursday,
June 6, 14:00 onwards
CME credits will only be awarded if
• You are logged into the official evaluation system with your
username and your Personal ESGAR ID (printed on your
badge)
• You have fully completed the electronic questionnaire for
each session
Please note that the evaluation of sessions is only possible from
June 5 – 12, 2019. Confirmation of attendance cannot be claimed
at a later date as late requests cannot be processed and can thus
not be included in your record of attendance.
Guidance
Confirmation of participation in the scientific programme may be
obtained as follows:
Scientific / Educational Sessions
1. P
 articipate in the session of your interest
2. L
 og into the Interactive Programme Planner (www.esgar.
org/programmeplanner2019) or use the ESGAR 2019 App to
evaluate the session
3. Fill out the form completely during or after the session
If you do not have a smartphone, tablet or laptop with you, please
use the Evaluation Terminals and evaluate the session(s) you
visited.
Please note that Lunch Symposia and Industry Satellite
Workshops are not CME accredited.
Electronic Poster Exhibition / Cases of the Day
Your attendance and evaluation are automatically recorded online
in the electronic poster system:
1. Enter the electronic poster system and view the posters of
your interest. Once you log out, you are asked to complete the
evaluation form.
2. Fill in this form completely and press the “submit” button. A
maximum of 0.5 hours/day of attendance at the electronic
poster exhibition is listed if the participant has completed
and submitted the online evaluation form using the electronic
poster system. Please note: This does not include the
“Terminals“.
3. A maximum of 0.5 hours/day is listed for participation in the
Cases of the Day.
CME Record / Certificate of Attendance
You can download and print the record of attendance from your
personal ESGAR Account.
This service will be available two weeks after the congress. The
printout of your record of attendance has to be submitted to the
respective national accreditation society. Please note that the
record of attendance is issued only to the participant. It will not be
supplied to any accreditation agency or other organisation/health
authority. Although participants may partially attend multiple
concurrent sessions, the total number of hours printed at the end
of the list limits the credit to the equivalent of a single session
during that time slot.
COFFEE CASH BARS
Within the congress centre the main catering area can be found in
the Exhibition Area on the Entrance Level. At the coffee cash bars
you can get drinks, snacks, sandwitches and hot lunch.
Opening hours:
Wednesday, June 5 07:30 – 17:30
Thursday, June 6 07:30 – 17:30
Friday, June 7 07:30 – 17:30
Saturday, June 8 07:30 – 15:30
Complimentary coffee will be available in the Exhibition Area at
the following times:
Wednesday, June 5 10:00 – 11:00 / 15:30 – 16:30
Thursday, June 6 10:00 – 11:00 / 15:30 – 16:30
Friday, June 7 10:00 – 11:00 / 15:30 – 16:30
Saturday, June 8 10:00 – 11:00 / 13:00 – 14:00
5
INFORMATION FROM A – Z
EDITORIAL SESSION
Friday, June 7 in Room Amalfi (14:30 – 16:00)
This session aims at introducing the editorial world. Chief Editors
of peer reviewed scientific journals provide insight into different
types of educational papers and their level of evidence. Different
impact factors and manuscript review handling processes are
explained. The session concludes with an interactive discussion
among editors and research leaders; attendees are encouraged to
actively participate and ask questions they always wanted to ask
the editors.
ELECTRONIC POSTER EXHIBITION
Exhibition Area (Entrance Level)
All scientific and educational exhibits (posters) at ESGAR 2019
are displayed in electronic poster format. The e-poster system
allows registrants to submit their exhibits online, to view them in
the conference centre and send selected material to participants’
individual e-mail addresses for easy referencing. The scientific
and educational posters displayed in the electronic poster
exhibition at ESGAR 2019 will be included in the permanent
ESGAR Online Poster Database after the meeting.
A number of computer terminals is available for viewing the
presentations. The posters are also accessible online via
www.esgar.org/programmeplanner2019.
Please refer to pages 54 – 70 of this programme for a complete
listing of presented e-posters sorted by topic.
Opening hours:
Wednesday, June 5 07:30 – 18:30
Thursday, June 6 07:30 – 18:00
Friday, June 7 07:30 – 18:00
Saturday, June 8 07:30 – 16:30
Poster Presentation Prizes
The evaluation of the poster presentations was completed in
advance of the meeting by a jury and was based on novelty,
accuracy, educational value and design. The winners are
indicated as such in the electronic poster system. The best poster
presentations receive a diploma which can be collected at the
Scientific Office (Entrance Level).
The following prizes are awarded: Magna Cum Laude, Cum Laude
and Certificates of Merit.
Furthermore, the Board of Achievement with pictures of all poster
prize winners is displayed in the Exhibition Area.
6
There are also the “Recommended Posters”, which were not
selected for an award but are recommended by the jury for their
interesting and valuable scientific and educational content.
The awarded posters as well as the recommended posters are
also displayed on special electronic poster terminals located in
the Exhibition Area.
EMERGENCY
The number 112 can be dialled to reach emergency services –
medical, fire and police – from anywhere in Europe. The operator
redirects the call to the appropriate service. This Pan-European
emergency number can be called from any telephone (landline,
pay phone or mobile phone) and is free of charge.
ESGAR 2019 ONLINE
All scientific and educational sessions that are part of the
Annual Meeting are recorded and will be available in the ESGAR
e-Education Portal shortly after the congress.
ESGAR TOP 20
The best 20 abstracts, submitted by residents, who appear as the
first author on the respective abstract and who actually present their
paper during the meeting, form the “ESGAR Top 20”.
Authors receive a diploma, which can be collected at the Scientific
Office (Entrance Level). Furthermore, the Board of Achievement with
pictures of all awarded presenters is displayed in the Exhibition Area.
ESGAR TUTORIALS
ESGAR 2019 continues a project to enhance the educational
impact of workshops, which have been renamed into tutorials.
Throughout the meeting, different tutorials will be offered to the
registrants. Compared to a formal lecture, the smaller tutorial
environment is intended to facilitate more active discussion
between expert instructors and the audience, allowing registrants
to address their specific needs. Five different lines of tutorials are
presented at ESGAR 2019:
#Single Topic / #From my Workstation / #Technical Tips /
#Questions from my Colleague / #Structured Reporting
FUTURE MEETINGS DESK
Feel free to contribute flyers and posters to promote your own
meetings and courses. The future meetings desk is located in the
Exhibition Area.
HONORARY LECTURES
ESGAR continues the traditional format of the Honorary Lecture
Sessions. Besides the ESGAR Honorary Lecture, two sessions are
organised in collaboration with the Asian Society of Abdominal
Radiology (ASAR) and the Society of Abdominal Radiology (SAR).
IMAGE GUIDED THERAPY
An educational feature focusing on Interventional Radiology
(IR) in the GI tract and Abdomen was first introduced during the
ESGAR 2009 Annual Meeting. Following positive comments, it
was expanded at subsequent meetings in order to reflect the
central role interventional techniques play in the multidisciplinary
management of patients with gastrointestinal and abdominal
diseases. Features include lecture sessions, tutorials, scientific
papers and posters as well as incorporating relevant techniques
into the Postgraduate Course. The daily IGT sessions are again
led by expert tutors, emphasising key practical issues, ranging
from basic to advanced knowledge and skills. Interactivity is
encouraged between delegates and tutors in order to facilitate
useful practical discussion. Therefore, cases provided by the
moderators are discussed by the interdisciplinary faculty in each
session. This particular format helps to augment the various
practical aspects and procedural tips/tricks and encourage the
audience to interact with IR experts in this learning environment.
INDUSTRY SATELLITE WORKSHOPS
On Thursday, June 6 and Friday, June 7 satellite workshops will
be held in collaboration with industrial companies on a variety of
hot topics.
For further information, please refer to page 87.
INTERNET ACCESS
Free wireless LAN access is available throughout the congress
venue and all lecture rooms free of charge (network and
password: ESGAR2019).
LANGUAGE
The entire meeting is held in English.
LEAD RETRIEVAL SYSTEM
Your name badge is your business card. ESGAR and its sponsors
are using a lead retrieval system during the congress. In practice
that means that when you present your badge for scanning at
an exhibition booth or for scanning when entering an industry
sponsored lunch symposium or workshop, the following
personal data is collected by the respective company: first name,
last name, address details, email address.
LECTURE HALLS
Entrance Level: Florence / Pisa / Bologna / Amalfi / Capri / Milan /
Meeting Room 4 / Meeting Room 5
Level 3: Auditorium “The Cloud”
LECTURE SESSIONS
All Lecture Sessions are dedicated to a special area of interest
with defined lecture objectives to ensure integration and avoid
overlap. Several sessions have a multidisciplinary approach
or are organised in collaboration with other societies such as
the European Society of Urogenital Radiology (ESUR) and the
European Crohn’s and Colitis Organisation (ECCO).
LIABILITY
ESGAR is not liable for personal injury and loss of or damage
to private property. Participants should obtain the appropriate
travel insurance. The place of performance of any duties and
obligations for both ESGAR and the participant’s sides shall be
Vienna, Austria. Any contractual relationship with ESGAR shall be
subject to Austrian law.
LOST AND FOUND
Lost and found articles may be picked up or handed in at the
registration desk (Entrance Level).
LUNCH SYMPOSIA
From Wednesday to Saturday at lunchtime, symposia will be held
in collaboration with industrial companies and corporate partners.
The subjects of these symposia will include a variety of “hot
topics” concerning the ongoing development in some major fields
of abdominal diagnostic and interventional radiology. Please refer
to pages 75 – 86 for further information.
7
INFORMATION FROM A – Z
MODERATORS’ DESK
Moderators are kindly asked to check in at the moderators’ desk
in the ESGAR Scientific Office (Entrance Level) at least 30 minutes
before the session they are chairing, in order to pick up their
documents.
NICK GOURTSOYIANNIS’ FOUNDATION COURSE I and II
Saturday, June 8 in Room Pisa
Foundation Course 1 (14:00 – 15:00): Radiologic-pathologic
correlation: Liver
Foundation Course 2 (15:15 – 16:15): Radiologic-pathologic
correlation: Small Bowel
This educational feature, named after Prof. Nicholas
Gourtsoyiannis, is a mini rad-path course designed to teach
fundamental imaging findings in specific abdominal conditions
correlated with up-to-date pathologic information. The specific
topics to be discussed in this year’s rad-path course are the
benign hepatic neoplasms (adenoma and FNH), malignant
hepatic tumours that scar (fibrolamellar HCC and HCC with a
scar), small bowel malabsorption including coeliac disease and
systemic disorders that affect the small bowel.
ONE CASE – THREE LESSONS
Thursday, June 6 in Room Florence (17:00 – 18:00)
In this session each panellist explains a clinical case where he/
she personally made a mistake and then develops the three
lessons that he/she got from this mistake. The goal of this format
is to learn how to avoid important mistakes in the diagnosis of
difficult cases, to understand the influence of clinical context
and radiology interpretation in the management of our patients.
The session is managed like a Jazz session, very entertaining,
educating with humour and rhythm.
PHOTOGRAPHY
Please be aware that the Annual Meeting and Postgraduate
Course is an event where photography may occur. By
participating in the event you consent to your likeness being
used, without compensation, in any and all media. If you do not
wish to be included in a photograph please let the respective
photographer know.
8
POSTER SESSIONS
Thursday, June 6 and Friday, June 7 at Terminal 1
Exhibition Area (13:45 – 14:30)
Highlighted Poster Sessions are again part of ESGAR 2019.
Electronic posters were selected by the ESGAR Programme
Committee based on highest score and topic relevance. Poster
authors have the great opportunity to present their work in a
moderated poster session to an international audience.
POSTGRADUATE COURSE
Wednesday, June 5 at the Auditorium “The Cloud”
A tour around abdominal emergencies
At ESGAR 2019, a Postgraduate Course named ”A tour around
abdominal emergencies“ is offered on the first day of the
meeting. Following an introductory lecture on imaging strategies
in the emergency room, the following three sessions cover the
most and the least common diagnoses in patients presenting
with acute abdomen. The course ends with a multidisciplinary
case-based discussion session involving a diagnostic radiologist,
an interventional radiologist and an abdominal surgeon.
PREVIEW CENTRE
Entrance Level
Speakers are reminded to check in no later than 90 minutes
before the beginning of their session. For ESGAR Tutorials taking
place in the early morning please check in the day before. Only
data projection is provided for oral presentations. Presentations
must be prepared using PowerPoint for PC. Speakers must
deliver their presentation to the Preview Centre on a USB memory
stick (ZIP disks are not accepted). The size of one presentation
should not exceed 500 MB. Presenters have the opportunity to
test their presentations directly in the Preview Centre which is
strongly recommended. Due to space and time limits it is not
possible to prepare and rehearse your complete presentation.
Opening hours:
Wednesday, June 5 07:30 – 18:30
Thursday, June 6 07:30 – 18:00
Friday, June 7 07:30 – 18:00
Saturday, June 8 07:30 – 16:30
REGISTRATION
Entrance Level Foyer
Opening hours:
Tuesday, June 4 15:00 – 18:00
Wednesday, June 5 07:30 – 18:30
Thursday, June 6 07:30 – 18:00
Friday, June 7 07:30 – 18:00
Saturday, June 8 07:30 – 16:30
Onsite Fees:
ESGAR Faculty Member € 490.00
ESGAR Member € 790.00
Non Member € 990.00
Resident* (ESGAR Member) € 450.00
Resident* (Non Member) € 550.00
Radiographer/Technician/Nurse (Member) € 450.00
Radiographer/Technician/Nurse (Non Member) € 550.00
Medical student** € 90.00
* Residents and radiographers must provide a letter from their head
of department confirming their status as a resident or radiographer to
register for this fee. The age limit for registrations as resident is 35 (incl.
the age of 35).
** Medical students under the age of 30 without academic title can
register for this fee. Please provide a student proof (student ID or letter of
university).
The registration fee includes:
• Admittance to all sessions, electronic poster exhibition,
technical exhibition
• Final Programme (in print) and Book of Abstracts (electronic
version)
• Certificate of Attendance
• Access to the ESGAR e-Education Portal after the congress
All prices are listed in Euro (€). Please contact your local tax
authority for refund options. The “ESGAR Member” registration
fee is only applicable for members in good standing – the
membership fee for 2019 has to be settled. Onsite membership
applications cannot be accepted.
Registration fees may be paid in cash in Euro (€) or by credit card
(VISA or MasterCard).
RESEARCH CENTRE – MEET THE PROFESSOR
Thursday, June 6 in Room Capri (13:00 – 13:45)
Have you begun your academic career and want to know how to
advance to become a leader in research? It is much more than
publishing papers, grant funding etc. In this session, which was
successfully introduced at ESGAR 2018, participants have the
opportunity to interact with a professor and obtain advice in how
to start and manage a research team, how to build an academic
career and advance towards seniority in research leadership.
SCHOOL OF ESGAR
Scientific Coordinator: M.A. Bali, Brussels/BE
Thursday, June 6 – Saturday, June 8, 2019 in Room Capri
This educational pathway within the Annual ESGAR Meeting
includes the most important topics of abdominal radiology
following the chapters of the European Training Curriculum and
the corresponding learning objectives. This pathway covers the
most fundamental and important technical aspects of abdominal
imaging including standard and innovative acquisition protocol/
strategies for ultrasound, CT and MR and the common and less
common diseases. The intention is for the attendees to participate
in all the workshops offered within this educational line.
SCIENTIFIC SESSIONS
Thursday, June 6 – Saturday, June 8 (11:00 – 12:30)
Researchers present original papers on new and original aspects
of abdominal imaging and intervention. Selected papers are
gathered into sessions, each dealing with a homogenous topic.
Time for discussion between researchers and attendees is
available after each presentation.
SMOKING
Smoking is not permitted inside the conference venue.
SOCIAL MEDIA
The official congress hashtag for Twitter and Facebook is
#esgar2019.
9
INFORMATION FROM A – Z
TECHNICAL EXHIBITION
Exhibition Area (Entrance Level)
For a complete list of exhibitors and a floorplan of the exhibition
area, please refer to pages 90 – 91.
Opening hours:
Wednesday, June 5 09:30 – 18:00
Thursday, June 6 09:30 – 17:00
Friday, June 7 09:30 – 17:00
Saturday, June 8 09:30 – 15:30
TOURIST INFORMATION DESK
At ESGAR 2019, we’re offering an information and travel desk
(Entrance Level Foyer). Here you can get information on the city
of Rome, recommendations for shopping as well as restaurants
and the best places to have a drink.
TRICKY CASES FROM MY DAY JOB
Coordinator: M. Laniado, Dresden/DE
Thursday, June 6 and Friday, June 7 (12:45 – 13:30)
Exhibition Area – US Village
A session format that involves brief case presentations
and discussion of challenging cases from everyday clinical
practice. Both sessions are held in the 45 minute time period
between the lunch symposium and the start of the afternoon
sessions. At each of the two sessions, a number of short
challenging cases is presented and interactive case discussion
encouraged. Both sessions will be held in the theatre of the
Ultrasound Village in the Exhibition Area.
10
ULTRASOUND VILLAGE
At ESGAR 2019, the modality of ultrasound is one of the
highlighted topics. Throughout the meeting, sessions, tutorials
and keynote lectures cover basic technical aspects of ultrasound
as well as innovations and new techniques such as elastography,
fusion imaging and 3D.
In addition, in the “Ultrasound Village”, several exhibitors and
expert tutors will offer live demonstrations on models as
well as the opportunity for hands-on training. The organised
demonstrations and hands-on trainings that take place at the
exhibitors’ booths are preceded by a keynote lectures in the
theatre installed in front of the “Ultrasound Village”.
VOTING
In order to increase the interactivity between the speakers
and the audience, voting is available for several sessions
during the congress. If it is available for a specific session it is
announced by the speakers and can be accessed via the
official ESGAR 2019 App as well as the ESGAR website
(www.esgar.org/voting2019). The respective link is also
included in the presentations of the speakers.
ABSTRACT REVIEWING PANEL
O. Akhan, Ankara/TR
C. Aubé, Angers/FR
M.A. Bali, Brussels/BE
I. Bargellini, Pisa/IT
T.V. Bartolotta, Palermo/IT
A. Ba-Ssalamah, Vienna/AT
R.G.H. Beets-Tan, Amsterdam/NL
E. Biscaldi, Genoa/IT
A. Blachar, Tel Aviv/IL
G. Brancatelli, Palermo/IT
D.J. Breen, Southampton/UK
F. Caseiro Alves, Coimbra/PT
N. Courcoutsakis, Alexandroupolis/GR
L. Crocetti, Pisa/IT
L. Curvo-Semedo, Coimbra/PT
R.F. Dondelinger, Liège/BE
M. D’Onofrio, Verona/IT
H. Fenlon, Dublin/IE
A.H. Freeman, Cambridge/UK
A. Furlan, Pittsburgh, PA/US
Y. Gandon, Rennes/FR
M.J. Gollub, New York, NY/US
S. Gourtsoyianni, Athens/GR
S. Gryspeerdt, Roeselare/BE
L. Guimaraes, North York, ON/CA
J.A. Guthrie, Leeds/UK
S. Halligan, London/UK
A. Hatzidakis, Heraklion/GR
T. Helmberger, Munich/DE
P. Huppert, Darmstadt/DE
F. Iafrate, Rome/IT
S. Jackson, Plymouth/UK
M. Karcaaltincaba, Ankara/TR
N. Kartalis, Stockholm/SE
A. Laghi, Rome/IT
D. Lambregts, Amsterdam/NL
M. Laniado, Dresden/DE
J.M. Lee, Seoul/KR
P. Lefere, Roselare/BE
M. Lewin, Villejuif/FR
O. Lucidarme, Paris/FR
M. Maas, Amsterdam/NL
A. Madureira, Porto/PT
M. Maher, Cork/IE
D.E. Malone, Dublin/IE
T. Mang, Vienna/AT
V. Maniatis, Sønderborg/DK
D. Marin, Durham, NC/US
L. Martí-Bonmatí, Valencia/ES
C. Matos, Lisbon/PT
Y. Menu, Paris/FR
G. Morana, Treviso/IT
G.H. Mostbeck, Vienna/AT
E. Neri, Pisa/IT
A. Palkó, Szeged/HU
P. Paolantonio, Rome/IT
N. Papanikolaou, Lisbon/PT
R. Pozzi Mucelli, Verona/IT
P. Prassopoulos, Thessaloniki/GR
E. Quaia, Padua/IT
G.A. Rollandi, Genoa/IT
S. Romano, Pozzuoli/IT
M. Ronot, Clichy/FR
L.H. Ros Mendoza, Zaragoza/ES
W. Schima, Vienna/AT
S. Schmidt Kobbe, Lausanne/CH
A.G. Schreyer, Regensburg/DE
O. Seror, Bondy/FR
S. Skehan, Dublin/IE
S. Somers, Dundas, ON/CA
M. Staunton, Cork/IE
S. Stojanovic, Novi Sad/RS
J. Stoker, Amsterdam/NL
J.-P. Tasu, Poitiers/FR
S.A. Taylor, London/UK
S. Terraz, Geneva/CH
D. Tolan, Leeds/UK
C. Triantopoulou, Athens/GR
V. Valek, Brno/CZ
V. Vilgrain, Clichy/FR
M.-P. Vullierme, Clichy/FR
D. Weishaupt, Zurich/CH
G.A. Zamboni, Verona/IT
C.J. Zech, Basel/CH
M. Zins, Paris/FR
11
POSTER JURY
O. Akhan, Ankara/TR
C. Aubé, Angers/FR
I. Bargellini, Pisa/IT
T.V. Bartolotta, Palermo/IT
A. Ba-Ssalamah, Vienna/AT
R.G.H. Beets-Tan, Amsterdam/NL
E. Biscaldi, Genoa/IT
A. Blachar, Tel Aviv/IL
G. Brancatelli, Palermo/IT
D.J. Breen, Southampton/UK
F. Caseiro Alves, Coimbra/PT
N. Courcoutsakis, Alexandroupolis/GR
L. Crocetti, Pisa/IT
L. Curvo-Semedo, Coimbra/PT
R.F. Dondelinger, Liège/BE
M. D’Onofrio, Verona/IT
H. Fenlon, Dublin/IE
A.H. Freeman, Cambridge/UK
A. Furlan, Pittsburgh, PA/US
Y. Gandon, Rennes/FR
M.J. Gollub, New York, NY/US
S. Gourtsoyianni, Athens/GR
S. Gryspeerdt, Roeselare/BE
L. Guimaraes, North York, ON/CA
J.A. Guthrie, Leeds/UK
S. Halligan, London/UK
A. Hatzidakis, Heraklion/GR
T. Helmberger, Munich/DE
P. Huppert, Darmstadt/DE
12
F. Iafrate, Rome/IT
S. Jackson, Plymouth/UK
M. Karcaaltincaba, Ankara/TR
N. Kartalis, Stockholm/SE
A. Laghi, Rome/IT
D. Lambregts, Amsterdam/NL
M. Laniado, Dresden/DE
J.M. Lee, Seoul/KR
P. Lefere, Roselare/BE
M. Lewin, Villejuif/FR
O. Lucidarme, Paris/FR
A. Madureira, Porto/PT
M. Maher, Cork/IE
D.E. Malone, Dublin/IE
T. Mang, Vienna/AT
V. Maniatis, Sønderborg/DK
D. Marin, Durham, NC/US
L. Martí-Bonmatí, Valencia/ES
C. Matos, Lisbon/PT
Y. Menu, Paris/FR
G. Morana, Treviso/IT
G.H. Mostbeck, Vienna/AT
E. Neri, Pisa/IT
A. Palkó, Szeged/HU
P. Paolantonio, Rome/IT
N. Papanikolaou, Lisbon/PT
R. Pozzi Mucelli, Verona/IT
P. Prassopoulos, Thessaloniki/GR
E. Quaia, Padua/IT
G.A. Rollandi, Genoa/IT
S. Romano, Pozzuoli/IT
M. Ronot, Clichy/FR
L.H. Ros Mendoza, Zaragoza/ES
W. Schima, Vienna/AT
S. Schmidt Kobbe, Lausanne/CH
A.G. Schreyer, Regensburg/DE
O. Seror, Bondy/FR
S. Skehan, Dublin/IE
S. Somers, Dundas, ON/CA
M. Staunton, Cork/IE
S. Stojanovic, Novi Sad/RS
J. Stoker, Amsterdam/NL
J.-P. Tasu, Poitiers/FR
S.A. Taylor, London/UK
S. Terraz, Geneva/CH
D. Tolan, Leeds/UK
C. Triantopoulou, Athens/GR
V. Valek, Brno/CZ
V. Vilgrain, Clichy/FR
M.-P. Vullierme, Clichy/FR
D. Weishaupt, Zurich/CH
G.A. Zamboni, Verona/IT
C.J. Zech, Basel/CH
M. Zins, Paris/FR
WELCOME
Dear ESGAR members, dear friends,
It is a great pleasure and honour for me to be able to welcome
you as ESGAR President to our 30th Annual Meeting and
Postgraduate Course, here in Rome, Italy. Once more, the
Programme Planning Committee, under the expert Chairmanship
of Marc Zins, has put together a raft of interesting, irresistible and
compelling topics all vying for your considered attention. Deciding
what to see and what to miss is going to be a real problem but
remember that registered participants can catch up online later at
www.esgar.org, so you won’t miss out.
My first ever ESGAR was an Italian meeting (well, Sicilian…) back
in 1994; Taormina. I remember it as if it were yesterday, not least
because it was my first ever presentation to an international
audience. I enjoyed myself thoroughly, was made to feel very
welcome, and knew at once that ESGAR was the premier meeting
for gastrointestinal and abdominal radiologists. We visited Italy
again for Florence 2005 and Venice 2011. The heady mix of
Italian culture, good weather, good food, and good radiology
always ensures a very successful meeting, attracting record
numbers of delegates. I have no reason to expect that Rome will
be any different. While in Taormina the meeting occupied a swish
hotel, our current success demands that we occupy a large,
modern conference centre, such as “The Cloud”.
Big conferences mean big planning: Your Meeting President,
Prof. Andrea Laghi, helped by the ESGAR administration (headed
by Brigitte Lindlbauer) and her local organising committee, has
worked quite literally for years to bring this meeting to fruition
in the midst of a difficult economic climate. I know their (and
our) reward will be yet another hugely successful four days of
education and scientific debate.
A meeting as large as the ESGAR cannot proceed without help
from multiple different directions. We’d all like to thank our
corporate members for their support and valuable contribution
in these troubled times. There’d be no meeting if there was no
Faculty so “thank you!” to those who have managed to find the
time (and money!) to come and help out in Rome; your teaching
and contribution is very much appreciated. Many have travelled
very long distances to get here to participate in a meeting far
from home. I know that our attendees appreciate your efforts
tremendously. A special thanks also goes out to our partner
societies represented in official sessions (ASAR, SAR, ECCO and
ESUR) as well as all others represented by attendees from inside
and outside of Europe.
Ultimately, I’d also like to thank all of the “ordinary” members
and non-members who found the time to submit abstracts and/
or who have come and registered for this 2019 ESGAR Annual
Meeting in Rome. In this troubled era, there are so many other
pressures and demands on our time; medical education is too
often pushed aside for other tasks and duties. Despite this, the
ESGAR continues to flourish thanks to your unstinting support.
I know you will all have a fantastic time in Rome and will make
memories and friends that will last a lifetime.
Best wishes,
Steve Halligan
ESGAR President
13
WELCOME
Dear ESGAR Delegates,
I am very honoured and glad to welcome you to Rome for the
30th ESGAR Annual Meeting and Postgraduate Course. A
combination of events will make the participation to this congress
a unique occasion: this is the 30th anniversary of our Society, this
is the first time that the ESGAR Annual Meeting is hosted in Rome
and, last but not least, early June is one of the best months of the
year to visit our city.
Rome, “the eternal city”, needs no introduction. Rome is an
open-air museum, where you can come across a Roman ruin, a
Renaissance church or a Baroque palace at every corner. When
walking from the Palatine hill, the Colosseum and the Roman
Forum to the Vatican City you can travel through two thousand
years of history within only a few minutes. But Rome offers not
only antiquities: restaurants proposing Italian and regional Roman
cuisine, shopping for all budgets, relaxing walks in the numerous
city parks and much more.
The ESGAR Annual Meeting has grown enormously since its
first edition in 1990 and it is today the reference congress for
abdominal radiology in Europe. The reasons for its success are
to be found in the special flavour of the meeting, a combination
of education and science, innovation and clinical practice,
experience of the old masters and exuberance of the young
speakers. The Annual Meeting has always been an opportunity for
society members to meet old colleagues and friends, exchange
14
opinions and keep abreast of the latest advances in abdominal
imaging. For occasional attendees, it offers the opportunity to
have a 4-day full immersion in abdominal radiology experiencing
different learning modalities in a friendly atmosphere. For the
young radiologists, the meeting represents the occasion to get
together and create a network of relationships that is increasingly
indispensable for the profession of the future. For the industry, it
is a showcase in front of which about two thousand participants
will stop.
The Congress will be hosted in a new Convention Centre,
“The Cloud”, inaugurated in 2016. Designed by the renowned
award-winning architect Massimiliano Fuksas, the complex
follows the simple orthogonal lines of the surrounding 1930s
rationalist architecture. “The Cloud” comprises two distinct
architectural concepts: “The Theca” and “The Cloud”. “The
Theca” is the stunning glass and metal outer shell and façade
of the Convention Centre. Suspended inside is “The Cloud”, an
independent cocoon-like structure, covered with a high-tech
fiberglass membrane, in which an auditorium with the capacity of
1800 participants can be found. The Convention Centre is located
in the south of the city’s downtown, in the business district of
EUR. The venue is a mere 15-minute underground journey from
Rome’s city centre with its many hotels, restaurants and visitor
attractions and a 20-minute taxi ride from the airport.
For the 2019 edition, the Programme Planning Committee for any further specific need. Sincere thanks also go to the
has put together another excellent programme. Abdominal ESGAR President, Prof. Steve Halligan, to the Programme
emergencies will be the leading theme of the Postgraduate Committee Chair, Dr. Marc Zins, to the ESGAR Board and to the
Course, largely based on case discussions that should attract ESGAR Office team, headed by Brigitte Lindlbauer. Without their
the attention of the participants. A multidisciplinary session, support, advices and tireless work, the meeting could not have
involving a diagnostic radiologist, an interventional radiologist and been organised, due to the challenges offered by a fantastic, yet
a surgeon discussing real-life cases from the emergency room, chaotic city given its southern being.
will conclude the course. Apart from the usual and successful
range of educational activities, including Lecture Sessions, I really do hope that Rome 2019 will be another successful story
ESGAR Tutorials (formerly “workshops”), the School of ESGAR for our society and on behalf of the entire ESGAR team, I am glad
series, the Nick Gourtsoyiannis’ Foundation Course focused on to welcome you to the eternal city!
rad-path correlations and the sessions dedicated to abdominal
interventional radiology, let me draw your attention to a new
initiative available for the first time in Rome: the “Ultrasound
Village”. This is a special space, located inside the Exhibition Area,
where the attendees will find US scanners available for live demos
guided by medical tutors and a theatre where brief lectures on Prof. Andrea Laghi
cutting-edge US technology will be presented by international Meeting President
experts. Last but not least, on the last day, our Annual Meeting
will host an Italian one-day session, under the patronage of the
SIRM sub-specialty group in gastrointestinal imaging, entitled “A
window to Italian Gastrointestinal Radiology”.

I would like to express my personal gratitude to the Local

Organising Committee, which has worked hard to make this
congress successful and which is available during the congress

15
HONORARY FELLOW
MICHAEL LANIADO
DRESDEN/DE
Michael Laniado received his high school diploma in 1971 and
obtained his medical degree from Freie Universität Berlin in 1981.
For the following two years, he was a research fellow at the
Department of Physiology at Freie Universität Berlin.
Initially interested in Cardiovascular Physiology, Michael Laniado
started to look for a more experimental experience and became a
research fellow and later resident at the Department of Radiology
at Klinikum Charlottenburg in Berlin. There he also met Claus
Claussen with whom he later moved to Eberhard-Karls-Universität
in Tübingen to continue his residency at the Departments of
Diagnostic Radiology, of Radiotherapy, and of Nuclear Medicine.
In 1993, Michael Laniado became Associate Professor in
Radiology at Eberhard-Karls-Universität Tübingen where he was
also employed as staff radiologist until 1995 and appointed
Deputy Chairman hereafter.
In 2000, Michael Laniado obtained a full Professorship at
Technische Universität Dresden and became Chairman of the
Department of Diagnostic Radiology of the Dresden University
Hospital Carl Gustav Carus. He held the post for the following 18
years before retiring in 2018.
Michael Laniado’s areas of expertise include the upper GI tract,
small bowel, liver, and colorectal imaging with MR and CT. He
has published extensively with 157 scientific papers, 62 book
chapters, 226 scientific presentations as well as 134 scientific
abstracts. Michael Laniado has given more than 240 invited
lectures at national and international meetings in the field.
He received the Editor’s Recognition Award for Special Distinction
in Reviewing from “Radiology” in 1993, 1994 and 2002, and was
awarded the Kernspintomographiepreis in 1997.
In 2010 Michael Laniado received the Honorary Membership of
16
the Österreichische Röntgengesellschaft (ÖRG) and the Polish
Medical Society of Radiology. He is Honorary Member of the
Schweizer Gesellschaft für Radiologie (SGR/SSR) since 2011
and Honorary Member of the Deutsche Röntgengesellschaft
since 2017.
Michael Laniado joined ESGAR in 1997 and became fellow of the
Society in 2002. He entered the ESGAR Executive Committee as
Education Committee Chair – a position he filled for four years.
In 2007, Dresden was officially approved as the venue for the
ESGAR 2010 congress and Michael Laniado was elected Meeting
President of the 21st ESGAR Annual Meeting.
Furthermore, Michael Laniado was a member of the Education
Committee of the European Society of Radiology (ESR) from
2006 – 2009. He was represented on the board of the Deutsche
Röntgengesellschaft (DRG) from 2005 until 2011 and served as
the DRG President from 2007 – 2009. Michael Laniado has been
a reviewer for numerous international publications including
Radiology, European Radiology, Urologia internationalis (since
2004) and Insights into Imaging (since 2019). He was represented
on the Editorial Board of Radiology and on the Scientific Editorial
Board of European Radiology. Since 2010, Michael Laniado is on
the Editorial Board of the Polish Journal of Radiology.
In recognition of his outstanding contribution to gastrointestinal
and abdominal radiology and to ESGAR, Michael Laniado is
awarded the Honorary Fellowship of the European Society of
Gastrointestinal and Abdominal Radiology.
HONORARY FELLOW
JUDY YEE
NEW YORK, NY/US
After finishing the Bronx High School of Science in 1979, Judy
Yee attended Barnard College at Columbia University, where she
graduated in 1983 with a B.A. degree with a major in Biology. In
1987, she received her medical degree from the Albert Einstein
College of Medicine, New York. She then completed an internship
in Paediatrics at Mount Sinai Hospital, New York before returning
to Albert Einstein College of Medicine as a radiology resident
from 1988 to 1992. At the University of California, San Francisco
(UCSF) Medical Center, Judy Yee performed an abdominal
imaging fellowship, before joining the UCSF Faculty in 1993.
Judy Yee was Assistant Professor at the University of California,
San Francisco (UCSF) and Chief of CT and Gastrointestinal
Radiology at the San Francisco VA Medical Center (VAMC)
from 1993 – 2001. In 2006, Judy Yee was appointed Professor
of Radiology at UCSF. She also served as Vice Chair of this
Department from 2003 – 2017. Furthermore, Judy Yee was Chief
of Radiology at the San Francisco VAMC, as well as Director of
UCSF’s 3D Imaging Laboratory.
In 2017, Judy Yee was named Professor and University Chair of
the Department of Radiology at Montefiore Health System and
Albert Einstein College of Medicine and returned to New York. She
also serves as President of Gunhill Advanced Medical Imaging
Center in New York.
Judy Yee’s areas of expertise range from CT Colonography,
to bowel, liver, and pancreatic imaging using CT and MR. Her
research mainly focuses on colorectal cancer screening and
early detection. Judy Yee is the editor and primary author of
“Virtual Colonoscopy” which is one of the main textbooks on the
topic. With more than 130 articles in peer-reviewed scientific
journals, 23 book chapters and another 120 abstracts, Judy
Yee has published extensively on techniques for innovative
liver, pancreatic, and GI tract imaging. She has also served as
the principal investigator for many funded research projects. In
recognition of her expertise, Judy Yee has been an invited speaker
at numerous national and international conferences. She also
holds a patent on Enhanced Virtual Colonoscopy.
She is the recipient of numerous awards including the Excellence
in Teaching Award from the Academy of Medical Educators,
the Best Speaker Award from the American Roentgen Ray
Society, the Visiting Professorship Award from the Society of
Gastrointestinal Radiologists, as well as the Inaugural 2015 UCSF
Outstanding Faculty Mentoring Award.
Judy Yee served on the Board of the Society of Abdominal
Radiology (SAR) and was the President of SAR from
2015 – 2016. She currently serves as Chair of the American
College of Radiology Colon Cancer Committee and Chair of
its Gastrointestinal Refresher Course Programme. Judy Yee
is the past chair of the Radiologic Society of North America’s
(RSNA) Information Committee. She is Co-Chair of the Diversity
and Inclusion Committee for the New York State Radiologic
Society and a member of the ACR Commission on Diversity and
Inclusion.
Judy Yee serves on the Editorial Boards of “RadioGraphics”,
“Abdominal Radiology”, and “Journal of Computed Tomography”,
and was represented on the Editorial Boards of both “Radiology”
and “AJR”.
Judy Yee became an ESGAR member in 2007 and gave the SGR
Honorary Lecture on “CT Colonography: Lessons Learned” on the
occasion of ESGAR 2008 in Istanbul, Turkey.
In recognition of her outstanding contribution to gastrointestinal
and abdominal radiology, Judy Yee is awarded the Honorary
Fellowship of the European Society of Gastrointestinal and
Abdominal Radiology. We are proud to note that she is the first
woman to receive this award.
17
18
PROGRAMME

Please note that sessions are marked with a logo to indicate their classification
according to the European Training Curriculum.

#LVL
First three years of training
I

#LVL Fourth and fifth year of training

II (general radiologist standard)

#LVL
Subspecialty training standard
III
The European Training Curriculum has been published by the ESR, the European Society of Radiology
and can be found on the ESR website www.myESR.org under ”Education“. This document is fully
supported by ESGAR. The classification of ESGAR 2019 sessions according to training levels simply
indicates that the session includes content of a certain training level according to the European
Training Curriculum. All sessions, regardless of the indicated level are open for all participants and
equally recommended whether the participant is in training, a board certified radiologist or sub
specialist.

19
 GRAND OPENING & CONCERT

GRAND OPENING & CONCERT

WEDNESDAY, JUNE 5
17:45 – 19:15
Auditorium “The Cloud”

17:45 Musical Opening MuSa Classica Orchestra
Conductor: F. Vizioli
From “Cavalleria Rusticana”
Pietro Mascagni (1863 – 1945)
17:50 Welcome Addresses
S. Halligan, London/UK (ESGAR President)
A. Laghi, Rome/IT (ESGAR 2019 Meeting President)
R. Grassi, Naples/IT (SIRM President)
E. Gaudio, Rome/IT (Magnifico Rettore Sapienza)
18:05 European Radiology Awards
18:30 Musical Interlude MuSa Classica Orchestra
From “Don Pasquale”
Gaetano Donizetti (1797 – 1848)
18:35 Opening Lecture
From TME to TMI: How Multidisciplinarity and Imaging
Revolutionised the Management of Rectal Cancer,
B. Heald, Basingstoke/UK
18:55 Concert MuSa Classica Orchestra
From “Carmen”
Georges Bizet (1838 – 1875)

18:15 Honorary Fellowship Awards

M. Laniado, Dresden/DE
J. Yee, New York, NY/US
 WEDNESDAY,
WEDNESDAY,JUNE
JUNE5,5,2019
2019

AUDITORIUM
AUDITORIUM
“THE
“THE
CLOUD”
CLOUD” PISA
PISA AMALFI
AMALFI

08:00–08:30
08:00–08:30

08:30–09:00
08:30–09:00
A tour
A tour
around
around
abdominal
abdominal
emergencies
emergencies
09:00–09:30
09:00–09:30 PGPG1 1
Imaging
Imaging
strategies
strategies
andand
thethe
most
most
common
common
diagnoses
diagnoses
09:30–10:00
09:30–10:00

10:00–10:30
10:00–10:30

10:30–11:00
10:30–11:00

A tour around
A tour abdominal
around emergencies
abdominal emergencies
11:00–11:30
11:00–11:30
PGPG2 2
What else
What to expect?
else to expect?
11:30–12:00
11:30–12:00

12:00–12:30
12:00–12:30

12:30–13:00
12:30–13:00

13:00–13:30
13:00–13:30
SYSY
1 1 SYSY
2 2
Lunch
Lunch
Symposium
Symposium Lunch
Lunch
Symposium
Symposium
13:30–14:00
13:30–14:00

HLHL
1 1
14:00–14:30
14:00–14:30
ESGAR
ESGAR

14:30–15:00
14:30–15:00
A tour
A tour
around
around
abdominal
abdominal
emergencies
emergencies

15:00–15:30
15:00–15:30 PGPG
3 3
... and do not forget …
... and do not forget …

15:30–16:00
15:30–16:00

16:00–16:30
16:00–16:30

A tour
A tour
around
around
abdominal
abdominal
emergencies
emergencies
16:30–17:00
16:30–17:00
PGPG4 4
In the
In the
emergency
emergency
room
room
– a–multidisciplinary
a multidisciplinary
round
round
table
table
17:00–17:30
17:00–17:30
discussion
discussion

17:30–18:00
17:30–18:00

18:00–18:30
18:00–18:30
PSPS
1 1
Opening
Opening
of ESGAR
of ESGAR
2019
2019
18:30–19:00
18:30–19:00

19:00–19:30
19:00–19:30

Welcome
Welcome
Reception
Reception
19:30–20:00
19:30–20:00
 THURSDAY, JUNE 6, 2019

MEETING
MEETING MEETING
MEETING ULTRASOUND
ULTRASOUND POSTER
POSTER
AREA/
AREA/
FLORENCE
FLORENCE PISA
PISA BOLOGNA
BOLOGNA AMALFI
AMALFI CAPRI
CAPRI MILAN
MILAN
ROOM
ROOM4 4 ROOM
ROOM5 5 VILLAGE
VILLAGE TERMINALS
TERMINALS

08:00–08:30
08:00–08:30 ET ET
1 1 ET ET
2 2 ET ET
3 3 ET ET
4 4 ET ET
5 5
Abdominal
Abdominal Acute
Acute Cirrhotic
Cirrhotic
liver
liver Mesenteric
Mesenteric CTC:
CTC:
howhowI I
emergencies
emergencies pancreatitis
pancreatitis panniculitis
panniculitis do do
it it
08:30–09:00
08:30–09:00

09:00–09:30
09:00–09:30 ET ET
6 6 ET ET
7 7
Large
Large
bowel
bowel Bariatric
Bariatric
LS LS1 1 LS LS
2 2 obstruction
obstruction IGTIGT
1 1 SOESOE
1 1 surgery
surgery
09:30–10:00
09:30–10:00 Artificial
Artifi
Artificial
cial Oncology
Oncology Portal
Portal Abdominal
Abdominal
intelligence
intelligence hypertension
hypertension Ultrasound
Ultrasound

10:00–10:30
10:00–10:30 ET ET
8 8 ET ET
9 9
Gallbladder
Gallbladder IronIron
andandfat fat
cases
cases in the
in the
liver
liver
USV USV
1 1
10:30–11:00
10:30–11:00
Keynote
Keynote
Lectures
Lectures

11:00–11:30
11:00–11:30 SSSS
2 2 SSSS 5 5
SSSS1 1 SSSS4 4
Rectal
Rectal SSSS
3 3 Liver
Liver
Diffuse
Diffuse
liver
liver TheThe
acute
acute SOESOE2 2
cancer:
cancer: Advances
Advancesin in interventional
interventional USV 2 2
USV
diseases:
diseases: abdomen:
abdomen: Imaging
Imaging
11:30–12:00
11:30–12:00 diagnosis
diagnosis abdominal
abdominal radiology
radiologyandand Hands-on
Hands-on
assessing
assessing diagnosis
diagnosis upper
upper
GI GI
andand
imaging
imaging oncologic
oncologic assessment
assessment Training
Training
fi brosis and
fibrosis and
fibrosis and andand tract
tract
of treatment
of treatment imaging
imaging of treatment
of treatment
12:00–12:30
12:00–12:30
steatosis
steatosis intervention
intervention
response
response response
response

12:30–13:00
12:30–13:00

SYSY
3 3 SYSY
4 4 TCTC1 1
13:00–13:30
13:00–13:30 Lunch
Lunch Lunch
Lunch RCRC IWS
IWS
1 1 Tricky
Tricky
Cases
Cases
Symposium
Symposium Symposium
Symposium Meet
Meet
thethe Interv.
Interv.
Professor
Professor Hands-on
Hands-on
13:30–14:00
13:30–14:00 WSWS

POPO1 1
USV USV
3 3 Poster
Poster
Session
Session
14:00–14:30
14:00–14:30 ISWS
ISWS
1 1
Keynote
Keynote Lectures
Lectures
Industry
Industry
ET ET
10 10 ET ET12 12 Satellite
Satellite
14:30–15:00
14:30–15:00 ET ET
11 11
Richard
Richard Technical Workshop
Technical Workshop
CTCT
andand
MRMR SOE SOE
3 3
Baron
Baron aspects
aspectsof of
enterography
enterography Peritnoeum
Peritnoeum USVUSV
4 4
LS LS
3 3 LS LS
4 4 Tutorial
Tutorial CEUSCEUS
15:00–15:30
15:00–15:30 andand Hands-on
Hands-on
BileBile
ducts
ducts GEP-NET
GEP-NET
abdominal
abdominal Training
Training
wall
wall
15:30–16:00
15:30–16:00 ET ET
13 13 ET ET
14 14 ET ET15 15
Chemo- Anal
Chemo- Anal
cancer
cancer Child
Child
with
with
embolisation
embolisation liver
liver
mass
mass
16:00–16:30
16:00–16:30

HLHL
2 2
16:30–17:00
16:30–17:00
ASAR
ASAR

17:00–17:30
17:00–17:30 PSPS 2 2
One
Onecasecase
– three
– three
17:30–18:00
17:30–18:00 lessons
lessons
 FRIDAY, JUNE 7, 2019

MEETING MEETING ULTRASOUND POSTER AREA/

FLORENCE PISA BOLOGNA AMALFI CAPRI MILAN
ROOM 4 ROOM 5 VILLAGE TERMINALS

ET 19
08:00–08:30 ET 16 ET 17 ET 18 ET 20
Benign liver
Cholangio- Perianal Pancreatic CTC pitfalls
lesions
carcinoma fi stulas lesions
(CEUS)
08:30–09:00

09:00–09:30 ET 21 ET 22
Targeted SOE 4 AI (robotics)
LS 6 therapy IGT 2 Abdominal
LS 5
09:30–10:00 Rectal Biliary inter- imaging
HCC
cancer ventions protocols
(CT, MR)
10:00–10:30 ET 23 ET 24
Peritoneal Pancreatic
malignancies cancer
10:30–11:00 USV 5
Keynote Lectures

SS 7
11:00–11:30
Machine SS 10
learning SS 9 Modern
SS 6 SS 8 Colorectal USV 6
and SOE 5 imaging
11:30–12:00 Diagnosis Pancreatic diseases: CT IWS 2 Hands-on
radiomics Pancreas of gastro-
of HCC neoplasms colonography Interv. Training
in pancreatic
and beyond Hands-on
12:00–12:30
abdominal diseases WS
imaging

12:30–13:00

SY 5 SY 6 TC 2
13:00–13:30 Lunch Lunch ET 25 Tricky Cases
Symposium Symposium CTC: polyp /
cancer cases
13:30–14:00

PO 2
14:00–14:30 ISWS 2 USV 7 Poster Session
Industry Keynote Lectures
Satellite
14:30–15:00 ET 27 Workshop
ET 26
Liver tumour
LS 7 LS 8 Spectral CT
ES SOE 6 ablation USV 8
Cystic IBD-CD
15:00–15:30 Editorial Benign liver Hands-on
pancreatic
Session disease Training
neoplasms
15:30–16:00 ET 28 ET 29
Malignant liver CTC Diffi
cult
lesions (CEUS) cases
16:00–16:30

HL 3
16:30–17:00
SAR

17:00–17:30
PS 3
Clinical
Files
17:30–18:00

18:00–18:30
ESGAR
General
Assembly
18:30–19:00
 SATURDAY, JUNE 8, 2019

ULTRASOUND
FLORENCE PISA BOLOGNA AMALFI CAPRI MILAN
VILLAGE

08:00–08:30 ET 30 ET 31 ET 32 ET 33 ET 34
Liver locoregional LIRADS Pancreas / small Hybrid imaging Thickened bowel
therapy bowel (CEUS) wall
08:30–09:00

09:00–09:30 ET 35
Small bowel
LS 9 LS 10 tumour IGT 3 SOE 7 SIRM
09:30–10:00 CTC A tour around the Liver colorectal lgG4-related Residents
-RADS cancer diseases meeting

10:00–10:30 ET 36
Rectal cancer

10:30–11:00 USV 9
Keynote Lectures

11:00–11:30
SS 13
SS 11 SS 14
Diffuse liver
GI tract: SS 12 Technical SOE 8 USV 10
diseases: SIRM
11:30–12:00 infl ammatory Advanced MRI in advances in Abdominal Hands-on
fi brosis, cirrhosis Residents
disease and liver imaging abdominal tumours Training
and portal meeting
beyond imaging
12:00–12:30
hypertension

12:30–13:00

SY 7
13:00–13:30 Lunch
Symposium
SIRM
13:30–14:00 Residents
meeting

14:00–14:30

14:30–15:00
PS 4 & 5
Foundation
15:00–15:30 Course

15:30–16:00 SIRM
Residents
meeting
16:00–16:30

16:30–17:00
HONORARY LECTURES
Wednesday, June 5 Friday, June 7
14:00 – 14:30 / ESGAR Honorary Lecture 16: 30 – 17:00 / SAR Honorary Lecture

HL 1 Auditorium HL 3 Florence
Moderators: S. Halligan, London/UK; A. Laghi, Rome/IT Moderator: S. Halligan, London/UK

How to routinely obtain robust MRI quantification of fat GU imaging pitfalls for GI radiologists
and iron in the liver? E.M. Remer, Cleveland, OH/US
Y. Gandon, Rennes/FR

Thursday, June 6
16:30 – 17:00 / ASAR Honorary Lecture

HL 2 Florence
Moderator: S. Halligan, London/UK

Air in the diagnosis of abdominal emergencies

K.-L. Liu, Taipei/TW

PLENARY SESSIONS
Thursday, June 6 Friday, June 7
17:00 – 18:00 17:00 – 18:00

PS 2 Florence PS 3 Florence
One case – three lessons Clinical Files Session: live interpretation of
Moderators: D. Tolan, Leeds/UK; G.H. Mostbeck, Vienna/AT abdominal cases
Panellists: Moderator: V. Vilgrain, Clichy/FR
M.A. Bali, Brussels/BE Panellists:
C. Valls, Stockholm/SE T. Bollen, Nieuwegein/NL
D. Ippolito, Monza/OT A. Corr, London/London/UK
G. Morana, Treviso/IT J. Heverhagen, Bern/CH
D, Burling, Harrow/UK A. Torregrosa Andrés, Valencia/ES
S. Schindera, Aarau/CH
J.-P. Tasu, Pointiers/FR Saturday, June 8
D. Tolan, Leeds/UK 14:00 – 16:15

PS 4 Pisa
Nick Gourtsoyiannis’ Foundation Course 1:
Radiologic-pathologic correlation: liver

PS 5
Nick Gourtsoyiannis’ Foundation Course 2:
Radiologic-pathologic correlation: small bowel
 WEDNESDAY, JUNE 5, 2019
PROGRAMME OVERVIEW – WEDNESDAY, JUNE 5, 2019
AUDITORIUM “THE CLOUD” PISA AMALFI

08:00–08:30

08:30–09:00
A tour around abdominal emergencies
09:00–09:30 PG 1
Imaging strategies and the most common diagnoses
09:30–10:00

10:00–10:30

10:30–11:00

A tour around abdominal emergencies

11:00–11:30
PG 2
What else to expect?
11:30–12:00

12:00–12:30

12:30–13:00

13:00–13:30
SY 1 SY 2
Lunch Symposium Lunch Symposium
13:30–14:00

HL 1
14:00–14:30
ESGAR

14:30–15:00
A tour around abdominal emergencies

15:00–15:30 PG 3
... and do not forget …

15:30–16:00

16:00–16:30

A tour around abdominal emergencies

16:30–17:00
PG 4
In the emergency room – a multidisciplinary round table
17:00–17:30
discussion

17:30–18:00

18:00–18:30
PS 1
Opening of ESGAR 2019
18:30–19:00

19:00–19:30

Welcome Reception
19:30–20:00
 WEDNESDAY, JUNE 5, 2019
MEETING MEETING ULTRASOUND POSTER AREA/
FLORENCE PISA BOLOGNA AMALFI CAPRI MILAN
ROOM 4 ROOM 5 VILLAGE TERMINALS

08:30 – 10:00 / Postgraduate Course 14:00 – 14:30 / Honorary Lecture

08:00–08:30 ET 1 ET 2 ET 3 ET 4 ET 5
Abdominal Acute Cirrhotic liver
Mesenteric CTC: how I
PG 1 emergencies pancreatitis Auditorium HL 1 do it
panniculitis Auditorium
Imaging
08:30–09:00 strategies and the most common #LVL ESGAR Honorary Lecture #LVL
II II
diagnoses Moderators: S. Halligan, London/UK; A. Laghi, Rome/IT
Moderators: S. Halligan, London/UK;ET
09:00–09:30
A. 6Laghi, Rome/IT ET 7
Large bowel How toBariatric
routinely obtain robust MRI quantification of fat and
LS 1 LS 2 obstruction IGT 1 SOE 1 surgery
08:30 
09:30–10:00
Imaging strategies
Artificial Oncology
in the emergency room
Portal Abdominal
iron in the liver?
J. Stoker, Amsterdam/NL
intelligence hypertension Y. Gandon, Rennes/FR
Ultrasound
08:45 Appendicitis ET 8 ET 9
10:00–10:30
Gallbladder
J.B.C.M. Puylaert, The Hague/NL Iron and fat
cases in the liver
09:10 Diverticulitis 14:30 – 15:45 / Postgraduate Course USV 1
10:30–11:00
S. Schmidt Kobbe, Lausanne/CH Keynote Lectures

09:35 Acute bowel obstruction PG 3 Auditorium

11:00–11:30 SS 2 SS 5
I.SSMillet,
1 Montpellier/FR
Rectal SS 3
SS 4 …and do not forget…
Liver
#LVL
Diffuse liver The acute SOE 2 II
cancer: Advances in USV 2
ImagingModerators: C. Stroszczynski, Regensburg/DE;
interventional
diseases: abdomen:
11:30–12:00 diagnosis abdominal radiology and Hands-on
assessing diagnosis upper GIP. D‘Andrea, Belluno/IT
and imaging oncologic assessment Training
fibrosis and and tract
10:45 – 12:00 / Postgraduate
of treatment Course
imaging of treatment
12:00–12:30
steatosis intervention
response 14:30  response
GI tract perforation
PG 2 Auditorium D. Tolan, Leeds/UK
12:30–13:00
What else to expect? 14:55 Acute GI bleeding
#LVL

Moderators: S. Jackson, II
SY Plymouth/UK;
3 SY 4 P. Bize, Lausanne/CH TC 1
13:00–13:30 Lunch Lunch RC Tricky Cases
M. Laniado, Dresden/DE 15:20 Blunt abdominal traumaIWS 1
Symposium Symposium Meet the Interv.
Professor V. Miele, Florence/IT Hands-on
10:45 Acute cholecystitis
13:30–14:00 WS

O. Benjaminov, Kfar Saba/IL PO 1

USV 3 Poster Session
11:10 Acute pancreatitis
14:00–14:30 16:30 – 17:30 / Postgraduate
ISWS 1 CourseKeynote Lectures
Industry
T. Bollen, Nieuwegein/NL
ET 10 ET 12 Satellite
11:35 Acute mesenteric ischemia
14:30–15:00 Richard
ET 11 PG 4 Technical Workshop Auditorium
CT and MR SOE 3 In the
M. Ronot, Clichy/FR Baron
enterography
emergency
aspects of room – a multidisciplinary #LVL

Tutorial Peritnoeum CEUS USV 4 II

and round table discussion
LS 3 LS 4
15:00–15:30 Hands-on
Bile ducts GEP-NET
abdominal Training
Moderators: M. Zins, Paris/FR; F. Pinto, Marcianise/IT
wall
12:15
15:30–16:00 – 13:15 / Lunch SymposiaET 13 ET 14 ET 15
Chemo- Anal cancer Panel:Child with
embolisation liver mass
SY 1
16:00–16:30
Pisa C.J. Zech, Basel/CH
Industry-sponsored Symposium G. Pernazza, Rome/IT
For details
HL please
2 refer to page 75 P. Taourel, Montpellier/FR
16:30–17:00
ASAR

SY 2 Amalfi
17:00–17:30 PS 2
Industry-sponsored
One case Symposium 17:45 – 19:15 / Plenary Session
– three
For details please refer to page 77
17:30–18:00 lessons
PS 1 Auditorium
ESGAR 2019 – Opening Ceremony

27
 THURSDAY,OVERVIEW
PROGRAMME JUNE 6, 2019
– THURSDAY, JUNE 6, 2019
MEETING MEETING ULTRASOUND POSTER AREA/
FLORENCE PISA BOLOGNA AMALFI CAPRI MILAN
ROOM 4 ROOM 5 VILLAGE TERMINALS

08:00–08:30 ET 1 ET 2 ET 3 ET 4 ET 5
Abdominal Acute Cirrhotic liver Mesenteric CTC: how I
emergencies pancreatitis panniculitis do it
08:30–09:00

09:00–09:30 ET 6 ET 7
Large bowel Bariatric
LS 1 LS 2 obstruction IGT 1 SOE 1 surgery
09:30–10:00 Artifi cial Oncology Portal Abdominal
intelligence hypertension Ultrasound

10:00–10:30 ET 8 ET 9
Gallbladder Iron and fat
cases in the liver
USV 1
10:30–11:00
Keynote Lectures

11:00–11:30 SS 2 SS 5
SS 1 SS 4
Rectal SS 3 Liver
Diffuse liver The acute SOE 2
cancer: Advances in interventional USV 2
diseases: abdomen: Imaging
11:30–12:00 diagnosis abdominal radiology and Hands-on
assessing diagnosis upper GI
and imaging oncologic assessment Training
fi brosis and and tract
of treatment imaging of treatment
12:00–12:30
steatosis intervention
response response

12:30–13:00

SY 3 SY 4 TC 1
13:00–13:30 Lunch Lunch RC IWS 1 Tricky Cases
Symposium Symposium Meet the Interv.
Professor Hands-on
13:30–14:00 WS

PO 1
USV 3 Poster Session
14:00–14:30 ISWS 1
Keynote Lectures
Industry
ET 10 ET 12 Satellite
14:30–15:00 ET 11 Workshop
Richard Technical
CT and MR SOE 3
Baron aspects of
enterography Peritnoeum USV 4
LS 3 LS 4 Tutorial CEUS
15:00–15:30 and Hands-on
Bile ducts GEP-NET
abdominal Training
wall
15:30–16:00 ET 13 ET 14 ET 15
Chemo- Anal cancer Child with
embolisation liver mass
16:00–16:30

HL 2
16:30–17:00
ASAR

17:00–17:30 PS 2
One case
– three
17:30–18:00 lessons

28
 THURSDAY, JUNE 6, 2019
MEETING MEETING ULTRASOUND POSTER AREA/
08:00 FLORENCE PISA
– 08:45 / ESGAR BOLOGNA
Tutorials AMALFI CAPRI
09:00MILAN
– 10:30 / Lecture
ROOM 4 Session
ROOM 5 VILLAGE TERMINALS

ET 19
08:00–08:30
ET 1 Pisa ET 16 ET 17 ET 18 ET 20
Benign liverLS 2 Pisa
Cholangio- Perianal Pancreatic CTC pitfalls
Abdominal emergencies
carcinoma in the
fi stulas patient lesions
oncologylesions #LVL Oncology – assessing response to anticancer #LVL
II
(CEUS) III
#SINGLE
08:30–09:00
TOPIC therapy
R.M. Gore, Highland Park, IL/US Moderators: R.G.H. Beets-Tan, Amsterdam/NL; M. Lewin, Villejuif/FR

09:00–09:30 ET 21 ET 22
ET 2 Bologna Targeted SOE 4 09:00  Novel non-cytotoxic therapies: an update for radiologists
AI (robotics)
LS 6 therapy Abdominal
Acute pancreatitis
LS 5 #STRUCTURED IGT
REPORTING 2 #LVL V. Goh, London/UK
09:30–10:00 Rectal Biliary inter- I
imaging
M. Maher,HCC
Wilton/IE cancer ventions protocols 09:20 RECIST 1.1 criteria: pros and cons
(CT, MR) A. Riddell, London/UK
10:00–10:30 ET 23 ET 24
ET 3 Peritoneal Amalfi 09:40 Beyond RECIST: mRECIST, iRECIST, Choi criteria,…
Pancreatic
Imaging the cirrhotic liver malignancies
#SINGLE TOPIC #LVL cancer
V. Vandecaveye, Leuven/BE
10:30–11:00 I USV 5
M. Karcaaltincaba, Ankara/TR; M. Renzulli, Bologna/IT 10:00 Functional imaging biomarkers: myths
Keynoteor reality?
Lectures

SS 7 M.A. Bali, Brussels/BE

11:00–11:30
ET 4 Machine Capri 10:20 SS
Questions
10 and answers
learning SS 9 Modern
MesentericSS 6 panniculitis and differentials:
SS 8 what
Colorectal
#LVL
USV 6
and II 5
SOE imaging
everyDiagnosis
11:30–12:00 radiologistradiomics
should know Pancreatic
#SINGLE diseases:
TOPIC CT Pancreas of gastro-
IWS 2 Hands-on
of HCC neoplasms colonography Interv. Training
in M. Lahaye, Amsterdam/NL
I. Boulay Coletta, Paris/FR; and beyond 09:00 – 10:30 / Image Guided
pancreatic Therapy
Hands-on
12:00–12:30
abdominal diseases WS
imaging
ET 5 Milan IGT 1 Amalfi
CTC:
12:30–13:00how I do it #TECHNICAL TIPS #LVL Treatment of portal hypertension and portal vein #LVL
II III
T. Mang, Vienna/AT;
SY 5 R.SY
Ferrari,
6 Rome/IT pathologies TC 2
13:00–13:30 Lunch Lunch ET 25 Moderators: C. Hassan, Rome/IT; O. Akhan, Ankara/TR
Tricky Cases
Symposium Symposium CTC: polyp /
cancer cases
09:00
13:30–14:00 – 10:30 / Lecture Session 09:00 Optimal pre- and post-procedural imaging strategies
M. Maurer, Bern/CH PO 2
LS
14:00–14:30 1 Florence 09:20 TIPSS revisited
ISWS 2 USV 7 Poster Session
Keynote Lectures
Artificial intelligence in abdominal imaging: how #LVL Industry
A. Hocquelet, Lausanne/CH
III Satellite
shall we reshape our future?
14:30–15:00 09:40  Portal
ET 27 veinWorkshop
IR procedures other than TIPSS
ET 26
Moderators: L. Martí-Bonmatí, Valencia/ES; LiverP.tumour
Huppert, Darmstadt/DE
LS 7 LS 8 Spectral CT
ES SOE 6 ablation USV 8
C.N.
15:00–15:30
De Cecco,
Cystic Atlanta, GA/US
IBD-CD
Editorial
10:00 Case discussion
Benign liver Hands-on
pancreatic
Session disease Training
neoplasms
09:00 Artificial intelligence, machine
ET 28
learning, deep learning: ET 29
15:30–16:00
what are they? Malignant liver 09:00 – 10:30
cult / School of ESGAR
CTC Diffi
cases
G. D‘Assignies, Clichy/FRlesions (CEUS)
16:00–16:30
09:20 Radiomics and radiogenomics SOE 1 Capri
E.HL
Neri,
3 Pisa/IT Abdominal US: technical aspects and innovations #LVL
16:30–17:00 II
09:40 Clinical
SAR implementation: liver Moderators: C. Aubé, Angers/FR; L. Romanini, Cremona/IT
B. Taouli, New York, NY/US
17:00–17:30
10:00 Clinical
PS 3 implementation: rectum 09:00 Basic concept: US & Color Doppler US
Clinical
J. Van Griethuysen, Amsterdam/NL D. Cokkinos, Athens/GR
Files
17:30–18:00
10:20 Panel discussion 09:30 Elastography
P. Ricci, Rome/IT
18:00–18:30 10:00 Fusion imaging & 3D
ESGAR
General T. Fischer, Berlin/DE
Assembly
18:30–19:00

29
THURSDAY, JUNE 6, 2019

09:00 – 09:45 / ESGAR Tutorials 11:08 SS 1.2 Evaluation of fatty liver with US attenuation
imaging: a prospective study using histopathology as a
ET 6 Bologna standard reference
Large bowel obstruction: challenging cases #LVL J. Bae, D.H. Lee, J.Y. Lee, H. Kim, J. Lee, E.J. Cho, Y.B. Lee,
II
#FROM MY WORKSTATION J.K. Han, B.I. Choi; Seoul/KR
J. Yang, Sydney, NSW/AU; E. Delabrousse, Besançon/FR 11:16 SS 1.3 Liver MRI susceptibility-weighted imaging and
T2* mapping in the presence of steatosis and fibrosis
ET 7 Milan V. Obmann, C. Marx, J. Hrycyk, L. Ebner, M. Ith, C. Gräni,
Imaging following bariatric surgery #LVL A. Berzigotti, J. Heverhagen, A. Christe, A. Huber; Bern/CH
II
#QUESTIONS FROM MY COLLEAGUE 11:24 SS 1.4 Quantitative hepatorenal B-mode ratio for the
M. Rengo, Rome/IT; A. Blachar, Tel Aviv/IL noninvasive diagnosis of liver steatosis
A. Paisant, A. Moret, J. Boursier, J. Lebigot, C. Aubé;
Angers/FR
10:00 – 10:45 / ESGAR Tutorials 11:32 SS 1.5 withdrawn by the authors
11:32 SS 1.6 The value of intravoxel incoherent motion in
ET 8 Bologna detecting and staging liver fibrosis: a systematic
Challenging gallbladder cases #LVL review and meta-analysis
II
#FROM MY WORKSTATION Z. Ye, Y. Wei, B. Song; Chengdu/CN
H.S. Park, Seoul/KR; S. Sen, Kolkata/IN 11:40 SS 1.7 Effect of nodular regenerative hyperplasia on
liver stiffness measurement in magnetic resonance
ET 9 Milan elastography
How I quantify iron and fat in the liver #LVL R. Cannella1, M.I. Minervini2, V. Rachakonda2, A.A. Borhani2,
II
#TECHNICAL TIPS A. Furlan2; 1Palermo/IT, 2Pittsburgh, PA/US
M. França, Porto/PT; J. Runge, Amsterdam/NL 11:48 SS 1.8 Evaluation of liver fibrosis and necro-
inflammation using stiffness and dispersion slope from
2D-shear wave elastography
10:30 – 11:00 / Ultrasound Village D.H. Lee, E.S. Lee; Seoul/KR
11:56 SS 1.9 Reduction in MRI liver proton density fat
USV 1 Ultrasound Village fraction in patients with type 2 diabetes mellitus
Keynote Lectures following treatment with duodenal mucosal resurfacing
N. Sakai1, A. Bainbridge1, D. Maggs2, M. Hall-Craggs1,
10:30 Color-Doppler US of the portal vein S.A. Taylor1, M.D. Chouhan1; 1London/UK, 2Lexington, MA/US
P. Ricci, Rome/IT 12:04 SS 1.10 CT-based liver surface nodularity for the
10:45 Elastography of the liver detection of clinically significant portal hypertension:
O. Lucidarme, Paris/FR defining measurement quality criteria
R. Sartoris, A. Nivolli, M. Lazareth, P.-E. Rautou, V. Vilgrain,
11:00 – 12:30 / Scientific Session M. Ronot; Clichy/FR

SS 1 Florence
Diffuse liver diseases: assessing fibrosis and steatosis
Moderators: M. Ronot, Clichy/FR; B. Song, Chengdu/CN

11:00 SS 1.1 US attenuation imaging coefficient for the

diagnosis and grading of hepatic steatosis: a pilot
study in a biopsy-proven cohort
M. Dioguardi Burgio, M. Ronot, E. Reizine, P.-E. Rautou,
L. Castera, V. Paradis, P. Garteiser, B. Van Beers, V. Vilgrain;
Clichy/FR

30

11:00 – 12:30 / Scientific Session
SS 2 Pisa
Rectal cancer: diagnosis and imaging of treatment
response
Moderators: D. Lambregts, Amsterdam/NL;
S. Gourtsoyianni, Athens/GR
11:00 SS 2.1 Performance of texture analysis in predicting
tumoural response to neoadjuvant chemoradiotherapy
in rectal cancer patients studied with 3T MR.
M. Zerunian1, D. Bellini2, M. Rengo2, N. Panvini2,
D. De Santis1, D. Caruso1, A. Laghi1; 1Rome/IT, 2Latina/IT
11:08 SS 2.2 Comparison of MRI morphology, diffusion-
weighted imaging patterns and a combination of both
in assessing complete response in patients with locally
advanced rectal cancer treated with neoadjuvant long-
course chemoradiotherapy
A. Chandramohan, U. Siddiqui, R. Mittal, A. Eapen,
M. Jesudason, T.S. Ram, A. Singh, D. Londhe; Vellore/IN
11:16 SS 2.3 Artificial intelligence automatic identification of
complete- and non-responders using texture analysis
of rectal cancer 3T MR images performed before,
during and after neoadjuvant chemoradiotherapy
M. Zerunian1, R. Ferrari1, C. Mancini Terracciano1,
C. Voena1, M. Rengo2, R. Paramatti1, D. Caruso1,
R. Faccini1, A. Laghi1; 1Rome/IT, 2Latina/IT
11:24 SS 2.4 18F-fluoro-2-deoxy-D-glucose-avid presacral
soft tissue mass in previously treated rectal cancer:
diagnostic outcome and additional value of MRI,
including diffusion-weighted imaging
J.P. Pennings, R. de Haas, K.J.A. Murshid, K.P. de Jong,
R.A.J.O. Dierckx, T.C. Kwee; Groningen/NL
11:32 SS 2.5 Diagnostic value of dynamic perfusion MRI
in patients with locally advanced rectal cancer in the
assessment of chemo-radiation treatment: relation to
tumor regression grade at histology
P.P. Arcuri1, A.K. Sikora1, S. Roccia1, G. Fodero1, V. Aiello1,
C. Bertucci2, D. Laganà1; 1Catanzaro/IT, 2Buckingham/IT
11:40 SS 2.6 T2-weighted, apparent diffusion coefficient
and positron emission tomography texture analysis
of locally advanced rectal cancer after preoperative
chemoradiotherapy: correlation with tumour regression
grade
F. Crimì, V. Aldegheri, G. Spolverato, C. Lacognata,
P. Zucchetta, A. Barison, L. Albertoni, C. Campi,
R. Stramare, E. Quaia; Padua/IT
THURSDAY, JUNE 6, 2019
11:48 SS 2.7 MR of rectal cancer response to therapy:
comparison between 3.0 and 1.5 Tesla
E. Lucertini, M. Zerunian, A. Guarnera, F. Pucciarelli,
D. De Santis, D. Caruso, A. Laghi; Rome/IT
11:56 SS 2.8 Association between texture analysis
parameters and oncogenic Kirsten-ras mutation in
patients with primary rectal cancer
S.H. Kim1, S.J. Jo1, S.J. Park2; 1Busan/KR, 2Seoul/KR
12:04 SS 2.9 Predicting neoadjuvant therapy response in
locally advanced rectal cancer using texture features
V. Giannini, S. Mazzetti, I. Bertotto, E. Delmastro,
P. Gabriele, D. Regge; Candiolo/IT
12:12 SS 2.10 Characteristics of non-metastatic lymph nodes
of rectal cancer: high-resolution MR and fast spin-echo
T2-weighted imaging with fat saturation
J. Zhu, X. Wang, J. Gao; Beijing/CN
11:00 – 12:30 / Scientific Session
SS 3 Bologna
Advances in abdominal oncologic imaging
Moderators: S. Barnes, Tel Aviv/IL; V. Goh, London/UK
11:00 SS 3.1 Measuring colorectal tumour hypoxia with
oxygen-enhanced and dynamic contrast-enhanced MRI
D. Prezzi1, I. Dregely1, R. Neji2, J. Stirling1, S. Jeljeli1,
G. Cook1, V. Goh1; 1London/UK, 2Frimley/UK
11:08 SS 3.2 Clinicopathologic significance of a new imaging
classification of intrahepatic cholangiocarcinoma into
ductal and parenchymal types
H. Rhee, M.-J. Kim, Y.N. Park, C. An; Seoul/KR
11:16 SS 3.3 Oral administration of multi-target tyrosine
kinase inhibitors targeting angiogenesis is associated
with submucosal fat deposition in the GI tract
S. Tamir1, S. Gavrielli1, C. Abitbol2, V. Neiman1, L. Yosef1,
E. Atar1, A. Zer1; 1Petah Tikva/IL, 2Beit Shemesh/IL
11:24 SS 3.4 CT-based nomogram for predicting survival in
patients with resectable gallbladder: a retrospective
multicenter analysis
S.-Y. Choi1, J.H. Kim2, J.E. Lee1; 1Bucheon/KR, 2Seoul/KR
11:32 SS 3.5 withdrawn by the authors
11:32 SS 3.6 Diagnostic accuracy for metastatic disease
in newly diagnosed colorectal cancer: prospective
comparison of whole-body MRI with standard staging
pathways – the “Streamline C” trial
S.A. Taylor1, S. Mallett2, L. Quinn2, S. Halligan1; 1London/UK,
2
Birmingham/UK
31
THURSDAY, JUNE 6, 2019
11:00 – 12:30 / Scientific Session – continuation
11:40 SS 3.7 Structured report for HCC: how we do it?
A. Perez Girbes1, A. Torregrosa Andrés1,
D.J. Ribeiro Castro Roriz2, J.P. Azorin Vicente1, P. Rudenko1,
A. Batista Domenech1, L. Martí-Bonmatí1; 1Valencia/ES,
2
Coimbra/PT
11:48 SS 3.8 Visceral obesity and colorectal cancer: is
there a relationship between them? First CT-based
volumetric study
M. Ersen, S. Akay, M. Urkan, U. Balyemez, M. Tasar;
Ankara/TR
11:56 SS 3.9 Correlation between apparent diffusion
coefficient value on MRI and histopathologic World
Health Organization grades of neuroendocrine tumors
W. Mebis, B. Corthouts, H. El Addouli, S. Nicolay,
A. Snoeckx, M.J. Spinhoven, A. Van Hoyweghen,
B. Op De Beeck; Edegem/BE
12:04 SS 3.10 Imaging evaluation of liver tumour burden in
metastatic pancreatic neuroendocrine tumours
G. Rizzo, A. Beleù, A. Sarno, N. Cardobi, A. Giaretta,
A. Grecchi, I. Testa, R. De Robertis, M. D’Onofrio; Verona/IT
11:00 – 12:30 / Scientific Session
SS 4 Amalfi
The acute abdomen: diagnosis and intervention
Moderators: D. Tolan, Leeds/UK;
R. Hammerstingl, Frankfurt am Main/DE
11:00 SS 4.1 Cost-effectiveness of imaging in the
assessment of appendicitis
C. Ivan, A. Al-Nowfal, S. Hudson, A. Osman, R. Verma,
J.A. Stephenson; Leicester/UK
11:08 SS 4.2 Non-strangulated adhesive small bowel
obstruction: CT findings predicting failure of non-
surgical treatment
Y. Lee, J.E. Kim, J.-H. Yoon, S.H. Kim; Busan/KR
11:16 SS 4.3 Bowel infarction from acute mesenteric
ischemia and strangulated small bowel obstruction:
distinct CT features
P. Calame, A. Malakhia, F. Grillet, E. Delabrousse;
Besançon/FR
11:24 SS 4.4 CT in occlusive and non-occlusive ischemic
colitis
N.S. Gonzalez1, V. Plodeck1, J. Dobroschke1, M. Wulf2,
M. Laniado1; 1Dresden/DE, 2Buenos Aires/AR
32
11:32 SS 4.5 Comparison of contrast-enhanced US and
MDCT with angiography: enhanced assessment of
bleeding in blunt abdominal trauma
J. Lee1, Y. Kim1, J.Y. Moon2, K.S. Park1; 1Cheongju/KR,
2
Seoul/KR
11:40 SS 4.6 Inflammation-related radiological findings of
gallbladder adenomyomatosis
W.-S. Chung, J.Y. Kim, H.J. Lee, J. An; Daejeon/KR
11:48 SS 4.7 Diagnostic accuracy of unenhanced CT in acute
abdominal pain
U. Russo, V. Murelli, R. Cobelli, G. Pedrazzi, A.A. Palumbo;
Parma/IT
11:56 SS 4.8 Clinical impact of iterative model reconstruction
algorithm in assessment of abdominal disease in a
department of emergency radiology: a large series of
patients
A. Pecorelli, C. Maino, C. Talei Franzesi, L. Riva, A. Devito,
T. Giandola, S. Sironi, D. Ippolito; Monza/IT
12:04 SS 4.9 Endovascular treatment of abdominal
visceral artery aneurysms and pseudoaneurysms:
extravascular stent graft migration as a possible long-
term complication
M.A. Tipaldi, F. Laurino, A. Pisano, G. Orgera, A. Laghi,
M. Rossi; Rome/IT
12:12 SS 4.10 Endovascular managemet of hepatic artery
thrombosis in the first post-operative day after living
donor liver transplantation
O. Abdelaziz, S. Emadeldin; Cairo/EG
11:00 – 12:30 / Scientific Session
SS 5 Milan
Liver interventional radiology and assessment of
treatment response
Moderators: C.J. Zech, Basel/CH; S. Pötter-Lang, Vienna/AT
11:00 SS 5.1 Predictive technetium-99 m macroaggregated
albumin-single-photon emission computed
tomography/CT dosimetry in patients with locally
advanced inoperable HCC treated by selective internal
radiotherapy with 90Y resin microspheres
A.-L. Hermann1, A. Dieudonne2, M. Ronot2, M. Sanchez2,
H. Pereira1, G. Chatellier1, E. Garin3, L. Castera2, R. Lebtahi2,
V. Vilgrain2; 1Paris/FR, 2Clichy/FR, 3Rennes/FR
 THURSDAY, JUNE 6, 2019

11:08 SS 5.2 Does the tumoral density heterogeneity after 12:12 SS 5.10 Clinical impact of a new cone beam CT
selective internal radiation therapy predict local angiography respiratory motion artifact reduction
progression in colorectal hepatic metastases? algorithm during hepatic intra-arterial treatment
A. Saifi, M. Lemort, S.-L. Chao, M.A. Bali, M. Vouche; M. Dioguardi Burgio1, T. Benseghir2, V. Roche1,
Brussels/BE C. Garcia Alba1, J.-B. Debry1, A. Sibert1, V. Vilgrain1,
11:16 SS 5.3 Yttrium 90-radioembolization in patients with M. Ronot1; 1Clichy/FR, 2Buc/FR
HCC and portal vein invasion: external validation of the
Milan prognostic score 11:00 – 12:30 / School of ESGAR
P. Scalise, I. Bargellini, E. Bozzi, O. Perrone, G. Boni, R. Cioni;
Pisa/IT SOE 2 Capri
11:24 SS 5.4 Correlation between the dose of Imaging of the upper GI tract #LVL
I
radioembolization and liver hypertrophy of the future Moderator: M.A. Mazzei, Siena/IT
remnant liver
M. Vouche, Y. Aboufirass, M. Lemort, P. Flamen; Brussels/BE 11:00 Imaging the oesophagus and stomach
11:32 SS 5.5 Value of diffusion-weighted MRI for response K. Foley, Cardiff/UK
evaluation of hepatic metastases of primary 11:45 Imaging the solid abdominal organs
neuroendocrine tumors undergoing selective internal P. Pokieser, Vienna/AT
radiotherapy
M.K. Ingenerf, L. Kaiser, H. Karim, H. Ilhan, J. Ricke,
C. Schmid-Tannwald; Munich/DE 11:00 – 12:30 / Ultrasound Village
11:40 SS 5.6 Prediction of treatment response following
transarterial chemoembolization in patients with HCC USV 2 Ultrasound Village
using dual-tracer positron emission tomography Hands-on Training
W.H.K. Chiu, H. Yuan, J. van Lunenburg, V. Vardhanabhuti,
D. Tse, E.Y.P. Lee; Hong Kong/HK Tutors
11:48 SS 5.7 CT texture analyses of colorectal liver C. Aubé, Angers/FR O. Lucidarme, Paris/FR
metastases before and after thermal ablation can T.V. Bartolotta, Palermo/IT P. Maceroni, Latina/IT
predict local tumour progression V. Cantisani, Rome/IT E. Quaia, Padua/IT
F. Staal1, M. Taghavi1, F. Imani1, F. Gómez Muñoz1, D. Cokkinos, Athens/GR P. Ricci, Rome/IT
E. Klompenhouwer1, D. Meek2, M. de Boer1, M. D’Onofrio, Verona/IT L. Romanini, Cremona/IT
D. Lambregts1, R.G.H. Beets-Tan1, M. Maas1; T. Fischer, Berlin/DE
1
Amsterdam/NL, 2Capelle Aan Den IJssel/NL
11:56 SS 5.8 CT texture analysis to predict response to
HER2-targeted therapy of hepatic metastases from 12:45 – 13:45 / Lunch Symposia
colorectal cancer
S. Mazzetti1, V. Giannini1, G. Cappello1, A. Vanzulli2, SY 3 Pisa
S. Marsoni2, D. Regge1; 1Candiolo/IT, 2Milan/IT Industry-sponsored Symposium
12:04 SS 5.9 Portosystemic shunt surgery in the era of For details please refer to page 79
transjugular portosystemic shunts: imaging-based
procedure planning SY 4 Amalfi
U. Fehrenbach, M. de Sousa Mendes, S. Gül, I. Steffen, Industry-sponsored Symposium
J. Stern, D. Geisel, G. Puhl, J. Pratschke, T. Denecke; For details please refer to page 81
Berlin/DE

33
THURSDAY, JUNE 6, 2019

12:45 – 13:30 / Tricky Cases 13:55 SE-034 Validation of the modified Van Assche index
for assessing response to anti-TNF therapy with MRI in
TC 1 Ultrasound Village perianal fistulising Crohn’s disease
Tricky cases from my day job K. Van Rijn, C. Lansdorp, J. Tielbeek, C. Nio, C. Buskens,
Moderator: M. Laniado, Dresden/DE G. D’Haens, M. Löwenberg, J. Stoker; Amsterdam/NL

12:45 The liver – an unusual cystic lesion
12:54 The biliary system – an unexpected differential
diagnosis
13:03 The pancreas – how more imaging can fool you
13:12 The spleen – lesions increasing in size and number
after years
13:21 The peritoneum and mesentery – new times but old
diagnosis
14:05 SE-037 MR Significant Factors for Survival Outcome
in Rectal Cancer Patients Following Neoadjuvant
Combined Chemotherapy and Radiation Therapy:
Stratification of Lateral Pelvic Lymph node
M.J. Kim, B.J. Park, K.C. Sim, D.J. Sung, N.Y. Han;
Seoul/KR
14:00 – 14:30 / Ultrasound Village

13:00 – 13:45 / Research Centre USV 3 Ultrasound Village

Keynote Lectures
RC 1 Capri
Meet the Professor #LVL 14:00 CEUS: liver guidelines
II
Moderator: A. Plumb, London/UK V. Cantisani, Rome/IT
14:15 Fusion imaging of the liver
13:00 Meet the Professor T. Fischer, Berlin/DE
S.A. Taylor, London/UK

14:00 – 15:00 / Industry Satellite Workshop

13:00 – 14:00 / Interventional Workshop
ISWS 1 Meeting Room 4
IWS 1 Meeting Room 5 Industry-sponsored Workshop
Percutaneous biliary forceps biopsy For details please refer to page 87
R. Inchingolo, Matera/IT

14:30 – 16:00 / Lecture Session

13:45 – 14:30 / Poster Session
LS 3 Florence
PO 1 Poster Area / Terminal 1 Bile ducts: a tour around cholangiopathies #LVL
II
Poster Session – Modern assessement of rectal Moderators: C. Matos, Lisbon/PT; G. Morana, Treviso/IT
cancer and perinanal fistulas
Moderators: J. Stoker Amsterdam/NL; 14:30 Inflammatory and infectious disease
L. Curvo-Semedo, Coimbra/PT A. Arora, Liverpool/UK
14:50 Cholangiocarcinoma: diagnosing and staging
13:45 SE-036 Prognostic value of extramural venous invasion J.H. Yoon, Seoul/KR
in non-metastatic rectal cancer patients. 15:10 Gallbladder pathologies
J. Ayuso-Colella, J. Maurel, O. Reig, R. Reyes, M. Pages, F. Akisik, Indianapolis, IN/US
S. Rodriguez; Barcelona/ES 15:30 Case discussion

34
 THURSDAY, JUNE 6, 2019

14:30 – 16:00 / Lecture Session 14:30 – 16:00 / Ultrasound Village

LS 4 Pisa USV 4 Ultrasound Village

What you need to know about GEP-NET – #LVL Hands-on Training
II
a multidisciplinary session
Moderators: S. Skehan, Dublin/IE; C. Cronin, Dublin/IE Tutors
C. Aubé, Angers/FR P. Ricci, Rome/IT
14:30 GEP-NET: setting the scene M. D’Onofrio, Verona/IT L. Romanini, Cremona/IT
G. Capurso, Milan/IT T. Fischer, Berlin/DE A. Taibbi, Palermo/IT
14:50 Initial diagnosis and follow up of GEP-NET with E. Quaia, Padua/IT
Radiology
M. Vullierme, Clichy/FR
15:10 Initial diagnosis and follow up of GEP-NET with 15:30 – 16:15 / ESGAR Tutorials
Nuclear Medicine
M. Ronot, Clichy/FR ET 13 Bologna
15:30 The multidisciplinary team in GEP- NET Chemoembolisation and radioembolisation #LVL
II
F. Panzuto, Rome/IT #TECHNICAL TIPS
M. Ronot, Clichy/FR I. Bargellini, Pisa/IT; R. Thomas, London/UK
M. Vullierme, Clichy/FR
ET 14 Amalfi
Anal cancer #TECHNICAL TIPS #LVL
II
14:30 – 16:00 / School of ESGAR M.J. Gollub, New York, NY/US

SOE 3 Capri ET 15 Milan

Imaging the peritoneum and the abdominal wall #LVL A child with a liver mass: how to image? #LVL
II
I
Moderator: A. Palkó, Szeged/HU #SINGLE TOPIC
S. Robben, Maastricht/NL
14:30 Peritoneum, retroperitoneum and extraperitoneum:
not as difficult as it may appear
C. Stoupis, Maennedorf/CH 16:30 – 17:00 / Honorary Lecture
15:15 Abdominal wall hernias
A. Plumb, London/UK HL 2 Florence
ASAR Honorary Lecture #LVL
III
Moderator: S. Halligan, London/UK
14:30 – 15:15 / ESGAR Tutorials
Air in the diagnosis of abdominal emergencies
ET 10 Bologna K.-L. Liu, Taipei/TW
Richard Baron Tutorial: become an expert in #LVL

rare liver tumours in 45 minutes! #SINGLE TOPIC II

Y. Menu, Paris/FR

ET 11 Amalfi
CT and MR enterography #TECHNICAL TIPS #LVL
A.R. Radmard, Tehran/IR; P. Paolantonio, Rome/IT II

ET 12
Technical aspects of contrast-enhanced Milan
ultrasound #TECHNICAL TIPS #LVL
II
V. Cantisani, Rome/IT; D. Cokkinos, Athens/GR

35
 THURSDAY,
THURSDAY, JUNE
JUNE 6, 2019
6, 2019
MEETING MEETING ULTRASOUND POSTER AREA/
17:00 –FLORENCE PISA
18:00 / Plenary SessionBOLOGNA AMALFI CAPRI MILAN
ROOM 4 ROOM 5 VILLAGE TERMINALS

08:00–08:30
PS 2 ET 1 ET 2 ETFlorence
3 ET 4 ET 5
Abdominal Acute Cirrhotic liver Mesenteric CTC: how I
One case – three emergencies
lessons pancreatitis
#LVL
IIpanniculitis do it
Moderators: D. Tolan, Leeds/UK; G.H. Mostbeck, Vienna/AT
08:30–09:00

17:00 Detection and perception in pancreaticET 6 malignancy ET 7

09:00–09:30
M.A. Bali, London/UK Large bowel Bariatric
LS 1
17:06 Satisfaction LS 2 in a obstruction
of search IGT 1
case of biliary obstruction SOE 1 surgery
09:30–10:00 Artifi cial Oncology Portal Abdominal
C. Valls, Stockholm/SE
intelligence hypertension Ultrasound
17:12 Satisfaction of search in rectal cancer
10:00–10:30 ET 8 ET 9
D. Ippolito, Monza/IT Gallbladder Iron and fat
17:18 Faulty reasoning and liver ultrasoundcases in the liver
USV 1
10:30–11:00
G. Morana, Treviso/IT Keynote Lectures
17:24 Questions from D. Tolan
11:00–11:30 SS 2 SS 5
17:30 Detection
SS 1 in inflammatory bowel disease SS 4
Rectal SS 3 Liver
Diffuse liver
D. Burling, Harrow/UK The acute SOE 2
cancer: Advances in interventional USV 2
diseases: abdomen: Imaging
11:30–12:00
17:36 Technical diagnosis abdominal radiology and Hands-on
assessing error in the acute abdomen diagnosis upper GI
and imaging oncologic assessment Training
fiS.
brosis and
Schindera, of Aarau/CH and tract
treatment imaging of treatment
12:00–12:30
steatosis intervention
17:42 Detection andresponseperception in GI haemorrhage response
J.-P. Tasu, Poitiers/FR
17:48 Miscommunication in the post-operative abdomen
12:30–13:00
D. Tolan, Leeds/UK SY 3 SY 4 TC 1
17:54 Questions fromLunch
13:00–13:30 G.H. Mostbeck Lunch RC IWS 1 Tricky Cases
Symposium Symposium Meet the Interv.
Professor Hands-on
13:30–14:00 WS

PO 1
USV 3 Poster Session
14:00–14:30 ISWS 1
Keynote Lectures
Industry
ET 10 ET 12 Satellite
14:30–15:00 ET 11 Workshop
Richard Technical
CT and MR SOE 3
Baron aspects of
enterography Peritnoeum USV 4
LS 3 LS 4 Tutorial CEUS
15:00–15:30 and Hands-on
Bile ducts GEP-NET
abdominal Training
wall
15:30–16:00 ET 13 ET 14 ET 15
Chemo- Anal cancer Child with
embolisation liver mass
16:00–16:30

HL 2
16:30–17:00
ASAR

17:00–17:30 PS 2
One case
– three
17:30–18:00 lessons

36
 FRIDAY, JUNE
PROGRAMME 7, 2019 – FRIDAY, JUNE 7, 2019
OVERVIEW
MEETING MEETING ULTRASOUND POSTER AREA/
FLORENCE PISA BOLOGNA AMALFI CAPRI MILAN
ROOM 4 ROOM 5 VILLAGE TERMINALS

ET 19
08:00–08:30 ET 16 ET 17 ET 18 ET 20
Benign liver
Cholangio- Perianal Pancreatic CTC pitfalls
lesions
carcinoma fi stulas lesions
(CEUS)
08:30–09:00

09:00–09:30 ET 21 ET 22
Targeted SOE 4 AI (robotics)
LS 6 therapy IGT 2 Abdominal
LS 5
09:30–10:00 Rectal Biliary inter- imaging
HCC
cancer ventions protocols
(CT, MR)
10:00–10:30 ET 23 ET 24
Peritoneal Pancreatic
malignancies cancer
10:30–11:00 USV 5
Keynote Lectures

SS 7
11:00–11:30
Machine SS 10
learning SS 9 Modern
SS 6 SS 8 Colorectal USV 6
and SOE 5 imaging
11:30–12:00 Diagnosis Pancreatic diseases: CT IWS 2 Hands-on
radiomics Pancreas of gastro-
of HCC neoplasms colonography Interv. Training
in pancreatic
and beyond Hands-on
12:00–12:30
abdominal diseases WS
imaging

12:30–13:00

SY 5 SY 6 TC 2
13:00–13:30 Lunch Lunch ET 25 Tricky Cases
Symposium Symposium CTC: polyp /
cancer cases
13:30–14:00

PO 2
14:00–14:30 ISWS 2 USV 7 Poster Session
Industry Keynote Lectures
Satellite
14:30–15:00 ET 27 Workshop
ET 26
Liver tumour
LS 7 LS 8 Spectral CT
ES SOE 6 ablation USV 8
Cystic IBD-CD
15:00–15:30 Editorial Benign liver Hands-on
pancreatic
Session disease Training
neoplasms
15:30–16:00 ET 28 ET 29
Malignant liver CTC Diffi
cult
lesions (CEUS) cases
16:00–16:30

HL 3
16:30–17:00
SAR

17:00–17:30
PS 3
Clinical
Files
17:30–18:00

18:00–18:30
ESGAR
General
Assembly
18:30–19:00

37
FRIDAY, JUNE 7, 2019

08:00 – 08:45 / ESGAR Tutorials 09:00 – 10:30 / Lecture Session

ET 16 Pisa LS 6 Pisa
Cholangiocarcinoma #STRUCTURED REPORTING #LVL Rectal cancer: a multidisciplinary approach #LVL
II II
J.M. Lee, Seoul/KR Moderators: L. Curvo-Semedo, Coimbra/PT;
S. Rafaelsen, Vejle/DK
ET 17 Bologna
Imaging of perianal fistulas #SINGLE TOPIC #LVL
09:00 Imaging of rectal cancer: how it influences treatment
II
P. Lung, London/UK choice
V. Valentini, Rome/IT
ET 18 Amalfi 09:20 ...how it influences surgical approach
Dealing with difficult pancreatic lesions and #LVL
II G. Beets, Amsterdam/NL
pseudo lesions #SINGLE TOPIC 09:40 …how modern techniques influence treatment and
R. Pozzi Mucelli, Huddinge/SE outcome
S. Gourtsoyianni, Athens/GR
ET 19 Capri 10:00 Case discussion
Benign liver lesions: assessment with contrast- #LVL
II
enhanced ultrasound #FROM MY WORKSTATION 09:00 – 10:30 / Image Guided Therapy
O. Lucidarme, Paris/FR; A. Taibbi, Palermo/IT
IGT 2 Amalfi
ET 20 Milan Biliary interventions #LVL
II
Pitfalls in CTC #FROM MY WORKSTATION #LVL
Moderators: A. Hatzidakis, Heraklion/GR;
II
M. Morrin, Dublin/IE; S. Gryspeerdt, Roeselare/BE D.J. Breen, Southampton/UK

09:00 Percutaneous management of hilar malignancy

09:00 – 10:30 / Lecture Session M. Krokidis, Cambridge/UK
09:20 Percutaneous management in benign extra-hepatic
LS 5 Florence biliary disease
HCC: imaging of hepatocellular carcinoma: #LVL
C.D. Becker, Geneva/CH
II
diagnostic criteria and challenging lesions 09:40 Percutaneous cholecystostomy
Moderators: F. Caseiro Alves, Coimbra/PT; B.I. Choi, Seoul/KR S. Silvera, Paris/FR
10:00 Case discussion
09:00 LI-RADS 3 – diagnosis and management of challenging
lesions in cirrhosis
A. Vanzulli, Milan/IT 09:00 – 10:30 / School of ESGAR
09:20 Non-invasive imaging criteria for the diagnosis of
hepatocellular carcinoma: a review of the current SOE 4 Capri
evidence and gaps in knowledge Abdominal imaging protocols: CT and MR #LVL
I
A. Furlan, Pittsburgh, PA/US Moderator: E.J. Rummeny, Munich/DE
09:40 Malignancies in cirrhosis other than hepatocellular
carcinoma: diagnosis and management 09:00 Computed tomography
T.K. Kim, Toronto, ON/CA D. Caruso, Rome/IT
10:00 Case discussion 09:45 Magnetic resonance
I. Santiago, Lisbon/PT

38
 FRIDAY, JUNE 7, 2019

09:00 – 09:45 / ESGAR Tutorials 11:08 SS 6.2 Evaluation of Liver Imaging Reporting and Data
System v2018 by MR in ≤ 2 cm US-detected nodules in
ET 21 Bologna cirrhotic patients
Imaging of side effects of targeted therapy #LVL A. Darnell, J. Rimola, E. Belmonte, E. Ripoll, C. Caparroz,
III
#SINGLE TOPIC Á. Díaz-González, M.E. Reig, C. Ayuso, J. Bruix,
C. Menias, Scottsdale, AZ/US A. Forner; Barcelona/ES
11:16 SS 6.3 Comparison of the Performance of European
ET 22 Milan Association for the Study of the Liver 2018 and Liver
Demystification of AI-driven medical image #LVL Imaging Reporting and Data System 2018 for the
II
interpretation: past, present & future noninvasive diagnosis of HCC using MRI
#SINGLE TOPIC S. Lee, M.-J. Kim; Seoul/KR
B. Gallix, Montreal, QC/CA 11:24 SS 6.4 Dynamic contrast-enhanced MRI features for
identifying macrotrabecular-massive HCC
A. Galletto Pregliasco, S. Mule, G. Amaddeo, L. Baranes,
10:00 – 10:45 / ESGAR Tutorials F. Pigneur, R. Kharrat, M. Djabbari, H. Regnault,
C. Hezode, J. Caldéraro, A. Luciani; Créteil/FR
ET 23 Bologna 11:32 SS 6.5 Modified v2018 Liver Imaging Reporting and
Peritoneal surface malignancies #LVL Data Systems: a prospective comparative study on
II
#QUESTIONS FROM MY COLLEAGUE gadoxetic acid-enhanced MRI
C. Dromain, Lausanne/CH; P. Sammartino, Rome/IT H. Jiang, B. Song; Chengdu/CN
11:40 SS 6.6 Inter-reader, intra-reader agreement, and
ET 24 Milan correlation with pathology of CT/MRI Liver Imaging
Pancreatic cancer before and after neoadjuvant #LVL Reporting And Data System v2018
II
treatment #STRUCTURED REPORTING A. Borgheresi, A. Agostini, D. Nicolini, G. Conte,
O. Brook, Boston, MA/US; E.M. Godfrey, Cambridge/UK E. Dalla Bona, M. Romano, M. Vivarelli, A. Giovagnoni;
Ancona/IT
10:30 – 11:00 / Ultrasound Village 11:48 SS 6.7 Additional value of contrast-enhanced US on
arterial phase non-hyperenhancement observations
USV 5 Ultrasound Village (≥ 2cm) of CT/MRI for high-risk patients: focusing on
Keynote Lectures the CT/MRI Liver Imaging Reporting and Data System
categories LR-3 and LR-4
10:30 US of the small bowel J.H. Kim, H.-J. Kang, I. Joo, J.K. Han; Seoul/KR
L. Romanini, Cremona/ IT 11:56 SS 6.8 Texture analysis on preoperative imaging
10:45 CEUS: liver guidelines identifies patients with high-risk HCC
T.V. Bartolotta, Palermo/IT R. Cannella1, G.C. Wilson2, G. Fiorentini2, C. Shen2,
A. Borhani2, A. Tsung2, A. Furlan2; 1Palermo/IT,
11:00 – 12:30 / Scientific Session 2
Pittsburgh, PA/US
12:04 SS 6.9 Assessment of histologic grade and
SS 6 Florence microvascular invasion in HCC with gadobenate
Diagnosis of HCC dimeglumine-enhanced MRI
Moderators: G. Brancatelli, Palermo/IT; J.-Y. Choi, Seoul/KR D.L. Rong, S.C. Kuang, S.D. Xie, Y. Zhang, B.J. He, Y. Deng,
H. Yang, S.M. Chen, J. Wang; Guangzhou/CN
11:00 SS 6.1 Hepatobiliary phase hypointensity in LR-3 and 12:12 SS 6.10 Incomplete tumor capsule on preoperative
LR-4 observations as a predictor of progression to HCC imaging reveals microvascular invasion in HCC:
F. Vernuccio1, R. Cannella1, M. Meyer2, K.R. Choudhoury2, a systematic review and meta-analysis
M.R. Bashir2, A. Furlan3, D. Marin2; 1Palermo/IT, 2Durham, F. Zhu, F. Yang, J. Li, W. Chen, W. Yang; Chengdu/CN
NC/US, 3Pittsburgh, PA/US

39
FRIDAY, JUNE 7, 2019
11:00 – 12:30 / Scientific Session
SS 7 Pisa
Machine learning and radiomics in abdominal
imaging
Moderators: B. Taouli, New York, NY/US; M. Zins, Paris/FR
11:00 SS 7.1 Machine learning-based analysis of CT
radiomics model for the prediction of colorectal
metachronous liver metastases
M. Taghavi1, S. Trebeschi1, D. Meek1, D. Lambregts1,
R.C.J. Beckers2, R. Dijkhoff2, C. Verhoef3, J.B. Houwers2,
U. van der Heide1, R.G.H. Beets-Tan1, M. Maas1;
1
Amsterdam/NL, 2Maastricht/NL, 3Rotterdam/NL
11:08 SS 7.2 Zero-click liver proton density fat fraction and
R2* quantification by deeply supervised convolutional
neural networks applied to multi-echo chemical sift-
encoded MR
A. Jimenez-Pastor, A. Alberich-Bayarri, R. Lopez-Gonzalez,
M. Garcia-Junco, L. Martí-Bonmatí, D. Marti-Aguado;
Valencia/ES
11:16 SS 7.3 CT texture analysis of liver metastases in
pancreatic neuroendocrine tumors versus non-
pancreatic neuroendocrine tumors: correlation with
histopathological findings
I. Martini, M. Polici, M. Zerunian, F. Landolfi, F. Panzuto,
M. Rinzivillo, A. Laghi, E. Iannicelli; Rome/IT
11:24 SS 7.4 Histogram and texture features in baseline
diffusion-weighted MRI predict tumor subtype, therapy
response and patient survival in pancreatic ductal
adenocarcinoma
G. Kaissis1, S. Ziegelmayer1, F. Lohöfer1, I. Heid1, J. Siveke2,
W. Weichert1, E.J. Rummeny1, R. Braren1; 1Munich/DE,
2
Essen/DE
11:32 SS 7.5 Synergistic analysis of micro-positron emission
tomography/MRI data using deep learning for
automatic detection of HCC
H.C. Chang1, T.Y. Huang2, E.S. Hui1, W.H.K. Chiu1,
Hong Kong/HK, 2Taipei/TW
11:40 SS 7.6 Assessing hepatic steatosis on US imaging
using deep learning
J.S.N. Tang, J.C.Y. Seah, D. Mitchell, T. Lovell,
M.W. McCusker, W. Wang, R.N. Gibson, F. Gaillard;
Melbourne, VIC/AU
40
11:48 SS 7.7 Radiomic analysis in HCC to predict clinical
outcome after liver transplantation: a preliminary study
R. Faletti, M. Gatti, A. Di Chio, F. Guarasci, F. Tandoi,
R. Romagnoli, P. Fonio; Turin/IT
11:56 SS 7.8 CT texture analysis and RECIST 1.1 criteria:
assessment of response to chemotherapy in colorectal
liver metastases
F. Landolfi1, D. Caruso1, V. Forte1, N. Panvini2, L. De Maria1,
B. D‘Arrigo1, G. Guido1, A. Laghi1; 1Rome/IT, 2Genoa/IT
12:04 SS 7.9 Machine learning-based automated image
registration improves reader confidence and lesion
colocalization in cross-sectional liver studies
K.A. Hasenstab1, G. Moura Cunha1, T.I. Delgado1, K. Wang1,
A. Higaki1, S. Ichikawa1, A. Schlein1, R.L. Brunsing2,
A. Schwartzman1, A. Hsiao1, C.B. Sirlin1, K. Fowler1;
1
La Jolla, CA/US, 2Stanford, CA/US
12:12 SS 7.10 withdrawn by the authors
11:00 – 12:30 / Scientific Session
SS 8 Bologna
Pancreatic neoplasms
Moderators: I. Santiago, Lisbon/PT; H. Xue, Beijing/CN
11:00 SS 8.1 Quantitative CT-based radiomics of pancreatic
ductal adenocarcinoma: a valuable tool for radiological
staging?
M.H.A. Janse1, G. Litjens1, S. Zinger2, P.H.N. de With2,
M. Prokop1, J.J. Hermans1; 1Nijmegen/NL, 2Eindhoven/NL
11:08 SS 8.2 Preoperative nomogram predicting malignancy
in the patients with intraductal papillary mucinous
neoplasm of the pancreas: focused on imaging
features
J.A. Hwang1, S.-Y. Choi2, J.E. Lee2, H.J. Park3, J.H. Min4,
S. Lee3, J.Y. Moon3; 1Cheonan/KR, 2Bucheon/KR,
3
Seoul/KR, 4Daejeon/KR
11:16 SS 8.3 Differential diagnosis of focal pancreatic
masses: autoimmune pancreatitis or adenocarcinoma?
Diagnostic accuracy of CT and post-processing CT
texture analysis
G. Cardano, A. Fighera, L. Frulloni, G.A. Zamboni,
G. Mansueto; Verona/IT

11:24 SS 8.4 Histogram analysis of MR images: assessment
of intra-tumoral heterogeneity and correlation
with the biological behavior of pancreatic ductal
adenocarcinoma
R. De Robertis1, N. Cardobi2, R. Negrelli1, M. D’Onofrio1,
S. Montemezzi1; 1Verona/IT, 2Peschiera Del Garda/IT
11:32 SS 8.5 Prediction of malignant potential in intraductal
papillary mucinous neoplasm of the pancreas:
comparison between contrast-enhanced CT and MRI
using Revised 2017 International Consensus Guideline
J.E. Lee1, S.-Y. Choi1, J.A. Hwang2, J.H. Kim3; 1Bucheon/KR,
2
Cheonan/KR, 3Seoul/KR
11:40 SS 8.6 Prediction of high-grade pancreatic
neuroendocrine neoplasms differentiation with imaging
A. Azoulay, J. Cros, M.-P. Vullierme, V. Vilgrain, M. Ronot;
Clichy/FR
11:48 SS 8.7 CT texture analysis and quantitative imaging
for detection of local tumor recurrence in patients
resected for pancreatic adenocarcinoma
A. Mazzaro, G.A. Zamboni, M. Chincarini, M.C. Ambrosetti,
G. Mansueto; Verona/IT
11:56 SS 8.8 Impact of structured report on the quality
of preoperative CT staging of pancreatic ductal
adenocarcinoma
M. Dimarco, R. Cannella, S. Pellegrino, F. Allegra,
D. Castiglione, F. Vernuccio, G. Brancatelli; Palermo/IT
12:04 SS 8.9 Adenosquamous carcinoma vs. ductal
adenocarcinoma of the pancreas: evaluation of CT and
MRI features
K. Schawkat1, A. Brook1, A. Descovich-Garces1, A.J. Moser1,
C. Decicco1, T. Singer1, J. Glickman1, M. Manning2,
K.J. Mortele1; 1Boston, MA/US, 2Washington, DC/US
12:12 SS 8.10 Solid pseudopapillary neoplasms of the
pancreas: clinicopathological and radiological features
according to size, twenty-year experience from a high-
volume center
A. Grecchi, R. De Robertis, A. Beleù, G. Rizzo, M. Catania,
M.C. Ambrosetti, M. D’Onofrio; Verona/IT
FRIDAY, JUNE 7, 2019
11:00 – 12:30 / Scientific Session
SS 9 Amalfi
Colorectal diseases: CT colonography and beyond
Moderators: A. Plumb, London/UK; L. Costa, Belo Horizone/BR
11:00 SS 9.1 Locally advanced rectal cancer: can diffusion-
weighted imaging and apparent diffusion coefficient
(ADC) predict complete response to chemo-
radiotherapy?
F. Landolfi, F. Coi, I. Martini, E. Pilozzi, M.F. Osti, M. Ferri,
A. Laghi, E. Iannicelli; Rome/IT
11:08 SS 9.2 Polyp detection rate as a quality measure in
CT colonography: analysis of the performance of
a CT colonography service using a reduced bowel
preparation without dietary restriction
S. Vicini1, M. Rengo1, F. Tiberia1, D. Bellini1, G. Trionfera2,
I. Carbone1, A. Laghi3; 1Latina/IT, 2Valmontone/IT, 3Rome/IT
11:16 SS 9.3 Detection rate for advanced neoplasia of single-
round CTC vs. three fecal immunochemical test rounds
in population screening of colorectal cancer: the SAVE
randomized trial
L. Sali, L. Ventura, M. Mascalchi, P. Mantellini, M. Zappa,
G. Grazzini; Florence/IT
11:24 SS 9.4 Role of CTC in differentiating sigmoid cancer
versus chronic diverticular disease
R. Valletta1, N. Faccioli1, M. Tagliamonte1, M. Bonatti2,
E. Santi1, F. Lombardo2, G. Mansueto1; 1Verona/IT,
2
Bolzano/IT
11:32 SS 9.5 Effectiveness of bowel preparation without diet
restriction for optimal quality CTC: a validation study
F. Tiberia1, M. Rengo1, S. Vicini1, D. Bellini1, G. Trionfera2,
I. Carbone1, A. Laghi3; 1Latina/IT, 2Valmontone/IT, 3Rome/IT
11:40 SS 9.6 Patient preferences for whole-body MRI or
conventional staging pathways for colorectal cancer: a
discrete choice experiment
S.A. Taylor, A. Miles, R. Evans, S. Morris, S. Halligan;
London/UK
11:48 SS 9.7 withdrawn by the authors
11:48 SS 9.8 Diagnostic accuracy of MDCT in the assessment
of mesorectal fascia invasion: comparison with MRI
C. Maino, D. Ippolito, C. Talei Franzesi, S.G. Drago,
A. Pecorelli, S. Sironi; Monza/IT
11:56 SS 9.9 Analysis of anatomic variants of superior
mesenteric artery and vein using MDCT
S. Pashapoor1, K.Ç. Atasoy2; 1Bursa/TR, 2Ankara/TR
41
FRIDAY, JUNE 7, 2019

11:00 – 12:30 / Scientific Session – continuation 11:48 SS 10.8 Diffusion-weighted imaging and dynamic
MRI in the study of intraductal papillary mucinous
12:04 SS 9.10 Hydrostatic reduction of intussusception in neoplasms: pathological comparison with tumor grade
pediatric age group: can failure be predicted? correlation
B. Agridag Ucpinar, B. Keles, S. Durmaz, E. Camurcuoglu, G. Giannotti, G. Tedesco, A. Beleù, G. Rizzo, N. Cardobi,
Z. Kazci, E. Ozmen, S.M. Erturk; Istanbul/TR R. De Robertis, M. D’Onofrio; Verona/IT
11:56 SS 10.9 Preoperative imaging evaluation after
downstaging of pancreatic ductal adenocarcinoma: a
11:00 – 12:30 / Scientific Session multi-center study
A. Beleù, G. Rizzo, N. Bellini, A. Grecchi, I. Testa,
SS 10 Milan G. Giannotti, N. Cardobi, R. De Robertis, M. D’Onofrio;
Modern imaging of gastro-pancreatic diseases Verona/IT
Moderators: P. Prassopoulos, Thessaloniki/GR; 12:04 SS 10.10 CT texture variables for the prediction of
A.J. Madureira, Porto/PT pancreatic fistula after pancreaticoduodenectomy
R. Valletta1, G.A. Zamboni1, M.C. Ambrosetti1, M. Bonatti2,
11:00 SS 10.1 Short MRI follow-up protocol in the evaluation F. Lombardo2, G. Mansueto1; 1Verona/IT, 2Bolzano/IT
of hepatic metastases from gastroenteropancreatic
neuroendocrine tumors
Z. Aleksander-Markuszewska1, L. Funicelli2, V. Giannetta2, 11:00 – 12:30 / School of ESGAR
R. Labruna2, N. Fazio2, M. Bellomi2; 1Warsaw/PL, 2Milan/IT
11:08 SS 10.2 The value of diffusion-weighted imaging in SOE 5 Capri
dynamic monitoring to chemotherapy effectiveness of Imaging the pancreas #LVL
I
advanced gastric carcinoma Moderator: C. Triantopoulou, Athens/GR
J. Xu, Xi‘an/CN
11:16 SS 10.3 Predictive value of metastatic CT findings 11:00 Acute and chronic pancreatitis
at initial diagnosis for overall survival in stage IV G.A. Zamboni, Verona/IT
gastric cancer 11:45 Differential diagnosis of solid pancreatic lesions
L. Soydan, A.A. Demir, B.B. Oven Ustaalioglu; Istanbul/TR W. Schima, Vienna/AT
11:24 SS 10.4 Risk assessment for pancreatic fistula after
pancreaticoduodenectomy with preoperative CT
R. Menghini, G.A. Zamboni, A. Cybulski, R. Valletta, 11:00 – 12:30 / Ultrasound Village
G. Mansueto; Verona/IT
11:32 SS 10.5 A 12-year experience of benign pancreatic USV 6 Ultrasound Village
hyperenzymemia: spectrum of secretin-MRCP findings Hands-on Training
C. Gullì1, A. Marrazzo1, G. Restaino2, M. Missere2, E. Cucci2,
G. Sallustio2; 1Rome/IT, 2Campobasso/IT Tutors
11:40 SS 10.6 Evaluation of pancreatic T.V. Bartolotta, Palermo/IT L. Romanini, Cremona/IT
fibrosis with gadolinium ethoxybenzyl D. Cokkinos, Athens/GR P. Ricci, Rome/IT
diethylenetriaminepentaacetic acid-enhanced MRI O. Lucidarme, Paris/FR M. Scheurkogel, The Hague/NL
D. Yunaiyama, H. Yamaguchi, Y. Nagakawa, T.L. Harada, J.B.C.M. Puylaert, The Hague/NL A. Taibbi, Palermo IT
T. Nagao, K. Saito; Tokyo/JP E. Quaia, Padua/IT
11:48 SS 10.7 withdrawn by the authors

42

11:30 – 12:30 / Interventional Workshop
IWS 2 Meeting Room 5
Transjugular interventional procedures:
TIPS and liver biopsy
D. Yu, London/UK
12:45 – 13:45 / Lunch Symposia
SY 5 Florence
Industry-sponsored Symposium
For details please refer to page 83
SY 6
Industry-sponsored Symposium
For details please refer to page 85
12:45 – 13:30 / Tricky Cases
TC 2 Ultrasound Village
Tricky cases from my day job
Moderator: M. Laniado, Dresden/DE
12:45 The stomach – a patient with no previous surgery
12:54 The small bowel – portal gas not only in ischemia
13:03 The small bowel – your diagnosis is right
13:12 The appendix – what the radiologist should know
13:21 The rectum – see one, do one, teach one
13:00 – 13:45 / ESGAR Tutorials
ET 25 Capri
CTC: polyp and cancer cases
#QUESTIONS FROM MY COLLEAGUE
N. Flor, Torre D‘Isola/IT; M. Liedenbaum, Aalborg/DK
FRIDAY, JUNE 7, 2019
13:45 – 14:30 / Poster Session
PO 2 Poster Area / Terminal 1
Poster Session – Diagnostic and interventional
imaging of the pancreas
Moderators: M.A. Bali, Brussels/BE; M. Zins, Paris/FR
13:45 SE-032 Utilisation of Tumour Growth Rate (TGR) in
Neuroendocrine Tumours (NETs): can we overcome the
limitations of RECIST?
S. Moalla1, M. Ronot2, A. Sundin3, D. Pezzutti4, P. Najran5,
R. Otaviano Franca Bezerra4, P. Borg5, N. Vietti Violi6,
H. Vidal Trueba7, E. Baudin1, L. De Mestier2, J. Crona3,
M. Opalinska8, C. Lopez Lopez7, L. Carvhalo4, F. Costa4,
Pisa M. Pavel9, N. Schaefer6, A. Lamarca5, C. Dromain6;
1
Villejuif/FR, 2Clichy/FR, 3Uppsala/SE, 4Sao Paolo/BR,
5
Manchester/UK, 6Lausanne/CH, 7Santander/ES,
8
Krakow/PL, 9Erlangen/DE
13:55 SE-097 Predictors of clinically successful
percutaneous catheter drainage in cute necrotizing
pancreatitis
S. Montagne, M. Zappa, M.-P. Vullierme, L. Paulatto,
V. Rebours, V. Vilgrain, M. Ronot; Clichy/FR
14:05 SE-089 Barriers affecting involvement in research of
abdominal radiology trainees: is the future bright?
F. Vernuccio1, S. Turk2, E. Terrazas Torres3, J. Choa4,
A. Udare5, D. Haroun6, E. Estades7, M. Arzanauskaite8;
1
Palermo/IT, 2Izmir/TR, 3Mexico City/MX, 4Taguig/PH,
5
Mumbai/IN, 6Cairo/EG, 7Newark, NJ/US, 8Liverpool/UK
14:00 – 14:30 / Ultrasound Village
USV 7 Ultrasound Village
Keynote Lectures
#LVL 14:00 Fusion imaging of the liver
II M. D’Onofrio, Verona/IT
14:15 Elastography of the liver
C. Aubé, Angers/FR
43
FRIDAY, JUNE 7, 2019

14:00 – 15:00 / Industry Satellite Workshop 14:30 – 16:00 / Editorial Session

ISWS 2 Meeting Room 4 ES 1 Amalfi

Industry-sponsored Workshop Editorial Session: from submission to publication #LVL
II
For details please refer to page 87 – all you want to know from our Editors in Chief
Moderators: J. Stoker, Amsterdam/NL;
R.G.H. Beets-Tan, Amsterdam/NL
14:30 – 16:00 / Lecture Session
14:30 Why was my manuscript rejected?
LS 7 Florence Y. Menu, Paris/FR
Cystic pancreatic neoplasms – #LVL 14:45 What is the impact of my manuscript in the wider
II
a multidisciplinary approach world?
Moderators: L. Grenacher, Munich/DE; R. Pozzi Mucelli, Verona/IT L. Martí-Bonmatí, Valencia/ES
15:00 Panel discussion: Questions you’ve always wanted to
14:30 Diagnostic accuracy of non-invasive imaging ask the editor but never dared to
modalities Y. Menu, Paris/FR
N. Kartalis, Stockholm/SE L. Martí-Bonmatí, Valencia/ES
14:50 The evolving role of endoscopic ultrasound C. Catalano, Rome/IT
P.G. Arcidiacono, Milan/IT
15:10 When to operate and when to watch and wait?
M. Falconi, Milan/IT 14:30 – 16:00 / School of ESGAR
15:30 Case discussion
SOE 6 Capri
Benign liver disease #LVL
I
14:30 – 16:00 / Lecture Session Moderator: A.G. Schreyer, Regensburg/DE

LS 8 Pisa 14:30 Benign focal liver lesions

ESGAR – ECCO Joint Session: IBD – CD Luminal #LVL B. Op De Beeck, Edegem/BE
Crohn’s Disease: what is known and what is new II 15:15 Vascular disease of the liver
Moderators: J. Rimola, Barcelona/ES; G. Fiorino, Rozzano/IT G. Brancatelli, Palermo/IT

14:30 What the radiologist needs to know

G. Fiorino, Rozzano/IT 14:30 – 15:15 / ESGAR Tutorials
14:45 Assessing small bowel disease activity: which imaging
biomarkers to use ET 26 Bologna
S.A. Taylor, London/UK Why use spectral CT in abdominal imaging? #LVL
II
15:00 Diagnosing fibrostenosing disease: what is new #TECHNICAL TIPS
S.H. Park, Seoul/KR D. Marin, Durham, NC/US; L. Copel, Zerifin/IL
15:15 Evaluation of penetrating disease: how to be most
accurate ET 27 Milan
F. Maccioni, Rome/IT Liver tumour ablation #TECHNICAL TIPS #LVL
II
15:30 Multidisciplinary case-based discussion F. Gómez Muñoz, Barcelona/ES; O. Seror, Bondy/FR

44
 FRIDAY, JUNE 7, 2019

14:30 – 16:00 / Ultrasound Village 16:30 – 17:00 / Honorary Lecture

USV 8 Ultrasound Village HL 3 Florence

Hands-on Training
Tutors
C. Aubé, Angers/FR
T.V. Bartolotta, Palermo/IT
M. D’Onofrio, Verona/IT
O. Lucidarme, Paris/FR
E. Quaia, Padua/IT
P. Ricci, Rome/IT
L. Romanini, Cremona/IT
SAR Honorary Lecture #LVL
II
Moderator: S. Halligan, London/UK
GU imaging pitfalls for GI radiologists
E.M. Remer, Cleveland, OH/US
17:00 – 18:00 / Plenary Session

15:30 – 16:15 / ESGAR Tutorials PS 3 Florence

Clinical Files Session: Live interpretation of #LVL
II
ET 28 Bologna abdominal cases
Malignant liver lesions including HCC: #LVL Moderator: V. Vilgrain, Clichy/FR
II
assessment with contrast-enhanced ultrasound
#FROM MY WORKSTATION Panellists:
T.V. Bartolotta, Palermo/IT; C. Aubé, Angers/FR T. Bollen, Nieuwegein/NL
A. Corr, London/UK
ET 29 Milan J. Heverhagen, Bern/CH
Difficult CTC cases #FROM MY WORKSTATION #LVL A. Torregrosa Andrés, Valencia/ES
II
D. Boone, Colchester/UK; F. Iafrate, Rome/IT

18:00 – 19:00
Amalfi

ESGAR GENERAL ASSEMBLY

For ESGAR Members in good standing only.

45
 HEADLINE
PROGRAMME OVERVIEW
SATURDAY, – SATURDAY, JUNE 8, 2019
JUNE 8, 2019

ULTRASOUND
FLORENCE PISA BOLOGNA AMALFI CAPRI MILAN
VILLAGE

08:00–08:30 ET 30 ET 31 ET 32 ET 33 ET 34
Liver locoregional LIRADS Pancreas / small Hybrid imaging Thickened bowel
therapy bowel (CEUS) wall
08:30–09:00

09:00–09:30 ET 35
Small bowel
LS 9 LS 10 tumour IGT 3 SOE 7 SIRM
09:30–10:00 CTC A tour around the Liver colorectal lgG4-related Residents
-RADS cancer diseases meeting

10:00–10:30 ET 36
Rectal cancer

10:30–11:00 USV 9
Keynote Lectures

11:00–11:30
SS 13
SS 11 SS 14
Diffuse liver
GI tract: SS 12 Technical SOE 8 USV 10
diseases: SIRM
11:30–12:00 infl ammatory Advanced MRI in advances in Abdominal Hands-on
fi brosis, cirrhosis Residents
disease and liver imaging abdominal tumours Training
and portal meeting
beyond imaging
12:00–12:30
hypertension

12:30–13:00

SY 7
13:00–13:30 Lunch
Symposium
SIRM
13:30–14:00 Residents
meeting

14:00–14:30

14:30–15:00
PS 4 & 5
Foundation
15:00–15:30 Course

15:30–16:00 SIRM
Residents
meeting
16:00–16:30

16:30–17:00

46
 SATURDAY, JUNE 8, 2019

08:00 – 08:45 / ESGAR Tutorials 09:00 – 10:30 / Lecture Session

ET 30 Pisa LS 10 Pisa
Follow-up after liver locoregional therapy: #LVL ESGAR – ESUR Joint Session: A tour around the #LVL
II II
according to guidelines #TECHNICAL TIPS -RADS
M. Maas, Amsterdam/NL; C. Reiner, Zurich/CH Moderators: S. Halligan, London/UK;
M.-F. Bellin, Le Kremlin-Bicêtre/FR
ET 31 Bologna
LIRADS: how to use it #STRUCTURED REPORTING #LVL 09:00 Why do we need -RADS?
II
K. Fowler, San Diego, CA/US; S. Halligan, London/UK
G. Moura Cunha, Rio De Janeiro/BR 09:05 Li-RADS
A. Luciani, Creteil/FR
ET 32 Amalfi 09:20 P-RADS
Pancreas and small bowel: assessment with #LVL J. Barentsz, Nijmegen/NL
III
contrast-enhanced ultrasound 09:35 Met-RADS
#FROM MY WORKSTATION D. Koh, Sutton/UK
M. D’Onofrio, Verona/IT; E. Quaia, Padua/IT 09:50 Vi-RADS
V. Panebianco, Rome/IT
ET 33 Capri 10:05 Panel discussion
Hybrid imaging: the best of both worlds #LVL
II
#SINGLE TOPIC
P.R. Ros, Cleveland, OH/US; R. Kochhar, Manchester/UK 09:00 – 10:30 / Image Guided Therapy

ET 34 Milan IGT 3 Amalfi

Thickened bowel wall #LVL Liver colorectal cancer metastases – treatment #LVL
II II
#FROM MY WORKSTATION strategies 2019
S. Upponi, Cambridge/UK; A. Negård, Lørenskog/NO Moderators: R. Golfieri, Bologna/IT; P. Huppert, Darmstadt/DE

09:00 – 10:30 / Lecture Session 09:00 Systemic therapies

F. Mazzuca, Rome/IT
LS 9 Florence 09:20 Surgical therapy of colorectal liver metastases
Hot topics in CT colonography #LVL D. Stippel, Cologne/DE
II
Moderators: M. Morrin, Dublin/IE; C. Hassan, Rome/IT 09:40 Local and locoregional therapies
R. Loffroy, Dijon/FR
09:00 Moderator’s introduction 10:00 Case discussion
M. Morrin, Dublin/IE
09:05 Diverticular disease: should CTC be the primary
imaging modality? 09:00 – 10:30 / School of ESGAR
P. Lefere, Roeselare/BE
09:25 Non polypoid and serrated lesions: where is the truth? SOE 7 Capri
P. Pickhardt, Madison, WI/US IgG4-related diseases #LVL
II
09:45 CT colonography and colo-rectal cancer screening: an Moderator: S. Kobayashi, Kanazawa/JP
update
D. Regge, Turin/IT 09:00 IgG4-related pancreatitis
10:05 Panel discussion: Crossfire – 10 burning questions M. Vullierme, Clichy/FR
from the gastroenterologist 09:45 IgG4-related extra-pancreatic diseases
H. Jang, Toronto, ON/CA

47
SATURDAY, JUNE 8, 2019
09:00 – 09:45 / ESGAR Tutorial
ET 35 Bologna
Small and large bowel tumours and mimics #LVL
II
#FROM MY WORKSTATION
L. Blomqvist, Stockholm/SE; E. Biscaldi, Genoa/IT
10:00 – 10:45 / ESGAR Tutorials
ET 36 Bologna
Rectal cancer #STRUCTURED REPORTING #LVL
II
K. Gormly, Norwood, SA/AU; D. Lambregts, Amsterdam/NL
10:30 – 11:00 / Ultrasound Village
USV 9 Ultrasound Village
Keynote Lectures
10:30 Color-Doppler US of the portal vein
D. Cokkinos, Athens/GR
10:45 US of the small bowel
J.B.C.M. Puylaert, The Hague/NL
11:00 – 12:30 / Scientific Session
SS 11 Florence
GI tract: inflammatory disease and beyond
Moderators: D. Bellini, Latina/IT; R. Fischbach, Hamburg/DE
11:00 SS 11.1 Comparison of a simplified MR index of
activity with and without gadolinium for assessing
luminal disease and therapeutic response in patients
with Crohn’s disease
J. Rimola, N. Capozzi, A. Fernandez-Clotet, I. Alfaro,
M. Masamunt, I. Ordás, J. Panes; Barcelona/ES
11:08 SS 11.2 Simultaneous T1 and T2 mapping for bowel
wall imaging in Crohn’s disease with MR fingerprinting
V. Obmann1, N. Seyfried2, A. Panda3, W.-C. Lo2, Y. Jiang2,
K. Wright2, P. Sinh2, M. Dave2, J. Katz2, K. Ropella-Panagis2,
V. Gulani2; 1Bern/CH, 2Cleveland, OH/US, 3Rochester, MN/US
48
11:16 SS 11.3 Evaluation of a new CT enterography score for
inflammatory activity in Crohn’s disease: correlation
with laboratory and endoscopic findings, and inter-
reader agreement
A. Agostini, A. Borgheresi, M. Antonarelli, D. Campioni,
L. Ottaviani, S. Gemini, A. Pisani, P. Mosca, A. Giovagnoni;
Ancona/IT
11:24 SS 11.4 Which diffusion-weighted imaging – Short-
TI Inversion Recovery or Spectral Presaturation
with Inversion Recovery-based – is better for the
assessment of quantification of Crohn’s disease
inflammation?
I. Apine, R. Pitura; Riga/LV
11:32 SS 11.5 Structured report on small bowel Crohn’s
Disease: how we developed it
P. Rudenko1, A. Batista Domenech1, A. Perez Girbes1,
P. Stajgis2, J.P. Azorin Vicente1, A. Torregrosa Andrés1,
L. Martí-Bonmatí1; 1Valencia/ES, 2Poznan/PL
11:40 SS 11.6 MR enterography for the assessment of
postoperative GI function: technique and patient
tolerability
S. Chapman1, J.A- Helliwell1, A. Menys2, D.G. Jayne1,
D. Tolan1; 1Leeds/UK, 2London/UK
11:48 SS 11.7 Qualitative and quantitative analyses of virtual
non-contrast images in CT enterography with a 3rd-
generation dual-source dual-energy CT
A. Agostini, A. Borgheresi, M. Antonarelli, F. Cela,
L. Ottaviani, F. Terilli, A. Giovagnoni; Ancona/IT
11:56 SS 11.8 MR fistulography with percutaneous
instillation of US gel and its role in preoperative
mapping
G. Fontanella, M. Mancinelli, A. Festa, S. De Lucia,
C.A.T. Manganiello, R. Villanacci; Benevento/IT
12:04 SS 11.9 Cine-MRI for the quantification of antral
motility: comparison between obese and normal weight
people
S. Picchia1, M. Rengo1, M.A. Bali2, D. Bellini1, S. Badia1,
I. Carbone1, A. Laghi3; 1Latina/IT, 2Brussels/BE,
3
Rome/IT
12:12 SS 11.10 Is there a relationship between the number
of middle colic artery and transverse colon length?
A study of radiological anatomy with 3D CT
S. Pashapoor, Bursa/TR

11:00 – 12:30 / Scientific Session
SS 12 Pisa
Advanced MRI in liver imaging
Moderators: M. Wagner, Paris/FR; L. Martí-Bonmatí, Valencia/ES
11:00 SS 12.1 Agreement between MR elastography liver
stiffness estimates obtained from fully automated
convolutional neural network-based and manually
drawn regions-of-interest
T.I. Delgado1, G. Moura Cunha1, K.A. Hasenstab1,
D.N. Batakis1, K. Wang1, A. Mamidiapalli1, A.S. Boehringer1,
W. Henderson1, C. Chung2, S. Djedjos2, R.P. Myers2,
M. Middleton1, C.B. Sirlin1; 1San Diego, CA/US,
2
Foster City, CA/US
11:08 SS 12.2 Enhancement patterns and
immunohistochemical features of gadoxetic acid-
enhanced MRI in patients with non-alcoholic fatty liver
disease: new results
D. Feier1, N. Bastati-Huber2, A. Beer2, S. Pötter-Lang2,
R. Fragner2, A. Ba-Ssalamah2; 1Cluj-Napoca/RO, 2Vienna/AT
11:16 SS 12.3 Comparison of diagnostic performance of
‘short’ and ‘long’ MRI protocols for the detection of
colorectal liver metastases
C. Ghorra1, R. Pommier1, S. Terraz2, V. Vilgrain1, M. Ronot1;
1
Clichy/FR, 2Geneva/CH
11:24 SS 12.4 Accuracy of gadolinium ethoxybenzyl
diethylenetriamine pentaacetic acid-enhanced MRI for
the diagnosis of liver metastases from neuroendocrine
tumors
R.H. Hayoz, C. Dromain, N. Vietti Violi, J.-F. Knebel,
R. Duran; Lausanne/CH
11:32 SS 12.5 Iso- or hyperintensity of hepatocellular
adenomas on hepatobiliary phase does not always
correspond to hepatospecific contrast agent uptake
E. Reizine1, M. Ronot2, F. Pigneur1, Y. Purcell2, S. Mule1,
M. Dioguardi Burgio2, V. Vilgrain2, A. Luciani1; 1Créteil/FR,
2
Clichy/FR
11:40 SS 12.6 Hepatic localization of extramedullary
hematopoiesis in beta-thalassemia patients: diagnostic
accuracy of T2*, apparent diffusion coefficient and
gadolinium-enhanced dynamic MRI
P.P. Arcuri1, A.K. Sikora1, S. Roccia1, V. Aiello1, G. Fodero1,
C. Bertucci2, M.C. Galati1, D. Laganà1; 1Catanzaro/IT,
2
Buckingham/UK
SATURDAY, JUNE 8, 2019
11:48 SS 12.7 Hepatocellular adenomas: is there
additional value of using gadolinium-ethoxybenzyl-
diethylenetriamine penta-acetic acid in subtype
differentiation?
U. Fehrenbach1, T.A. Auer1, C. Grieser1, N. Raschzok1,
H. Bläker1, D. Geisel1, D. Seehofer2, T. Müller1,
M. Schmelzle1, T. Denecke1; 1Berlin/DE, 2Leipzig/DE
11:56 SS 12.8 The effect of steatosis, iron overload, and
renal function on the uptake and excretion of gadoxetic
acid-enhanced MRI
S. Pötter-Lang, L. Beer, N. Bastati-Huber, M. Mandorfer,
M.C. Elmer, T. Reiberger, A. Ba-Ssalamah; Vienna/AT
12:04 SS 12.9 Findings of sinusoidal obstruction syndrome
on gadoxetic acid-enhanced MRI in patients with
chemotherapy for colorectal liver metastases are
poorly reproducible between radiologists
F. Staal1, J.B. Houwers2, B. Heeres1, D. van Dorth1,
D. Lambregts1, R.G.H. Beets-Tan1, M. Maas1;
1
Amsterdam/NL, 2Maastricht/NL
12:12 SS 12.10 Inter-observer reproducibility of liver
stiffness measurement using MR elastography
V. Phou, P.-A.Lampson, A. Fourquet, M. Dubois,
P.-H. Jouve de Guibert, A. Ayed, A. Prenois, L. Le Deunf,
J. Barcellitti, O. Lucidarme, M. Wagner; Paris/FR
11:00 – 12:30 / Scientific Session
SS 13 Bologna
Diffuse liver diseases: fibrosis, cirrhosis and portal
hypertension
Moderators: A. Huber, Bern/CH; B. Sureka, Jodhpur/IN
11:00 SS 13.1 Performance of morphologic criteria for
the diagnosis of cirrhosis in patients with different
etiologies of chronic liver disease
R. Cannella1, N. Dasyman2, A. Furlan2, A.A. Borhani2;
1
Palermo/IT, 2Pittsburgh, PA/US
11:08 SS 13.2 Performance of liver surface nodularity
quantification for the detection of portal hypertension
in cirrhotic patients: comparison between gadobenate
disodium-MRI and CT
N. De Vos, R. Sartoris, F. Cauchy, P.-E. Rautou, V. Vilgrain,
M. Ronot; Clichy/FR
49
SATURDAY, JUNE 8, 2019
11:00 – 12:30 / Scientific Session – continuation
11:16 SS 13.3 Liver vein to cava attenuation improves
prediction of clinically significant fibrosis when
combined with liver volumetry and caudate-right lobe
ratio on portal venous CT scans
C. Marx, V. Obmann, J. Hrycyk, L. Ebner, A. Berzigotti,
J. Heverhagen, A. Christe, A. Huber; Bern/CH
11:24 SS 13.4 Evaluation of the risk of esophageal varices
bleeding in cirrhotic patients with multi-slice CT
portography
S. Wan, B. Son; Chengdu/CN
11:32 SS 13.5 Acute alcoholic hepatitis, towards a
radiological diagnosis?
F. Grillet, P. Calame, J.P. Cervoni, E. Delabrousse;
Besançon/FR
11:40 SS 13.6 Predicting different stages of liver fibrosis
with 2D shear-wave elastography: histopathological
correlation study
M. Aksakal, S. Özhan Oktar, H. Şendur, G. Esendağlı Yılmaz,
S. Özenirler, M. Cindoruk, K. Hızel, F.N. Baran Aksakal,
C. Yücel; Ankara/TR
11:48 SS 13.7 withdrawn by the authors
11:48 SS 13.8 Revisiting the role of US surveillance for HCC
in chronic liver disease
J.H. Kim, S.J. Ahn, J.K. Han; Seoul/KR
11:56 SS 13.9 Resona 7 speed of sound index diagnostic
performance in B-mode US using liver biopsy as ‘Gold
Standard’ for non-alcoholic fatty liver disease and non-
alcoholic steatohepatitis assessment
I. Gatos1, P. Drazinos1, S.D. Yarmenitis2, E. Manessis2,
P.S. Zoumpoulis1; 1Kifissia/GR, 2Athens/GR
12:04 SS 13.10 Liver surface nodularity quantification on
preoperative CT: a predictive measurement of the
operative risk after liver resection for resectable HCC
C. Hobeika, F. Cauchy, R. Sartoris, V. Vilgrain, O. Soubrane,
M. Ronot; Clichy/FR
50
11:00 – 12:30 / Scientific Session
SS 14 Amalfi
Technical advances in abdominal imaging
Moderators: R. De Robertis, Verona/IT; F. Vernuccio, Palermo/IT
11:00 SS 14.1 Prognostic value of preoperative diffusion-
weighted MRI in colorectal peritoneal carcinomatosis
patients using leading prediction models
M. Engbersen, I. Van‘t Sant, J. Velzing, D. Lambregts,
H. Van Eden, R.G.H. Beets-Tan, A. Aalbers, N. Kok,
M. Lahaye; Amsterdam/NL
11:08 SS 14.2 Optimization of contrast medium volume in
abdominal CT: a prospective comparison between
fixed and lean body weight-adapted injection protocols
E. Rosati1, N. Panvini2, G. Moltoni1, E. Lucertini1, B. Bracci1,
D. Caruso1, A. Laghi1; 1Rome/IT, 2Latina/IT
11:16 SS 14.3 Breath-hold compressed-sensing 3D MRCP
compared to free-breathing 3D MRCP: prospective
study of image quality and diagnostic performance in
pancreatic disorders
I. Mannes1, A. Dallongeville2, N. Badat2, H. Beaussier2,
G. Chatellier2, M. Zins2; 1Le Kremlin-Bicêtre/FR, 2Paris/FR
11:24 SS 14.4 Evaluation of liver MR elastography
analyzability criteria using a simulation method based
on successively decreasing the size of the selected
region-of-interest: a proof-of-concept study
M. Middleton1, W. Henderson1, C.K. Potu1, T.I. Delgado2,
C. Chung3, S. Djedjos3, R.P. Myers3, J. Chen4, C.B. Sirlin5;
1
San Diego, CA/US, 2Encinitas, CA/US, 3Foster City, CA/US,
4
Rochester, MN/US, 5La Jolla, CA/US
11:32 SS 14.5 Spleen MR elastography: what are the
predictive factors of successful and usable data on a
liver MR elastography acquisition?
P.A. Lampson1, R.H. Kim2, O. Lucidarme1, M. Wagner1;
1
Paris/FR, 2Seoul/KR
11:40 SS 14.6 Probe pressure for shear wave elastography
liver exams?
M. Byenfeldt, Umeå/SE
11:48 SS 14.7 withdrawn by the authors
11:48 SS 14.8 Influence of injection rate in determining the
development of artifact during acquisition of dynamic
arterial phase in gadoxetic acid MRI studies
C. Maino, A. Pecorelli, C. Talei Franzesi, L. Riva, E.B. Orsini,
S. Sironi, D. Ippolito; Monza/IT
 SATURDAY, JUNE 8, 2019

11:56 SS 14.9 Role of dedicated subspecialized radiologists
in multidisciplinary team recommendations for gastric
neoplasms
S. Jang, S.H. Kim, H.-K. Yang, H.J. Lee, S.-H. Kong, S.-A. Im,
D.-Y. Oh, H.S. Chung, J.K. Han; Seoul/KR
12:04 SS 14.10 Expert-reader validation of optimised super-
resolution reconstruction for upper abdominal MRI
M.D. Chouhan, M. Ebner, P. Patel, D. Atkinson, L. Firmin,
Z. Amin, P.D. Coppi, S. Ourselin, T. Vercauteren, S.A. Taylor;
London/UK
11:00 – 12:30 / School of ESGAR
12:45 – 13:45 / Lunch Symposium
SY 7 Amalfi
Industry-sponsored Symposium
For details please refer to page 86
14:00 – 15:00 / Plenary Session
PS 4 Pisa
Nick Gourtsoyiannis’ Foundation Course 1: #LVL
II
Radiologic-pathologic correlation: liver
Moderators: H. Fenlon, Dublin/IE; A. Ba-Ssalamah, Vienna/AT

SOE 8 Capri 14:00 Benign hepatic neoplasms – adenoma and FNH

Abdominal tumours #LVL V. Vilgrain, Clichy/FR
II
Moderator: M. Radzina, Riga/LV 14:20 Comments from the pathologist
V. Paradis, Paris/FR
11:00 Imaging features in abdominal lymphoma 14:30 Malignant hepatic tumours – HCC with central scar and
E. De Kerviler, Paris/FR fibrolamellar HCC
11:45 How to diagnose a mass in the spleen? L. Grazioli, Brescia/IT
L.H. Ros Mendoza, Zaragoza/ES 14:50 Comments from the pathologist
V. Paradis, Paris/FR

11:00 – 12:30 / Ultrasound Village

USV 10 Ultrasound Village
Hands-on Training
Tutors
T.V. Bartolotta, Palermo/IT
D. Cokkinos, Athens/GR
O. Lucidarme, Paris FR
P. Maceroni, Latina/IT
J.B.C.M. Puylaert, The Hague/NL
E. Quaia, Padua/IT
15:15 – 16:15 / Plenary Session
PS 5 Pisa
Nick Gourtsoyiannis’ Foundation Course 2: #LVL
II
Radiologic-pathologic correlation: small bowel
P. Ricci, Rome/IT Moderators: H. Fenlon, Dublin/IE; G.A. Rollandi, Genoa/IT
L. Romanini, Cremona/IT
M. Scheurkogel, The Hague/NL 15:15 Small bowel malabsorption including Coeliac disease
A. Taibbi, Palermo/IT and its complications
F. Scholz, Burlington, MA/US
15:35 Comments from the pathologist
V. Villanacci, Brescia/IT
15:45 Small bowel – systemic disorders affecting the small
bowel
C. Hoeffel, Reims/FR
16:05 Comments from the Pathologist
V. Villanacci, Brescia/IT

51
SABATO, 8 GIUGNO, 2019

UNA FINESTRA SULLA RADIOLOGIA

GASTROENTEROLOGICA ITALIANA
(con il patrocinio della Sezione di studio in Radiologia Addominale
Gastroenterologica della SIRM)

SESSIONE I. Aggiornamenti in TC multienergia SESSIONE III. 

Moderatori: D. Marin, Durham, NC/US;
B. Beomonte Zobel, Roma/IT
09:00 – 09:20 Principi fisici e differenti tecnologie
D. Caruso, Roma/IT
09:20 – 09:40 Evidenze e beneficio clinico nell’imaging del
fegato
M.A. Mazzei, Siena/IT
Approccio multidisciplinare alla malattia
peritoneale maligna
Moderatori: P. Sammartino, Roma/IT;
F. Iafrate, Roma/IT
13:00 – 13:20 Le richieste del chirurgo
M. Vaira, Candiolo/IT
13:20 – 13:40 Stadiazione pre-operatoria
E. Iannicelli, Roma/IT

09:40 – 10:00 Altre applicazioni GI: presente e futuro 13:40 – 14:00 Ristadiazione dopo terapia neoadiuvante
D. Marin, Durham, NC/US D. Campanella, Candiolo/IT

10:00 – 10:30 Discussione interattiva di casi clinici 14:00 – 14:30 Discussione interattiva di casi clinici
D. Marin, Durham, NC/US; B. P. Sammartino, Roma/IT; F. Iafrate, Roma/IT
Beomonte Zobel, Roma/IT

SESSIONE IV. Patologie non neoplastiche del colon

SESSIONE II. P
 atologie del pavimento pelvico Moderatori: G. Lo Re, Palermo/IT;
Moderatori: G. Masselli, Roma/IT; D. Palladino, San Giovanni Rotondo/IT
L. Manganaro, Roma/IT
15:00 – 15:20 Colonoscopia virtuale e malattia diverticolare
11:00 – 11:20 Imaging funzionale integrato N. Flor, Milano/IT
P. Cerro, Roma/IT
15:20 – 15:40 Diverticolite acuta e diagnosi differenziali
11:20 – 11:40 Come l’imaging guida la gestione del paziente R. Rizzati, Ferrara/IT
A. Reginelli, Napoli/IT
15:40 – 16:00 La TC nelle coliti
11:40 – 12:00 Esiste un ruolo per l’ecografia? E. Biscaldi, Genova/IT
G. Serafini, Savona/IT
16:00 – 16:30 Discussione interattiva di casi clinici
12:00 – 12:30 Discussione interattiva di casi clinici G. Lo Re, Palermo/IT;
G. Masselli, Roma/IT; L. Manganaro, Roma/IT D. Palladino, San Giovanni Rotondo/IT

12:30 – 12:45 Interludio: Saluto del Presidente SIRM 16:30 – 16:45 Conclusioni
R. Grassi, Napoli/IT A. Laghi, Roma/IT

52
 POSTER
PRESENTATIONS

ALL EDUCATIONAL / SCIENTIFIC EXHIBITS ARE DISPLAYED

IN THE E-POSTER AREA ON THE ENTRANCE LEVEL.

A NUMBER OF COMPUTER TERMINALS ARE AVAILABLE FOR

VIEWING THE PRESENTATIONS.

THE POSTERS ARE ACCESSIBLE ONLINE AS WELL:

WWW.ESGAR.ORG/PROGRAMMEPLANNER2019

POSTER PRESENTATIONS – EDUCATIONAL Page 54 – 63

POSTER PRESENTATIONS – SCIENTIFIC Page 64 – 70

MCL Magna Cum Laude CL Cum Laude CM Certificate of Merit RP Recommended Poster

53
POSTER PRESENTATION – EDUCATIONAL
HEADLINE
ABDOMINAL VASCULAR IMAGING
EE-001 Leiomyosarcoma of Inferior Vena Cava
A. Thomas1, L. Pelegrí1, F. Calaf1, V. Valles1,
D. De Bonadona1, R. Oliveira1, X. Sanjuan Garriga2;
1
Barcelona/ES, 2L’hospitalet De Llobregat/ES
EE-002 The Abdominal Manifestations of Kawasaki
Disease in Children: A Pictorial Review
E.L.H. Teo, Singapore/SG
EE-003 CT and angiographic findings of segmental
arterial mediolysis
N. Inmutto, T. Srisuwan, T. Kattipatanapong,
W. Na Chiang Mai, S. Pojchamarnwiputh;
Chiang Mai/TH
EE-004 Arterial Segmental Mediolysis
C. Pancotte, M. Fong, G. Silva, A. Buissa, U. Torres,
A. Albuquerque, G. D’Ippolito; São Paulo/BR
EE-005 Liver vascular diseases: a pictorial review
J. Elias, C. Fregonesi, D. Assunção, N. Assunção,
L. Ferreira, T. Bricio, V. Ricci, A. Trazzi, V. Muglia;
Ribeirao Preto/BR
EE-006 Arterial supply and venous drainage of biliary
tree and their relevance to vasculobiliary injuries
following liver transplantation, cholecystectomy
and trauma
J. Elias, C. Fregonesi, D. Assunção, N. Assunção,
L. Ferreira, T. Bricio, V. Ricci, A. Trazzi, V. Muglia;
Ribeirao Preto/BR
ACUTE ABDOMEN
EE-008 Pylephlebitis: a rare and potentially fatal
complication
N. Caserta1, T. Penachim1, R. Barros1, G. Martins2,
B. Loureiro1, D. Martins1; 1Campinas/BR, 2São Paulo/BR
EE-009 Spontaneous Isolated Coeliac Artery Dissection
(SICAD)– Imaging Findings and Therapeutic
Approach
K. Ganesan, S. Alam, S. Bhalja, A. Jain, S. Jalkote,
S. Seelan, S. Nellore; Mumbai/IN
EE-010 Acute Right Iliac Fossa pain, beyond appendicitis
A. Thomas, L. Pelegrí, F. Calaf, E. Almazan, J. Míguez,
P. Lozano; Barcelona/ES
EE-011 The role of MRI in the assessment of
pregnant women and children presenting with acute
abdominal pain
N. Bashar, M. Simpson, R. Hawkins; Crewe/UK
54
EE-012 Radiological findings of ischemic abdominal
diseases compared with pathological findings
S.J. Park, H.C. Kim, J.S. Park, M. You, S.K. Moon;
Seoul/KR
EE-013 Proper ultrasonographic approach to right upper
quadrant pain: what radiologists should know
H.C. Kim, S.W. Kim, D.M. Yang, S.J. Park; Seoul/KR
EE-014 Blunt Abdominal Trauma by Motor Vehicle Accidents
– Review of MDCT Findings
D.J. Kim, Seongnam/KR
EE-015 A Review of uncommonly encountered conditions
related to appendix on CT
H.C. Kim, S.W. Kim, D.M. Yang, S.J. Park, J.S. Park;
Seoul/KR
EE-017 CT Findings of Blunt Bowel and Mesenteric Injuries:
RP from the Subtle to the Specifics
H. Shi, W.C. Teoh, P. Ng, C.K. Cheong, S.F. Lim,
E.L.S. Koh, K. Lin, T.W. Ang, S.C.W. Cheong;
Singapore/SG
EE-018 Adhesion-related Small Bowel Obstruction:
Be aware of the ominous CT findings.
S.Z. Ali, D. Singh; Singapore/SG
EE-019 The A – Z of Abdominal Radiography:
Mapping abdominal radiograph signs
R. Hughes, G. Vigneswaran, J. Dunbar, P. Jarvis;
Southampton/UK
EE-020 The role of imaging in acute abdominal pain in
women of child-bearing age
F. Perillo, Rome/IT
EE-021 Always check the vessels! Considering arteritis
as a cause of acute abdominal pain
M. Dawood, P. Gaur, S. Vessal; London/UK
EE-022 The Abdominal Trauma CT for Junior Radiologists
in Training
R. Hughes, P. Jarvis, J. Dunbar, G. Vigneswaran;
Southampton/UK
EE-023 Internal hernia and closed loop obstruction:
an important CT diagnosis following Roux-en-Y
gastric bypass
S. Sammut, P. Venkatappa, A. James, B. Thomas;
Stoke-on-Trent/UK
EE-024 Diagnosis and classification of splenic injuries.
”For whom the bell tolls“.
O. Nikolaidou, R. Goulimari, L. Panagiotidou,
E. Tsamourlidou, K. Dimitrova, V. Giatskos, G. Passias,
S. Dimitriadis; Xanthi/GR
 POSTER PRESENTATION – EDUCATIONAL
HEADLINE
BILE DUCTS AND GALLBLADDER
EE-025 How to differentiate UK cancer from the mimickers?
H.W. Eun, J.H. Kim; Seoul/KR
EE-026 Gallbladder Adenomyomatosis:
Differentiating from mimics
G. Nandra, P. Patel, K. Patel, O. Duxbury, J. Patel, N. Patel;
London/UK
EE-027 The Cholangiopathies – diseases of the biliary tract:
Radiologists quandary
B. Sureka, N. Sharma, P. Khera, P. Garg, T. Yadav,
V. Varshney, P. Elhence; Jodhpur/IN
EE-028 Acute cholecystitis complications:
what to be aware of
C. Silva1, A.C. Silva2, P. Mendes da Costa2;
1
Guimarães/PT, 2Matosinhos/PT
EE-029 Various Diseases Causing Gallbladder Wall
Thickening: Imaging Findings
Y.Y. Jung, Seoul/KR
EE-030 Gallbladder conundrums: A case-based approach.
A. Al-Khatib, V. Leung, D. Bowden, N. Carroll,
E.M. Godfrey; Cambridge/UK
EE-031 Choosing the best test for biliary imaging.
Re-examining the role of MRCP
A. Nair, D. Macdonald, S. Kenshil; Ottawa, ON/CA
EE-032 Primary sclerosing cholangitis:
RP Emphasis on role of MRI in assessing evolution &
complications
A. Nair, D. Macdonald, S. Kenshil; Ottawa, ON/CA
EE-033 Biliary cast: don’t call it a stone!
M. Pezzullo1, A. Lemmers1, V. Lucidi1, A. Hadefi1,
S. Picchia2, M.A. Bali1; 1Brussels/BE, 2Latina/IT
EE-034 Gall Bladder Polyp to Carcinoma – “The Road to Hell”
RP K. Ganesan, S. Jalkote, A. Jain, S. Bhalja, S. Alam,
S. Nellore; Mumbai/IN
EE-035 Primary and Secondary Sclerosing Cholangitis:
A Practical Guide for Diagnostic Management Based
on Imaging Patterns
A. Motoyama Caiado, U. Torres, H. Pria, L. Senna,
L. Bueno, F. Velloni, D. Tiferes, G. D’Ippolito;
São Paulo/BR
EE-036 The gallbladder beyond the stones
RP P.G. Maciel Lopes, F. Velloni, R. de Oliveira, R. Blasbalg;
São Paulo/BR
EE-037 Deep in Intraductal Papillary Neoplasm of the Bile
Duct: Imaging and Pathologic features.
X. Merino-Casabiel, A. Anton-Jimenez,
M.T. Salcedo-Allende, D. Armario Bel, S. Roche,
R. Mast, M. Vera-Cartas, M.J. Moreno-Negrete,
N. Roson; Barcelona/ES
EE-038 Emergency, chronic and iatrogenic conditions
RP of the gallbladder
M. Guilloique, A. Paisant, A. Venara, P. Bazeries,
J. Lebigot, C. Aubé; Angers/FR
COMPUTER TOMOGRAPHY
EE-039 Pelvic Computed Tomography Angiography Prior to
Prostatic Artery Embolization: Technical Applications
and Advantages
X.Y. Fong, S.F. Muhammad, S. Chandramohan;
Singapore/SG
EE-040 Abdominal manifestations of IgG4-related disease:
A pictorial review
R. Hodnett, K. Watt, A. Abdellaoui, B. Fox, S. Jackson;
Plymouth/UK
EE-041 Dual Energy- Game changer in Emergency and
Trauma Radiology
P. Mukherjee1, S. Mathur2, A. Chawla1, S. Nicolaou2;
1
Singapore/SG, 2Vancouver, BC/CA
EE-042 Dual Energy CT applications in patients with
hepatocellular carcinoma
C. Sofia, M. Marino, A. Blandino, G. Ascenti; Messina/IT
GI TRACT – COLON
EE-043 Colorectal cancer staging – what your surgeon needs
to know
S. Thipphavong, J. Sammon; Toronto, ON/CA
EE-044 Pitfalls in colorectal cancer imaging – if you don’t put
your thought in it, you’ll put your foot in it
V. Leung, S. Upponi, D. Bowden, A. Al-Khatib, N. Carroll,
E.M. Godfrey; Cambridge/UK
EE-045 Colorectal Carcinomas Presenting As Acute
Abdomen: An Interactive Case Based Review.
M. Subramanian, Singapore/SG
55
POSTER PRESENTATION – EDUCATIONAL
HEADLINE
GI TRACT – COLON – CONTINUATION
EE-046 Differentiation of Pneumatosis Intestinalis;
between benign and life-threatening cause
S.S. Hong, H.J. Cha; Seoul/KR
EE-047 Colorectal MDT: Does this patient need PET/CT?
V. Leung, A. Al-Khatib, S. Upponi, D. Bowden,
H. Cheow, E.M. Godfrey; Cambridge/UK
EE-048 The ”blind“ bowel: a comprehensive review
on cross-sectional imaging of the cecum
U. Torres, D. Tiferes, L. Torres, E. Bretas, S. Ueda,
G. D’Ippolito, A. Motoyama Caiado; São Paulo/BR
EE-049 Acute mesenteric ischemia: CT findings not to miss
F. Costeira, F. Gomes, P. da Silva, C. Leite; Braga/PT
GI TRACT – OESOPHAGUS
EE-051 Brief review of most common oesophageal
pathology. Yes, Barium swallow is still alive!
P. Vlachou1, N. Lama2, L. Adamopoulou2,
C. Triantopoulou2; 1Nea Ionia/GR, 2Athens/GR
EE-052 2019 GI Fluoroscopy: We Must OWN the Esophagus
CM D. DiSantis, B. Hauck, J. Cernigliaro; Jacksonville, FL/US
EE-053 Locally advanced esophageal cancer: A pictorial
essay about complications
P. Araujo, L. Albieri, A. Aranha, F. Ribeiro Ferreira,
A.F. de Paiva; São Paulo/BR
GI TRACT – OTHER
EE-054 Do not Underestimate the Omentum!
An Illustrated Guide to Omental Infarcts
C. Leidersnaider, R. Perrotta, S. Araujo, C. Arantes,
J. Morales, R. Zeitoune, C. Constantino;
Rio De Janeiro/BR
EE-055 Imaging finding of acute invasive gastrointestinal
Anisakiasis
J.H. Park, G.M. Choi, B.S. Kim, J.S. Lee, S.H. Kim,
I.K. Hwang, M.J. Koh; Jejusi/KR
EE-056 CT Findings related to Fish Bone in GI tract
RP J.H. Park, G.M. Choi, B.S. Kim, J.S. Lee, S.H. Kim,
I.K. Hwang, K.R. Lee; Jejusi/KR
EE-057 Pathology not to overlook in the investigation
MCL of suspected appendicitis
V. Halai, S. Higginson, A. Higginson, C. Ball,
R. Beable; Portsmouth/UK
56
EE-058 Ingested and inserted foreign bodies in the abdomen
and pelvis: radiographic and CT findings
Y.S. Lee1, J.Y. Woo2, J. Jung1, D.B. Kim1, E.K. Lee1,
E.J. Lee1; 1Goyang-Si/KR, 2Seoul/KR
EE-059 Inflammatory Bowel disease and cancer:looking
CM beyond the surface
T. Chawla, M.E. O‘Malley, J. Conner, R. Ridell,
H. Macrae; Toronto, ON/CA
EE-060 Malignant bowel obstruction (MBO): what does your
RP clinician need to know?
T. Chawla, Y.C. Lee, S. Lheureux, N. Jivraj, E. Shlomovitz,
P. Dhar, S. Ferguson, A. Oza; Toronto, ON/CA
EE-061 ”Around ileo-caecal region in 2500 words“- an organ
RP based imaging review of pathologies
V. Kalia, V. Kalia; Akureyri/IS
EE-062 Imaging findings of acute appendicitis with
secondary hydronephrosis
J.Y. Woo1, J.H. Kim1, Y.S. Lee2; 1Seoul/KR, 2Goyang-Si/KR
EE-063 Three uncommon imaging scenarios in patients
with Crohn’s. Three interesting learning points to aid
diagnostic interpretation
O. Evans, B. Rea, T. Shareef; Sheffield/UK
EE-064 Out of the labyrinth: a radiologist’s guide to the
main surgical techniques, postsurgical imaging
anatomy and common complications of major
abdominal surgeries
U. Torres, S. Ueda, L. Torres, E. Bretas,
A. Motoyama Caiado, G. D‘Ippolito; São Paulo/BR
EE-065 Volvulus of the gastrointestinal tract:
radiographic features
A. Aguiar Ferreira, J. Macedo, N. Pereira da Silva,
N. Campos, C. Terra, P. Gomes, P. Donato; Coimbra/PT
EE-066 An algorithmic step-by-step approach to pathologies
involving Duodenum and Paraduodenal region
K. Ganesan, S. Jalkote, S. Bhalja, A. Jain, S. Alam,
S. Nellore; Mumbai/IN
EE-067 Untangling the Diagnostic Enigma: Imaging Pearls
and Pitfalls in Gastrointestinal Tract Endometriosis
A. Jaramillo, K. Mortele; Boston, MA/US
GI TRACT – RECTUM
EE-068 Test Your Assessment of Rectal Cancer Response
RP using Tumour Regression Grading (TRG) Systems
J. Mercer1, S. Nishtala2, P. Manoharan1, A. Taheri1,
A. Renehan1, M. Saunders1, R. Kochhar1; 1Manchester/UK,
2
Stoke-on-Trent/UK
 POSTER PRESENTATION – EDUCATIONAL
HEADLINE
EE-069 Rectal lesions on MR- beyond adenocarcinoma
C. Ivan, S. Hudson, A. Osman, V. Shah, R. Verma,
J. Stephenson; Leicester/UK
EE-070 Perianal sepsis – surgical perspective and practical
CM MRI reporting for radiologists
E. Ho1, M. Rickard1, M. Suen1, A. Keshava1, C. Kwik2,
Y. Ong1, J. Yang1; 1Sydney, NSW/AU,
2
St. Leonards, NSW/AU
EE-071 Preoperative assessment of rectal cancer: What the
radiologist should know
A. Primitivo, A. Gonçalves, A. Loureiro; Loures/PT
EE-072 Anal squamous cell carcinoma – What are the
RP differences in MRI evaluation compared to low rectal
adenocarcinoma?
F. Ribeiro Ferreira, R. Bispo, A. Aranha, C.D. Ortega,
V. Monteiro; São Paulo/BR
GI TRACT – SMALL BOWEL
EE-073 CT evaluation of primary tumors of small intestine
C. Silva1, P. Mendes da Costa2, A.C. Silva2; 1Guimarães/PT,
2
Matosinhos/PT
EE-074 Tuberculous infection of abdomen
Y. Kim, O. Cho, Y.S. Cho; Guri Si/KR
EE-075 Small bowel involvement in general diseases:
RP CT and MRI patterns
C. Durot1, A. Pecot1, M. Djelouah1, P. Rousset2, L. Arrivé3,
C. Hoeffel1; 1Reims/FR, 2Pierre Benite/FR, 3Paris/FR
EE-077 The small bowel beyond Crohn’s disease: a pictorial
review with emphasis on CT and MR enterography
findings
E. Bretas, U. Torres, B. Ribeiro, D. Tiferes, L. Torres,
S. Ueda, G. D’Ippolito, L. Chamié, A. Motoyama Caiado,
V. Weizen Lo; São Paulo/BR
EE-078 CT/MRI enterography: not only for Crohn‘s disease.
What every resident should know
C. Perna, G.M. Argiolas, A. Ferrari, F. Schirru, C.D. Arru,
P. Siotto, L. Saba; Cagliari/IT
EE-079 An approach to small bowel tumors with computed
tomography
E. Negrao, B. Flor de Lima, J. Rebelo, C. Sousa,
B. Viamonte; Porto/PT
EE-080 Meckel’s diverticulum with ileitis or Crohns disease
with Meckel’s diverticulum: Radiological approach to
distinguish between these two diagnoses
A. Neukamm1, J. Bomer1, J. Stoker2, A. Negård1;
1
Lørenskog/NO, 2Amsterdam/NL
EE-081 MRI findings in complicated Crohn‘s disease
CL D. Bencardino, M. Lopez, D. Vitale, F. Maccioni; Rome/IT
EE-082 Imaging of Small Bowel Transplantation: A Pictorial
CM Review of the Expected Post-Operative Anatomy and
Complications
R. Downey, N. Hansen, S. Merani, E. Granader, L. Vargas;
Omaha, NE/US
EE-083 CT and MR Enterography in inflammatory Bowel
disease “How the radiologist can help”
P.D.C. Barros1, J. Amorim1, E. Tomás2, R. Marques Maia1,
M. França1; 1Porto/PT, 2Luanda/AO
GI TRACT – STOMACH
EE-084 Nodal Staging of Gastric Cancer – A pictorial guide
S. Sen, P. Maru, S. Mukhopadhyay, A. Chatterjee,
P. Ghosh, D. Lingegowda, A. Chandra; Kolkata/IN
EE-085 Bariatric surgery or endoscopic bariatric treatment;
What Radiologist need to know
S.S. Hong, H.J. Cha; Seoul/KR
EE-086 Don’t Forget the Barium Upper GI: Case-Based Proof
of Contemporary Clinical Relevance
B. Hauck, J. Cernigliaro, D. DiSantis; Jacksonville, FL/US
EE-087 Total gastrectomy with Roux-en-Y gastric
reconstruction: post- surgical anatomy and common
complications
S. Rodrigues1, J. Santos1, L. Samouco1, D. Foyedo2;
1
Porto/PT, 2Braga/PT
EE-088 Stomach Turning Abdominal Pain – Gastric Volvulus
S.G. Estanislao, Quezon City/PH
EE-089 When to think on GIST? A review of CT and MRI
CM features with pathologic correlation
A. Primitivo, H. Oliveira, A. Loureiro, J. Castelo Branco,
R. Cruz; Loures/PT
EE-090 Gastric Mesenchymal Tumors – A Pictorial Review
J. Santos, N. Almeida Costa, S. Rodrigues, L. Samouco,
M. Gouvea, L. Gonçalves; Porto/PT
EE-091 Gastric imaging: what to look for
B. Flor de Lima, E. Negrao, J. Rebelo, C. Sousa,
J. Calheiros Lobo; Porto/PT
IMAGE GUIDED THERAPY
EE-092 Ultrasound-guided percutaneous interventional
procedures in pancreatic diseases: new applications
and technologies
A. Beleù, R. De Robertis, G. Rizzo, N. Cardobi,
G. Giannotti, M. D‘Onofrio; Verona/IT
57
POSTER PRESENTATION – EDUCATIONAL
LIVER – DIFFUSE LIVER DISEASE
EE-093 Pearls and pitfalls in diagnosing cholangiocarcinoma
in patients with primary sclerosing cholangitis,
10 years experience in a large transplant unit.
J. Bell, A. Laverty, C. Smith, R. Albazaz, J.A. Guthrie,
M. Sheridan; Leeds/UK
EE-094 Quantitative evaluation of fat and iron overload of the
liver using MRI: the state of art.
B. Frittoli, M. Bertuletti, R. Ambrosini, A. Villanacci,
G. Mazza, L. Grazioli; Brescia/IT
EE-095 Evaluation of Diffuse Liver Diseases Using Two
Dimensional Ultrasound Shear Wave Elastography:
Reflection of Various Liver Conditions
Y.R. Kim, Y.H. Lee, K.-H. Yoon, D.M. Kang; Iksan/KR
EE-096 Imaging of oxaliplatin induced hepatic lesions
including FNH
L. Menassa-Moussa, P. Audi, V. Trak-Smayra, T. Samyra,
N. Aoun; Beirut/LB
EE-097 Hepatic involvement in Rendu-Osler-Weber
Syndrome: pictorial review
F. Costeira, F. Vieira, P. da Silva, C.A. Oliveira, C. Leite;
Braga/PT
LIVER – FOCAL LIVER LESIONS
EE-098 ”All that glitters is not gold.“ Another simple case of a
haemangioma within the liver? A Radiological primer
for high T2 liver lesions.
B. Rea, T. Shareef; Sheffield/UK
EE-099 LI-RADS 2018 ancillary features at MRI: what should
you look for? A pictorial review.
B. Petresc, C. Caraiani; Cluj-Napoca/RO
EE-100 Haemangiomas Untangled? Multimodality imaging
of typical, atypical and lesions mimicking hepatic
haemangiomas
T. Viyasar, S. Lapsia; Blackburn/UK
EE-101 What do we know about hepatic angiomiolipomas?
K. Ramirez Tucas, X. Merino-Casabiel, N. Roson;
Barcelona/ES
EE-102 Great Imposters: Benign Hepatic Lesions Which
Mimic Malignant Disease
S. Kamaledeen, V. Halai, C. Ball, A. Higginson, R. Beable;
Portsmouth/UK
EE-103 When may imaging diagnosis of hepatocellular
carcinoma fail?
M. Kim, S. Lee, C. An; Seoul/KR
58
EE-104 Focal uptake of liver-specific contrast in focal liver
lesions: is it always benign?
K. Watt, R. Hodnett, B. Fox, A. Abdellaoui; Plymouth/UK
EE-105 Is Ultrasonography enough? Alternative Imaging
RP Techniques for the Surveillance of Hepatocellular
Carcinoma
J. Choi, M.H. Choi, Y.J. Lee, S. Whang; Seoul/KR
EE-106 Steatosis and beyond: Fat-Containing focal liver
Lesions on cross-sectional imaging
N. Pereira da Silva, M.I. Abreu, L. Curvo-Semedo, F. Cruz,
P. Donato; Coimbra/PT
EE-107 Multimodality imaging of exophytic hepatic lesions:
pearls and pitfalls
U. Torres, A. Motoyama Caiado, E. Bretas, L. Torres,
G. D‘Ippolito; São Paulo/BR
EE-108 Improving HCC imaging in Community Hospitals:
Lessons learned from a systematic audit and
engagement with community radiology practices
K. Khalili1, A. Chan1, M. Sertic1, M.E. O‘Malley1,
L. Guimaraes2, J. Sammon1; 1Toronto, ON/CA,
2
North York, ON/CA
EE-109 Complications of hepatic hydatid disease: imaging
CM features for the diagnosis.
S. Greco, R. Cannella, G. Pecoraro, D. Giambelluca,
E. Battaglia, F. D‘Arpa, G. Brancatelli, M. Midiri; Palermo/IT
EE-110 Large liver masses. Still in diagnostic difficulties.
CM I. Puig, D. Leiva Pedraza, L. Martínez Carnicero,
S. Ruiz Osuna, G.C. Rivera Sierra, E. De Lama Salvador,
C. Aguilera Grijalvo; L‘ Hospitalet De Llobregat/ES
EE-111 Imaging in cirrhotic patients: only challenging cases
L. Farias, M. Filho, F. Ferreira, I. Oliveira, M. da Rocha,
R. Pinheiro, L. D‘Albuquerque, G. Cerri, R.O. Bezerra;
São Paulo/BR
EE-112 Liver perfusion CT: technical aspects and
applications in transarterial radioembolization of
primary and secondary tumors
C. Delhaye, M.A. Bali, D. Gomes, M. Deforche,
A. Acquisto, P. Flamen, M. Vouche; Brussels/BE
EE-113 Mass lesion characterization in a cirrhotic liver on
MRI simplified: Utilization of LI-RADS Classification
B.B.B. Shafi, L. Kania, F. Guglielmo, C. Roth, D.G. Mitchell;
Philadelphia, PA/US
EE-114 Imaging of the Liver after Chemotherapy
G. Ficarra1, E. Barabino1, S. Mennella2, M.C. D‘Auria2,
A. Gastaldo2, G. Cittadini1; 1Genoa/IT, 2Savona/IT
EE-115 Hepatic Pseudo-lesions and Unusual Tumors
A. Davarpanah, S. Nandwana; Atlanta, GA/US
 POSTER PRESENTATION – EDUCATIONAL
LIVER – OTHER
EE-116 Complications of Non-Endovascular Hepatic
Interventions
Y.K. Lai, L.T. Cheng, A.S.C. Low; Singapore/SG
EE-117 Hepatopancreatic tuberculosis – simplifying the
diagnostic enigma
K. Ganesan, S. Jalkote, S. Bhalja, A. Jain, S. Alam,
S. Nellore; Mumbai/IN
EE-118 Infectious Lesions of the Liver – Imaging features
J. Macedo, N. Pereira da Silva, A. Aguiar Ferreira,
F. Alves, P. Donato; Coimbra/PT
EE-119 A guidebook to understand hepatic vascular
disorders
J. Macedo, N. Pereira da Silva, A. Aguiar Ferreira,
F. Alves, P. Donato; Coimbra/PT
EE-120 Beyond morphology: what radiologists should know
RP about liver function tests
C. Terra, D.J. Ribeiro Castro Roriz, N. Campos,
A. Aguiar Ferreira, L. Curvo-Semedo, M.A. Portilha,
P. Donato; Coimbra/PT
EE-121 The challenging conundrum of cystic lesions in liver:
RP to treat or to observe?
B. Sureka, N. Sharma, P. Khera, P. Garg, T. Yadav,
R. Choudhary, V. Varshney, P. Elhence; Jodhpur/IN
EE-122 A sonographic review of hepatic vasculature.
D. Cokkinos, E. Antypa, S. Tsolaki, G. Skoufogiannis,
P. Petaloudis, E. Lytra, C. Aslanidi, A. Letsos,
I. Kalogeropoulos; Athens/GR
EE-123 Atypical appearances of fatty infiltration of the liver
K. Watt, R. Hodnett, B. Fox, A. Abdellaoui; Plymouth/UK
EE-124 Pseudolesions in liver imaging
A. Naves1, L.R. Souza2; 1Ribeirao Preto/BR, 2Uberaba/BR
EE-125 Limits of Couinaud’s Liver Segment Classification
Y. Fukukura, Y. Kumagae, T. Yoshiura; Kagoshima/JP
LIVER – TRANSPLANTATION
EE-127 Comprehensive Orthotopic Liver Transplantation
(OLT) Evaluation and Graft Survival Prediction Using
Gadoxetic Acid-enhanced MRI (GA-MRI)
N. Bastati-Huber, S. Pötter-Lang, H. Einspieler, Y. Bican,
L. Beer, A. Ba-Ssalamah; Vienna/AT
MAGNETIC RESONANCE
EE-128 ”A fat load of thrombus“ – fat within portal vein
tumour thrombus from HCC.
B. Rea, T. Shareef; Sheffield/UK
EE-130 Abbreviated Liver MRI for the Surveillance,
Screening, and Treatment response evaluation, Using
Gadoxetic acid with Second Shot Method
C.H. Lee, C.M. Park; Seoul/KR
EE-131 Iron overload in MR elastography of liver: what can
be done?
R. Castilhos, A. Schuch, B. Valentini, L. Torres,
M. Wagner; Porto Alegre/BR
EE-132 Less is more! Abbreviated MRI protocols in metabolic
syndrome, chronic liver disease and oncology
J. Santos, F. Velloni, R. Blasbalg; São Paulo/BR
EE-133 ARPKD, Congenital Hepatic Fibrosis and Caroli‘s
Syndrome: a Case Report of Fibropolycystic Disease
M. Maturi, E. Genco, S. Mehrabi, G. Mansueto; Verona/IT
EE-134 MRI or am I wrong? Acute abdominal pain in
pregnancy
F. Din, V. Eze, A. Brown, B. Musaddaq, D. Murray,
P. Brown, M. Steward; London/UK
EE-135 MR Elastography of Liver- Fibrosis and Beyond!
CL S. Venkatesh1, M. Yin1, C. Welle1, P. Navin1, J. Wang2,
R. Ehman1; 1Rochester, NY/US, 2Guangzhou/CN
MISCELLANEOUS
EE-136 Intraabdominal lesions mimicking neoplasms:
Imaging findings
M.H. Atalar, S. Bulut, N. Kose, S. Berdibek, E. Gul; Sivas/TR
EE-137 Rare but important mimickers; inflammatory
pseudotumors in the abdomen and pelvis.
J. Park, M. Kwag, H. Jung, S. Cha; Busan/KR
EE-138 Classical Signs and Appearances in Abdominal
Radiology
M.H. Atalar1, N. Bozbiyik2, B. Seker1, N. Kose1,
V. Gasanovi1; 1Sivas/TR, 2Aydin/TR
EE-139 Hepatobiliary and pancreatic manifestations of cystic
fibrosis: multimodality imaging findings
R. De Robertis, G. Salandini, R. Negrelli, S. Montemezzi;
Verona/IT
EE-140 Have you lost the clot? Venous Thrombosis on
Abdominal and Pelvic Imaging
A. Brown, B. Musaddaq, F. Din, V. Eze, D. Murray,
P. Brown, M. Steward; London/UK
59
POSTER PRESENTATION – EDUCATIONAL
MISCELLANEOUS – CONTINUATION
EE-142 Common Variable Immune Deficiency (CVID)
Below the Diaphragm: Abdominal Manifestations
and Complications of CVID Observed in a Large
Patient Cohort
J. Bretherton, A. Brown, F. Lam, D. Yu, A. Papadopoulou,
B. Musaddaq; London/UK
EE-143 Foreign Body within the abdominal cavity: Emphasis
on its potential complications
Y. Kim, O. Cho, Y.S. Cho; Guri Si/KR
EE-144 Tips and tricks for diagnosing abdominal soft
RP tissue tumors.
K. Khalili, S. Ghai, S. Thipphavong, A. Kielar; Toronto, ON/CA
EE-145 Secret SANT-a, A benign vascular lesion of the spleen.
V. Eze, London/UK
EE-146 Imaging of foreign pelvic bodies.
C. Durot1, M. Djelouah1, A. Bonnin1, I. Adlani1, P. Rousset2,
C. Hoeffel1; 1Reims/FR, 2Pierre Benite/FR
EE-147 Artifacts in Abdominal CT: They all look the same to
CL me! Let’s recognize it and eliminate it!
B. Sureka, N. Sharma, P. Khera, P. Garg, T. Yadav,
S. Tiwari, A. Fernandus; Jodhpur/IN
EE-148 Gone with the wind! Abnormal gas collections in the
abdomen revisited.
D. Cokkinos, E. Antypa, S. Tsolaki, C. Kampaki,
A. Anagnostopoulou, P. Tserotas, S. Athanasiou,
M. Pripa, I. Kalogeropoulos; Athens/GR
EE-149 Assessing the effectivity of social media strategies
of Radiological societies (using RSNA, ESR and BIR
as case studies)
S. Syed1, B. Azam2, I. Imtiaz2, H. Ahmad2, A. Sujith1,
S. Khan1; 1Basildon/UK, 2London/UK
EE-150 68Ga-Dotatate PET/CT: Tips and Tricks
RP A. Aranha, J. Santos, F. Velloni, D. Anjos, R. Blasbalg;
São Paulo/BR
EE-151 Spleen Imaging for the Dummies
A. Ayed, M. Wagner, P. Lampson, M. Dubois,
O. Lucidarme; Paris/FR
EE-153 Abdominal imaging in the immunocompromised
patient – opportunistic infections and beyond
A.T. Vilares, C. Silva, C. Sousa, M. Correia da Silva,
B. Flor de Lima, E. Negrao, A. Silva; Porto/PT
EE-154 Dissolving the Challenge: Key Points for Primary
Retroperitoneal Masses
O. İnce, S. Deniz Onol; Istanbul/TR
60
EE-155 Endometriosis: beyond the pelvis
N. Campos, C. Terra, A. Aguiar Ferreira, L. Curvo-Semedo;
Coimbra/PT
EE-156 The Role of Radiology in Undergraduate Medical
Education : A Systematic Review
C. Chew, P. Cannon, P.J. O’Dwyer; Glasgow/UK
EE-158 Gastrointestinal imaging manifestation in Graft-
versus-Host Disease
L. Samouco1, J. Santos1, S. Rodrigues1, D. Foyedo2,
M.J. Magalhães1, M. Gouvea1; 1Porto/PT, 2Braga/PT
EE-159 So You Have to Write Multiple-choice Questions:
Easy Tips for How to Write Good Ones
D. DiSantis, B. Hauck, J. Cernigliaro; Jacksonville, FL/US
ONCOLOGY
EE-160 Demystifying Pseudomyxoma Peritonei: An
Illustrated and Explanatory Guide
C. Leidersnaider, J. Morales, R. Perrotta, S. Araujo,
C. Arantes, B. Campos, R. Zeitoune, C. Constantino;
Rio De Janeiro/BR
EE-161 Uveal Melanoma Hepatic Metastases Pre and Post
treatment: An Imaging Conundrum Simplified on MR
Imaging
B.B.B. Shafi, L. Kania, A. Albini, G. Acikocz, F. Guglielmo,
C. Roth, D.G. Mitchell; Philadelphia, PA/US
EE-162 Von Hippel-Lindau syndrome: abdominal imaging
RP findings.
E. Landi, C. Roncella, F. Donati, P. Boraschi, D. Caramella;
Pisa/IT
EE-163 Collateral Damage: A Pictorial Review of Abdominal
CL and Pelvic Complications of Chemoradiotherapy
L.L. Chew, Y.L. Chin; Singapore/SG
EE-164 Rectal Cancer MRI: A step by step approach
MCL to staging
D. Gish, R. Khot; Charlottesville, VA/US
EE-165 Retroperitoneal Venous Leiomyosarcoma. What the
radiologist needs to know
M. Urizar Gorosarri1, D. Pereira Boo1, D. Hernandez
Aceituno1, J. Sanchez Hernandez1, P. Artuñedo1,
A. Cabeza Carreto2; 1Mostoles/ES, 2Collado Villalba/ES
EE-166 TNM 8: What the GI radiologist needs to know. An
educational pictorial review.
S. Hudson, C. Ivan, A. Osman, V. Shah, R. Verma,
J. Stephenson; Leicester/UK
 POSTER PRESENTATION – EDUCATIONAL
EE-167 Multidisciplinary Approach to Pancreas Cancer;
Role of Radiologist
D.J. Kim, Seongnam-Si/KR
EE-168 The rich diversity of SMARCB1-deficient tumors:
RP The seminal role of SMARCB1/INI 1 tumor
suppressor gene in the pathogenesis of unique
malignant rhabdoid tumors.
L. Marcal1, A. Morani1, C. Devine1, S. Yedururi1,
V. Katabathina2, S. Prasad1; 1Houston, TX/US,
2
San Antonio, TX/US
EE-169 Pelvic exenteration surgery for locally advanced
pelvic malignancy: Selection criteria and
contraindications-What the Radiologist needs
to know
S. Nishtala, T. Westwood, J. Mercer, A. Taheri, M. Wilson,
S. O‘Dwyer, P. Manoharan, R. Kochhar; Manchester/UK
EE-170 Intra- and extrahepatic cholangiocarcinomas: what
the surgeon needs to know
C. Sousa, J. Rebelo, A. Moreira, B. Viamonte; Porto/PT
EE-171 A case series of inferior vena cava leiomyosarcoma.
H. Singh, L. Preston, C. Chew; Glasgow/UK
EE-172 Radiology errors in abdominal oncology scans:
understanding the mistakes and improving our
performance.
T. Ribeiro, L. Paiva, A.S. Barros, M. Costa, D. Minami,
C. Branco, R. Rstom, A. Nascimento, F. Machado;
São Paulo/BR
EE-173 Gastrointestinal Stromal Tumors – a Pictorial Review
D. Foyedo, D. Fonseca, S. Rodrigues, L. Samouco,
J. Santos, C. Carneiro, M. Gouvea; Porto/PT
EE-174 Guiding the way: Insertion & Imaging of Abdominal
Fiducial markers for Radiotherapy
N. Mcaddy, E. Guilhem, H. Taylor, N. Fotiadis; London/UK
EE-175 Esophageal Lymphatic Drainage – A Pictorial Review
J. Santos, C. Baraças, L. Samouco, S. Rodrigues,
N. Almeida Costa, M. Gouvea, L. Gonçalves; Porto/PT
EE-176 Parasitic Hepatocellular Carcinoma:
Leaching Liver Lesions
B. Oliver, M. Cline; Ann Arbor, MI/US
EE-177 False diagnostic confidence; mimics of
Neuroendocrine Tumours (NET) on Gallium (Ga)
DOTA-peptide PET-CT imaging
A. Taheri1, S. Nishtala2, J. Mercer1, A. Chander1,
R. Kochhar1, P. Manoharan1, T. Westwood1;
1
Manchester/UK, 2Stoke-on-Trent/UK
EE-178 Imaging of Tumor Thrombus in Abdominal
Malignancies
K. Elbanna, K. Khalili, M.E. O‘Malley, T. Chawla;
Toronto, ON/CA
EE-179 Imaging Hepatocellular carcinoma: What to look for?
A. Primitivo, A. Gonçalves, A. Loureiro; Loures/PT
EE-180 Child with abdominal distension
C. Leung, J. Ferguson; Exeter/UK
EE-181 Gastrointenstinal Complications of Novel
RP Oncological Therapies
N. Mcaddy, E. Guilhem, D. Christodoulou, K. De Paepe,
N. Butterfield; London/UK
PANCREAS BENIGN LESIONS
EE-182 The many faces of pancreatic pathology-
Multimodality imaging with case based review and
focus on solid and cystic lesions
C.A. Oliveira, F. Vieira, V. Mendes; Braga/PT
PANCREAS DIFFUSE DISEASE
EE-183 Acute pancreatitis: assessment of severity with
CT evaluation
C. Silva, A.C. Silva, P. Mendes da Costa; Matosinhos/PT
EE-184 Acute Pancreatitis and its complications: what
endoscopist want to know
L. Samouco, S. Rodrigues, J. Santos, M. Rodrigues,
M.J. Magalhães, B. Viamonte; Porto/PT
EE-185 Chronic pancreatitis: Alcohol, cigarettes and beyond
V. Leung, A. Al-Khatib, D. Bowden, N. Carroll, S. Varghese,
E.M. Godfrey; Cambridge/UK
EE-186 Diffuse neoplastic involvement of the pancreas:
histotypes and spectrum of imaging presentations
with differential diagnosis
A. Grecchi, I. Testa, A. Beleù, G. Rizzo, A. Giaretta,
G. Giannotti, R. De Robertis, M. D‘Onofrio; Verona/IT
EE-187 Diffuse pancreatic lesions: an overview with an
CM emphasis on clinical decision making
P. Araujo, G. Nogueira, F. Ribeiro Ferreira, R.O. Bezerra,
R. Tavares, M. da Rocha; São Paulo/BR
61
POSTER PRESENTATION – EDUCATIONAL
PANCREAS MALIGNANT LESIONS
EE-188 Comprehensive Pictorial Review of tumors in the
Pancreas Tail
C.M. Park, K.A. Kim, C.H. Lee, J.W. Choi, J. Lee, Y.S. Park,
H.J. Lee; Seoul/KR
EE-189 Imaging challenges and pitfalls of pancreatic ductal
CM adenocarcinoma
K. Elbanna, H. Jang, T.K. Kim; Toronto, ON/CA
EE-190 Fistulization as a complication of Intraductal
Papillary Mucinous Neoplasms (IPMNs):
a pictorial review
A. Ventosa, C. Carneiro, R. Monteiro, H. Sousa, J. Brito;
Portimão/PT
EE-191 The role of computed tomography in the staging of
borderline resectable pancreatic adenocarcinoma
M. Dimarco, O. Montalbano, G. Carpani, D. Giambelluca,
R. Cannella, T. Bartolotta, M. Midiri; Palermo/IT
EE-192 Cystic lesions of pancreas: tips and tricks.
A. Acquisto, Y. Zaouak, C. Delhaye, M. Vouche,
M. Pezzullo, J. Engelholm, M.A. Bali; Brussels/BE
EE-193 CT after pancreatico-duodenectomy: anatomy,
postsurgical findings and complications.
F. Andresciani, C.A. Mallio, R. Grippo, E. Faiella,
B. Beomonte Zobel; Roma/IT
EE-194 Intraductal Tubulopapillary Neoplasms of the
Pancreas
A. Aranha, R. Polizio, F. Ribeiro Ferreira, J. Santos,
L. Albieri, R.O. Bezerra; São Paulo/BR
EE-195 Pancreatic carcinoma and its imaging mimickers:
a comprehensive multimodality approach.
E. Negrao, B. Flor de Lima, J. Rebelo, C. Sousa,
B. Viamonte; Porto/PT
EE-196 Radiology-pathology correlation of pancreatic
adenocarcinoma and implications for
treatment planning
J. Amorim, N. Lamas, J. Raposo, J. Gomes Carvalho,
J. Ferreira Pinto, E. Abreu, J. Vizcaíno, M. França;
Porto/PT
PELVIC FLOOR
EE-197 Imaging in pelvic mesh: a primer for abdominal
RP radiologists
S. Hudson, C. Ivan, A. Osman, V. Shah, J. Stephenson;
Leicester/UK
62
EE-198 MR imaging of anal fistula: what radiologists
need to know
F. Costeira, F. Vieira, P. da Silva, C. Leite; Braga/PT
EE-200 MDCT imaging examination of the abdomen:
A significant imaging tool for Fournier gangrene
management.
M. Smarda, D. Fagkrezos, C. Triantopoulou, P. Maniatis;
Nea Ionia/GR
RADIOLOGIC-PATHOLOGIC CORRELATION
EE-201 Giant abdominal and pelvic masses – what could
they be? Radiologic – Pathologic correlation
C. Moldovanu, O. Anton, T. Zaharie; Cluj Napoca/RO
EE-202 A Pictorial Review of Xanthogranulomatous
Inflammation of Various Organs in the Abdomen
and Pelvis
D.M. Yang, H.C. Kim, S.W. Kim; Seoul/KR
EE-203 Abdominal Manifestations of Actinomycosis
A. Osman, U. Mahmood, C. Ivan, S. Hudson, A. Rajesh,
R. Verma, J. Stephenson; Leicester/UK
EE-204 How to localize a lesion or a fluid collection in the
RP peritoneum: an anatomical analysis on CT studies
with surgical correlation
N. Courcoutsakis1, B. Panagiotopoulou2, K. Frigkas1,
A.A. Tentes3, P. Prassopoulos2; 1Alexandroupolis/GR,
2
Thessaloniki/GR, 3Peiraeus/GR
STRUCTURED REPORT
EE-205 Imaging of the retroperitoneum: a pictorial review
P. Oliveira, D. Roriz, C. Ferreira, M. Cruz,
L. Curvo-Semedo, J. Ilharco; Coimbra/PT
TECHNICAL ADVANCES
EE-206 Abdominal applications of ultrasound fusion imaging
technique: liver, kidney and pancreas
A. Beleù, G. Rizzo, R. De Robertis, A. Giaretta,
G. Giannotti, M. D‘Onofrio; Verona/IT
ULTRASOUND
EE-207 Bee-aware of the honeycomb sign in Dengue fever
M.C. Corral, I. Bandong; Quezon City/PH
 POSTER PRESENTATION – EDUCATIONAL
EE-208 Complications of renal transplantation: role of CEUS
S. Martin-Garre, J. Hernández Montero,
J.M. Espejo Domínguez, M.Á. Moreno de la Higuera Díaz,
B. Rodríguez Cubillo, E. Contreras Cecilia,
J. Barrera Ortega; Madrid/ES
EE-209 Ultrasonographic Atlas of Splenic Lesions
RP K.A. Kim, Y.S. Park, J. Lee, J.W. Choi, C.H. Lee, C.M. Park;
Seoul/KR
EE-210 Usefulness of intermediate mechanical index technique
for nonvisible HCC on contrast enhanced US
D.J. Chung, Seoul/KR
WALL, PERITONEUM, MESENTERY
EE-212 Abdominal Wall Hernias – What should radiologists
RP be aware of?
P. Costa1, A.C. Silva2, C. Silva3, M. Ribeiro2, C. Campos2,
C. Martinez4; 1Ramalde Porto/PT, 2Matosinhos/PT,
3
Guimarães/PT, 4Vigo/ES
EE-213 Imaging findings of the various abdominal wall
masses; clinicopathologic correlation
H.Y. Han, K.S. Shin, J.H. Kim; Daejeon/KR
EE-214 Retroperitoneal masses: A diagnostic approach
RP R. Sousa, S. Amante, M. Chaves, Z. Rego;
Ponta Delgada/PT
EE-215 Primary peritoneal tumors
E. Ortiz, J. Golia Pernicka; New York, NY/US
EE-216 The perihepatic space: added value of Magnetic
RP resonance imaging.
A. Bonnin1, C. Durot1, M. Djelouah1, A. Dohan2,
P. Rousset3, C. Hoeffel1; 1Reims/FR, 2Paris/FR,
3
Pierre Benite/FR
EE-217 A six-pack educational workout: an overview of
rectus sheath pathologies
S. Cheshire, E. White, S. Lapsia, E. Nanda Kumar,
T. Viyasar; Blackburn/UK
EE-219 Mesenteric lymph nodes – how to solve the puzzle
A. Al-Khatib, V. Leung, D. Bowden, S. Upponi,
E.M. Godfrey; Cambridge/UK
EE-220 Abdominal hernias from A to Z: practical tips and
RP tricks for radiologists
S. Greco, R. Cannella, G. Pecoraro, D. Giambelluca,
M. Dimarco, M. Midiri; Palermo/IT
EE-221 Magnetic resonance imaging of tailgut cysts:
surgical implications
V. Brentano, G. Camerin, T. Vieira, A. Pereira, I. Oliveira,
R. Bezerra, G. Cerri; São Paulo/BR
EE-222 The Peritoneum and Bowel Mesentery
P. Gaur, London/UK
EE-223 New organ, same old tumors – CT appearances of
primary and secondary mesenteric tumors
R. Pintican, V. Bura, O. Anton, A.M. Calin-Vainak;
Cluj-Napoca/RO
EE-224 Imaging of the peritoneum: from normal to
pathological
P. Oliveira, D. Roriz, M. Cruz, C. Ferreira, L. Curvo-Semedo,
J. Ilharco; Coimbra/PT
63
POSTER PRESENTATION – SCIENTIFIC
ABDOMINAL VASCULAR IMAGING
SE-001 Is Transcatheter Arterial Embolization in Upper
Gastrointestinal Bleeding an effective solution?
A single-center experience.
T. Kratimenos, I. Thanou, D. Tomais, P. Ioannidi,
V. Mellou, C.I. Sierrou, D. Stefanou, D. Farsaris,
I. Kalogeropoulos; Athens/GR
SE-002 Thrombosis where? Thrombosis everywhere.
A multimodality approach
C.A. Oliveira, F. Costeira, V. Mendes; Braga/PT
ACUTE ABDOMEN
SE-004 CT assessment for Acute Appendicitis: A Year in the
Life of a University Teaching Hospital
N. Shangwa, R. Tiam, E. Helbren; Hull/UK
AI, MACHINE LEARNING, RADIOMICS
SE-005 Texture analysis of hepatocellular carcinoma on
magnetic resonance imaging (MRI): assessment for
performance in predicting histopathologic grade
J.M. Choi, E. Cho, J.H. Kim, J. Yu, J. Chung; Seoul/KR
SE-008 Development of a Machine Learning/Imaging
Classifier Model to Differentiate Classic
Hepatocellular Carcinoma From Its Steatohepatitic
Subtype
K. Smith1, A. Silva1, F. Gao2, Y. Xu2, A. McGirr1,
M. Salomao1, S. Singh1, T. Buck1, A. Panda1,
W. Sensakovic1, T. Wu2; 1Phoenix, AZ/US, 2Tempe, AZ/US
SE-010 Optimal approach to evaluate accessory spleen
using feature learned pattern recognition algorithm:
Preliminary Study to detect intrapancreatic
accessory spleen.
S.J. Park, H. Kim, J.S. Park, H.C. Kim; Seoul/KR
BILE DUCTS AND GALLBLADDER
SE-011 Diagnostic value of functional MRCP in the diagnosis
of acute cholecystitis
S. Ramanathan, D. Kumar, M. Heidous, A. Faki; Doha/QA
SE-012 Periampullary duodenal diverticulum: effect
on extrahepatic bile duct dilatation after
cholecystectomy
J.H. Ham, J. Yu, J.M. Choi, E. Cho, J.H. Kim, J. Chung;
Seoul/KR
64
SE-013 Intestinal type ampullary adenocarcinoma vs.
duodenal adenocarcinoma: role of ampullary MDCT
in preoperative differentiation
A. Ivanovic1, K. Mortele2; 1Belgrade/RS, 2Boston, MA/US
SE-014 The role of steady-state coherent coronal images in
the diagnosis of choledocholithiasis
U. Erdem, I. Uysal, S.M. Erturk; Istanbul/TR
SE-015 Diagnostic performance of 2D-SWE at UK bed of liver
for acute cholecystitis: preliminary study
E.S. Lee1, B.Y. Hur2, B.I. Choi1, W.S. Choi1; 1Seoul/KR,
2
Goyang-Si/KR
SE-016 Characteristics of Gallbladder Polyps on Dedicated
Ultrasound and MRI; a Prospective, Exploratory Study
S. Wennmacker, E. de Savornin Lohman, P. de Reuver,
J. Drenth, I. Nagtegaal, J. Hermans, C. van Laarhoven;
Nijmegen/NL
SE-017 The efficacy of coronal ZOOMit diffusion-weighted
MR imaging at 3T MRI for differentiation of
malignant distal bile duct stricture
M.J. Kim, B.J. Park, K.C. Sim, D.J. Sung, N.Y. Han; Seoul/KR
SE-018 The Efficacy of Gadoxetic acid enhanced Magnetic
Resonance Cholangiography (MRC) in the Diagnostic
Work Up of Dominant Strictures in Patients with
Primary Sclerosing Cholangitis (PCS). Preliminary
Results.
S. Pötter-Lang, N. Bastati-Huber, L. Beer, H. Einspieler,
M.C. Elmer, A. Ba-Ssalamah; Vienna/AT
SE-019 Adjuvant endobiliary photodynamic therapy in hilar
cholangiocarcinoma patients after non-curative
hepatobiliary surgery: initial results.
O. Sergeeva, D. Frantsev, M. Shorikov, M. Lapteva,
N. Kudashkin, A. Polyakov, E. Virshke, B. Dolgushin;
Moscow/RU
COMPUTER TOMOGRAPHY
SE-020 Factors associated with severe Cholecystitis in
elderly patients with Acute abdominal pain
H. Park, S.H. Woo; Incheon/KR
SE-021 A case-control study using water only (cases) or
Télébrix Gastro diluted in water (controls) as oral
contrast in patients undergoing contrast-enhanced
abdominal CT scan
P. de Wit, J. Tielbeek, P. van Diepen, I. Oulad Abdennabi,
L. Beenen, S. Bipat; Amsterdam/NL
 POSTER PRESENTATION – SCIENTIFIC
GI TRACT – COLON
SE-022 Tertiary centre review of safety and efficacy of
self-expanding metal stents in acute large bowel
obstruction secondary to distal colorectal tumours
J. Noreikaite, A. Dobson, J. Alsousou, S. Chawla;
Liverpool/UK
SE-023 Virtual colonoscopy vs optical colonoscopy:
a cost analysis
S. Hudson, C. Ivan, R. Verma, M. Elabassy,
J. Stephenson; Leicester/UK
SE-024 Complicated diverticulitis, radiological and surgical
outcome correlation with imaging scoring systems.
G. Mitreski, Z. Nikolovski, Y. Al-Kaisey, W. Jamel,
N. Kutaiba; Melbourne, VIC/AU
SE-025 Colorectal laterally spreading tumors detected at CT
colonography
M. Iwabuchi, M. Sugimura, Y. Mano, K. Ukai; Sendai/JP
SE-026 Right-sided colonic stenting as a viable option for
malignant obstruction
K. Watt1, J. Ricketts2, B. Fox1; 1Plymouth/UK, 2Exeter/UK
SE-027 CT colonography in preoperative T staging of
colorectal cancer
M. Sugimura, M. Iwabuchi, K. Ukai; Sendai/JP
SE-028 CT-Colonography in Preoperative T and N Staging of
Colorectal Cancer
M.J. Martinez-Sapiña Llanas, A. Vega Chaves,
C. Crespo Garcia, L. Abelairas López, M. Cruz Sánchez,
C. Fontenla Martínez, L. Misiego Trabado; A Coruña/ES
SE-029 Use of MDCT Imaging in Acute Diverticulitis
S. Merola, Narbonne/FR
GI TRACT – OESOPHAGUS
SE-030 Comparison of the Efficacy of Timed Barium
Esophagography with Esophageal Transit
Scintigraphy in Patients with Achalasia
J. Chung, E. Cho; Seoul/KR
SE-031 Patient outcomes following stenting of Upper
Gastrointestinal Malignancies in a DGH.
R. Thomas1, K. Foley2, G. Davies1, A. Yates1; 1Llantrisant/UK,
2
Cardiff/UK
GI TRACT – OTHER
SE-032 Utilisation of Tumour Growth Rate (TGR) in
Neuroendocrine Tumours (NETs): can we overcome
the limitations of RECIST?
S. Moalla1, M. Ronot2, A. Sundin3, D. Pezzutti4, P. Najran5,
R. Otaviano Franca Bezerra4, P. Borg5, N. Vietti Violi6,
H. Vidal Trueba7, E. Baudin1, L. De Mestier2, J. Crona3,
M. Opalinska8, C. Lopez Lopez7, L. Carvhalo4, F. Costa4,
M. Pavel9, N. Schaefer6, A. Lamarca5, C. Dromain6;
1
Villejuif/FR, 2Clichy/FR, 3Uppsala/SE,
4
São Paulo/BR, 5Manchester/UK, 6Lausanne/CH,
7
Santander/ES, 8Krakow/PL, 9Erlangen/DE
SE-033 CT evaluation of bowel perforation: correlation of
imaging findings according to locations and causes
K.N. Jee, M.H. Park, D.C. Kim; Cheonan/KR
GI TRACT – RECTUM
SE-034 Validation of the modified Van Assche index for
assessing response to anti-TNF therapy with MRI in
perianal fistulising Crohn’s disease
K. Van Rijn, C. Lansdorp, J. Tielbeek, C. Nio, C. Buskens,
G. D‘Haens, M. Löwenberg, J. Stoker; Amsterdam/NL
SE-035 Radiological accuracy of reporting EMVI in
MRI rectum studies when compared to
pathological outcome
N. Ali, J. Whitworth, R. Colliver; Bath/UK
SE-036 Prognostic value of extramural venous invasion in
non metastatic rectal cancer patients.
J. Ayuso-Colella, J. Maurel, O. Reig, R. Reyes, M. Pages,
S. Rodriguez; Barcelona/ES
SE-037 MR Significant Factors for Survival Outcome in
Rectal Cancer Patients Following Neoadjuvant
Combined Chemotherapy and Radiation Therapy:
Stratification of Lateral Pelvic Lymph node
M.J. Kim, B.J. Park, K.C. Sim, D.J. Sung, N.Y. Han; Seoul/KR
GI TRACT – SMALL BOWEL
SE-038 Investigating the validity and reliability of the
simplified Magnetic Resonance Index of activity
(sMaRIA) for Crohn’s disease without using
gadolinium
N. Capozzi1, A. Fernandez-Clotet2, I. Ordás2,
S. Rodriguez2, M. Masamunt2, J. Panes2, J. Rimola2;
1
Bologna/IT, 2Barcelona/ES
65
POSTER PRESENTATION – SCIENTIFIC
GI TRACT – SMALL BOWEL – CONTINUATION
SE-039 Correlation between calprotectin levels alterations
and intestinal wall US changes in Paediatric patients
affected by Cystic Fibrosis
V. Angelini, M.B. Cipullo, A. Catzola, A. Tosco, A. Sepe,
V. Raia, G. Vallone, M.G. Caprio; Naples/IT
GI TRACT – STOMACH
SE-040 Clinical significance of pre-operative tumor
volumetry measured by three-dimensional computer
tomography in gastic cancer
S. Kikuchi, Sagamihara/JP
SE-041 CT preoperative analysis of the iatal surface in
patients candidate to iatoplasty: a valid help in the
choice of the treatment of the iatal defects?
S. Badia1, M. Rengo1, D. Bellini1, M. Osimani1,
M. Maceroni1, P. Lucchesi1, S. Picchia1, I. Carbone1,
G. Trillò1, A. Laghi2; 1Latina/IT, 2Rome/IT
SE-042 Gastric diverticula: A pictorial-essay of a rare condition’
T. Demirbas, T. Cimilli, M. Oncu; Istanbul/TR
SE-043 Alpha-fetoprotein-producing gastric cancer: CT
imaging features and hepatic metastasis
J.H. Lee, H.J. Kim, B. Kim, J. Huh, J.K. Kim; Suwon/KR
IMAGE GUIDED THERAPY
SE-044 Trans-catheter embolization of massive abdominal
hemorrhage: a single center results
R. Marcello, D. Konda, G. Assegnati, G. Marcello,
F. Cortese, A. Di Blasi, E. Pofi; Rome/IT
SE-045 Assessment of Ablative Margin using Gd-EOB-DTPA
enhanced Liver MRI for Radiofrequency Ablation of
Hepatocellular Carcinoma
H.J. Cho1, Y.K. Cho2; 1Incheon/KR, 2Seoul/KR
SE-046 Interventional procedure for hemorrhoids:
arterial embolization
R. Marcello, G. Marcello, D. Konda, A. Di Blasi, F. Cortese,
G. Assegnati, E. Pofi; Rome/IT
SE-047 Radiation Exposure during Transarterial
Chemoembolization: Angio-CT versus cone-beam CT
L. Piron1, L. Escal1, C. Cassinotto2, B. Guiu1; 1Montpellier/FR,
2
Castelnau Le Lez/FR
66
SE-048 Improved survival in patients undergoing colonic
stent compared to open surgery in patient‘s
presenting with acute obstruction due to
malignant stricture
P.K. Shedthikere Manjappa, D. Henry, M. Kaduthodil,
Q. Yamani; Doncaster/UK
SE-049 Our experience in the value of mean drainage
volume in the treatment of cystobiliary fistulas after
percutaneous hydatid treatment
Y. Aydın Çarpaz, E. Çağlar, İ.İ. ÖZ, B.K. Aribas;
Zonguldak/TR
SE-050 Endovascular treatment of Giant Visceral Artery
Aneurysms: Long term outcomes.
M. Pignatelli, M.A. Tipaldi, A. Pisano, A. Laghi, M. Rossi;
Rome/IT
LIVER – DIFFUSE LIVER DISEASE
SE-051 Multiparametric MR Index for the Diagnosis of Non-
Alcoholic Steatohepatitis (NASH) from Non-Alcoholic
Fatty Liver Disease (NAFLD)
C.H. Lee, C.M. Park; Seoul/KR
SE-052 MR elastography in nonalcoholic fatty liver
disease: efficacy of automated analysis of liver
stiffness measurements
S.J. Choi, Incheon/KR
SE-053 R2* relaxometry of the liver with and without fat-
saturation for the evaluation of iron overload:
clinically relevant differences
M. Plaikner, C. Kremser, H. Zoller, W. Jaschke,
B. Henninger; Innsbruck/AT
LIVER – FOCAL LIVER LESIONS
SE-054 Optimal noncontrast MRI sequences for
characterizing small CT-detected arterial enhancing
lesions in chronic liver disease patients
B. Kim1, S.H. Park2, H.J. Kim1, J. Huh1, J.H. Lee1,
J.K. Kim1; 1Suwon/KR, 2Incheon/KR
SE-055 Comparison of diagnostic performance of LI-
RADS between v2017 and v2018 for diagnosis
of hepatocellular carcinoma on gadoxetic acid
enhanced MRI
H.J. Park, A. Ko, E.S. Lee; Seoul/KR
 POSTER PRESENTATION – SCIENTIFIC
SE-056 HCC screening for high risk patients who have
suboptimal screening ultrasound: A Screening
Protocol with Abbreviated, Non-Contrast Magnetic
Resonance Imaging
M. Chan, S. McDonald, Y. Ong, K. Mastrocostas, E. Ho,
Y. Huo, C. Santhakumar, A. Lee, J. Yang; Sydney, NSW/AU
SE-057 Imaging characteristics of spontaneous regression
of hepatocellular carcinoma
A. Kitao, N. Yoneda, K. Kozaka, S. Kobayashi, O. Matsui,
T. Gabata; Kanazawa/JP
SE-058 Intravoxel Incoherent Motion Diffusion-weighted
Imaging (IVIM) to differentiate solid hepatic lesions
using a volumetric approach.
M. Puglia1, S. Picchia2, M.A. Bali3, M. Orton4, S. Doran4,
T. Feiweier5, D. Koh4, G. Morana6; 1Pozzuoli/IT, 2Latina/IT,
3
Brussels/BE, 4Sutton/UK, 5Erlangen/DE, 6Treviso/IT
SE-059 Differentiating hepatic Mucinous Cystic Neoplasms
(MCNs) from Biliary Cysts (BCs): value of
radiological findings and cyst classification
according to internal complexity
R. Cannella1, A. Furlan2, M. El Hag2, A. Tsung2,
A. Borhani2; 1Palermo/IT, 2Pittsburgh, PA/US
SE-060 Does the Liver Imaging Reporting and Data
Systems (LI-RADS) treatment response algorithm
predict survival?
W. Ormiston, H. Yarmohammadi, S. Velayati, J. Zheng,
M. Capanu, R. Do; New York, NY/US
SE-061 Lipiodol-based angiography and CT in pretherapeutic
differentiation of hepatocellular carcinoma and
non-malignant lesions in cirrhotic liver: A new
diagnostic pathway
M. Langenbach, T. Vogl, I. von den Driesch,
B. Kaltenbach, R. Hammerstingl, T. Gruber-Rouh;
Frankfurt/DE
SE-062 Revisiting the role of ultrasound surveillance of
hepatocellular carcinoma (HCC): does it work well?
S.J. Ahn, J.H. Kim, J.K. Han; Seoul/KR
SE-065 Stereotactic Body Radiotherapy (SBRT) for primary
and secondary liver tumors: efficacy and dosimetric
correlation with Focal Liver Reaction (FLR).
F. Castagnoli, A. Villanacci, B. Frittoli, R. Ambrosini,
F. Frassine, P. Vitali, L. Grazioli; Brescia/IT
SE-066 CT-Liver-Perfusion analysis for assessment of
Hepatocellular Carcinoma lesions: Diagnostic value
of Hepatic-Arterial-Blood-Flow parametric map
A. Hatzidakis, G. Kalarakis, K. Perisinakis,
S. Charalambous, I. Karageorgiou, E. Akoumianakis,
A. Karantanas; Heraklion/GR
SE-069 MRI hallmarks of liver metastatic neuroendocrine
tumor differentiation grade
M. Lapteva, O. Sergeeva, M. Shorikov, D. Frantsev,
E. Virshke, B. Dolgushin; Moscow/RU
SE-070 Cross-sectional imaging findings and effect of
surgery for symptomatic giant hepatic hemangioma.
F. Willemssen, R. Dwarkasing; Rotterdam/NL
SE-071 Optimization of MR protocol for rectal cancer staging:
Added value of liver DWI in comparison to CT.
M. Bezerra, M. Queiroz, C. Buchpiguel, R. Blasbalg,
F. Ribeiro Ferreira; São Paulo/BR
LIVER – OTHER
SE-072 Gadoxetic acid-enahnced liver MRI for the
surveillance of patients with primary sclerosing
cholangitis (PSC): Is MRCP necessary?
A. Grigoriadis1, F. Mosbach2, N. Voulgarakis1, K. Said1,
A. Bergquist1, N. Kartalis1; 1Stockholm/SE, 2Zurich/CH
SE-073 Comparison of multi-slice spiral CT portography and
endoscopy in the diagnosis of esophageal varices in
patients with liver cirrhosis
S. Wan, B. Song; Chengdu/CN
SE-074 Performance of a non-rigid registration algorithm for
liver post contrast images
M. Wagner1, S. Campana2, M. Scudeler2, N. Kieusseyan2,
Y. Chaibi2, V. Daum3; 1Paris/FR, 2La Ciotat/FR, 3Erlangen/DE
SE-075 US assessment of hepatic capsular thickness in Fitz-
Hugh-Curtis syndrome: Correlation with CT
E. Yoon, J.W. Kim, Y.S. Cho, H.J. Seon, J.N. Byun;
Kwangju/KR
SE-076 Intraindividual comparison of liver parenchymal
enhancement with gadobenate dimeglumine and
gadoxetic acid in cirrhotic patients: is the portal
venous phase different? – Preliminary data.
C. Gozzo, F. Vernuccio, V. Greco, R. Cannella, M. Midiri,
G. Brancatelli; Palermo/IT
SE-077 Effects of unilobar radioembolization on the portal
venous system
M. Vouche, S.L. Tchang, P. Flamen, M. Lemort;
Brussels/BE
67
POSTER PRESENTATION – SCIENTIFIC
LIVER – TRANSPLANTATION
SE-078 Bile lakes: a rare biliary complication of orthotopic
liver transplantation
I. Vicentin1, A. Coppola1, G. Platania1, S. Greco2,
C. Sgrazzutti1, S. Di Sandro1, A. Vanzulli3; 1Milan/IT,
2
Palermo/IT
MAGNETIC RESONANCE
SE-080 Visibility of bile duct stones in magnetic resonance
cholangiopancreatography: comparison of
compressed sensing-accelerated breath-hold 3D
SPACE with conventional navigator-triggered 3D
SPACE
A. Mayr1, C. Kranewitter1, S. Ostermann1, M. Plaikner1,
E. Weiland2, C. Kremser1, B. Henninger1; 1Innsbruck/AT,
2
Erlangen/DE
SE-081 Gadoxetate acid disodium-enhanced MRI: Multiple
arterial phases using differential sub-sampling
with cartesian ordering (DISCO) may achieve more
optimal late arterial phases than the single arterial
phase imaging
Y. Wei, Z. Ye, H. Tang, B. Song; Chengdu/CN
SE-082 Magnetic resonance enterography versus endoscopy
in paediatric inflammatory bowel disease: a UK
tertiary centre experience.
V. Balian1, M. Paddock2; 1Sheffield/UK, 2Barnsley/UK
SE-083 Chronic liver disease and secondary portal
hypertension result in impaired gadoxetic acid
uptake in the hepatobiliary phases of MR.
C. Caparroz, A. Forner, A. Darnell, J. Rimola,
J. Ayuso-Colella, J. Bruix, C. Ayuso; Barcelona/ES
SE-084 Detection of bowel lesions in newly diagnosed
patients with Crohn´s disease by MR enterography
versus ileocolonoscopy
A.K. Lunder, L. Bakstad, A. Negård; Lørenskog/NO
SE-085 Improved display of hepatic arterial anatomy using
differential sub-sampling with cartesian ordering
(DISCO): comparison with single arterial phase MR
imaging and computed tomographic angiography
Y. Wei, Z. Ye, H. Tang, B. Song; Chengdu/CN
SE-086 Magnetic resonance imaging assessement of
newly diagnosed patients with Crohn´s disease in
a population-based cohort of patients in Norway
(IBSEN III)
A.K. Lunder, L. Bakstad, A. Negård; Lørenskog/NO
68
SE-087 MRI characterization of the pancreatic stiffness
by DWI (ADC and IVIM) in patients scheduled for
pancreatic resection: comparison with
pathological and clinical data after resection
(preliminary project report).
B. Frittoli1, R. Grimm2, F. Carpanese2, A. Villanacci1,
R. Ambrosini1, G. Mazza1, G. Baiocchi1, F. Castagnoli1,
L. Grazioli1; 1Brescia/IT, 2Erlangen/DE
SE-088 Pancreatic screening in high risk patients: is fast
non-contrast MR protocol feasible? A proposal
F. Maio1, V. Pasqualino2, L. Bertana3, S. Venturini3,
V. Cantoni1, M. Fusaro3, G. Morana3; 1Naples/IT,
2
Padua/IT, 3Treviso/IT
MISCELLANEOUS
SE-089 Barriers affecting involvement in research of
abdominal radiology trainees: is the future bright?
F. Vernuccio1, S. Turk2, E. Terrazas Torres3, J. Choa4,
A. Udare5, D. Haroun6, E. Estades7, M. Arzanauskaite8;
1
Palermo/IT, 2Izmir/TR, 3Mexico City/MX, 4Taguig/PH,
5
Mumbai/IN, 6Cairo/EG, 7Newark, NJ/US, 8Liverpool/UK
SE-090 Cost-effectiveness analysis of inclusion of contrast
enhanced ultrasound (CEUS) in the surveillance of
asymptomatic pancreatic cystic lesions
E. Santi, N. Faccioli, G. Foti, G. Mansueto; Verona/IT
ONCOLOGY
SE-092 Imaging of abdominal complications following
hematopoietic stem cell transplantation
D. Foyedo, D. Fonseca, L. Samouco, S. Rodrigues,
J. Santos, C. Carneiro, M. Gouvea; Porto/PT
PANCREAS BENIGN LESIONS
SE-093 Pancreatic Intraductal Papillary Mucinous Neoplasm:
Inter-reader agreement and Intra-reader agreement
for standardized evaluation according to Fukuoka
Guidelines
A. Borgheresi, T. Manisco, M. Coletta, L. Ottaviani,
A. Agostini, M. Vivarelli, A. Giovagnoni; Ancona/IT
 POSTER PRESENTATION – SCIENTIFIC
PANCREAS DIFFUSE DISEASE
SE-094 Quantitative MR Evaluation of the Normal Pancreas;
T1 Relaxation Time and Extracellular Volume Fraction
T. Tirkes1, J. Mitchell1, A. Patel1, F. Akisik1, J. Swensson1,
X. Zhao1, C. Lin2; 1Indianapolis, IN/US, 2Jacksonville, FL/US
SE-096 Radiological assessment of body composition and
pancreatic fibrosis of patients with
pancreatic diseases
J. Kemesiene1, E. Bieliuniene1, J. Brøndum Frøkjær2,
S. Lukosevicius1, A. Basevicius1, V. Atstupenaite1,
P. Ignatavicius1, A. Gulbinas1, Z. Dambrauskas1;
1
Kaunas/LT, 2Aalborg/DK
SE-097 Predictors of clinically successful percutaneous
catheter drainage in cute necrotizing pancreatitis
S. Montagne, M. Zappa, M. Vullierme, L. Paulatto,
V. Rebours, V. Vilgrain, M. Ronot; Clichy/FR
SE-098 Changes in pancreatic volume and pancreatic
insufficiency under sorafenib treatment
E. Belmonte, Á. Díaz-González, A. Darnell, J. Rimola,
M.E. Reig, M. Sanduzzi-Zamaparelli, V. Sapena, J. Bruix,
C. Ayuso; Barcelona/ES
PANCREAS MALIGNANT LESIONS
SE-099 Enhancement Parameters of pancreatic ductal
adenocarcinoma at Contrast-enhanced Computed
Tomography (CT): Correlation with
Pathologic grading.
Y.C. Kim, Hwaseong/KR
SE-100 New scoring system based on preoperative CA125
and CA19-9 levels for prognosis of patients with
liver metastasis from pancreatic cancer treated with
thermal ablation
X. Yan, Shanghai/CN
SE-101 Magnetic resonance imaging for evaluating
malignant potential of intraductal papillary
mucinous neoplasms and mucinous cystic
neoplasms of the pancreas.
M. Shiraishi, T. Igarashi, R. Yamaguchi, Y. Fujii,
K. Watanabe, K. Ohki, G. Kawakami, H. Ojiri; Tokyo/JP
SE-102 Assessment of local vascular invasion in pancreatic
carcinoma by MDCT using the angle measuring tool
D. Saponjski, A. Djuric-Stefanovic; Belgrade/RS
SE-103 Is endoscopic ultrasound-guided iodine-125 seed
implantation following relief of obstructive jaundice
using ERCP able to improve the quality of life in
patients with unresectable pancreatic carcinoma?
W. Li, Z. Wang, T. Zhang, X. Wang, F. Cai, S. Li; Beijing/CN
SE-104 The Value of MDCT Image Texture analysis in the
Grading Diagnosis of Pancreatic Neuroendocrine
Neoplasms
Y. Li, L. Jiang; Beijing/CN
SE-105 CT control study after percutaneous radiofrequency
ablation of locally advanced pancreatic cancer
E. Genco, A. Sarno, A. Beleù, G. Rizzo, A. Grecchi,
R. De Robertis, M. D‘Onofrio; Verona/IT
SE-106 Diagnostic accuracy of low-kV Multidetector-
CT study combined with knowledge based
iterative reconstruction algorithm in the
detection and characterization of incidental
pancreatic cystic lesions: comparison with MR
cholangiopancreatography
C. Maino, D. Ippolito, A. Pecorelli, A. Devito, L. Riva,
C. Talei Franzesi, S. Sironi; Monza/IT
SE-107 Preoperative structured evaluation of resectability
of pancreatic cancer: inter-reader agreement and
intra-reader agreement between operators with
different experience.
A. Borgheresi, T. Manisco, M. Coletta, M. Vivarelli,
A. Agostini, A. Giovagnoni; Ancona/IT
QUANTITATIVE IMAGING
SE-108 Measurement of the Pancreatic Fat Fraction by CT
Histogram Analysis to Predict Pancreatic Fistula
after Pancreaticoduodenectomy
H.I. Ha, Anyang-Si/KR
SE-109 Comparison of diagnostic performance of magnetic
resonance elastography and T1 mapping for
diagnosis of liver fibrosis according to the presence
of fatty liver.
J. Ahn, S.H. Kang; Wonju/KR
SE-110 MR quantification of iron and fat in patients with
isolated hyperferritinemia
J. Gomes Carvalho1, M. França1, C. Costa1,
L. Martí-Bonmatí2, G. Porto1; 1Porto/PT, 2Valencia/ES
69
POSTER PRESENTATION – SCIENTIFIC

QUANTITATIVE IMAGING – CONTINUATION ULTRASOUND

SE-111 Sarcopenia as a predictor of rapidly progressive
hepatocellular carcinoma following interventional
treatment
A. Morgado, J. Elias, A. Teixeira, J. Kajiwara,
L. Monsignore, A. Martinelli, D. Abud, E. Mente,
V. Muglia; Ribeirao Preto/BR
SE-112 Prognostic value of dynamic CT-Perfusion Imaging in
assessment of Tumour Response to Antiangiogenetic
Treatment in Patients with Advanced HCC Lesions
A. Pecorelli, D. Ippolito, C. Maino, G. Querques,
M. Ragusi, C. Talei Franzesi, S. Sironi; Monza/IT
SE-118 Ultrasound Guided Non-Targeted Liver Biopsies:
What have we learnt after 1000 biopsies?
J. Zhong, H. Ng, R. Allard, J. Bell, D. Hewitson, V. Gudla,
R. Albazaz; Leeds/UK
SE-120 Inter-observer variance in Contrast-enhanced
ultrasound (CEUS) of the Liver
S. Syed1, A. Ali1, H. Dharmana2, R. Khurram3, N. Malik4,
A. Kabeer1, A. Suri1, A. Thavakumar1, S. Biswas1,
A. Sujith1, Q. Malik1, S. Khan1, I. Syed1; 1Basildon/UK,
2
Kingston Upon Thames/UK, 3London/UK,
4
Colechester/UK

RADIOLOGIC-PATHOLOGIC CORRELATION WALL, PERITONEUM, MESENTERY

SE-113 MRI of Extramural Venous Invasion in rectal cancer: SE-122 CT Imaging Features of Extrapleural Solitary Fibrous
assessment of the interobserver agreement and Tumors in Abdomen and Pelvis: A Single Center
comparison with histopathology stained with Experience for 10 Years
hematoxylin/eosin and elastin. J. Chung, J.M. Choi; Seoul/KR
E.A. Frøyen1, L. Lyckander1, O. Grandal1, A.K. Lunder1,
S. Meltzer1, K. Redalen2, A. Ree1, A. Negård1;
1
Lørenskog/NO, 2Trondheim/NO
SE-114 Characterization of epithelial subtypes of IPMN of
the pancreas: assessment with MDCT
Y. Fukukura, Y. Kumagae, T. Yoshiura; Kagoshima/JP

STRUCTURED REPORT

SE-115 Structured Reporting versus Free-Text Reporting for

Appendiceal Computed Tomography in Adolescents
and Young Adults: Preference Survey of 594
Referring Physicians, Surgeons, and Radiologists
from 20 Hospitals
M. Kim1, S.B. Park2, K.H. Lee3, S. Yeo4; 1Anyang-Si/KR,
2
Seoul/KR, 3Seongnam-Si/KR, 4Cheonan-Si/KR

TECHNICAL ADVANCES

SE-116 Magnetic resonance cholangiopancreatography with

compressed-sensing: clinical application for the
evaluation of IPMN of the pancreas
B. Henninger1, M. Steurer1, E. Weiland2, W. Jaschke1,
C. Kremser1; 1Innsbruck/AT, 2Erlangen/DE
SE-117 Feasibility and complication rate of irreversible
electroporation (IRE) in locally advanced pancreatic
adenocarcinoma (LPAC).
J.P. Tasu1, I. Bennis2; 1Poitiers/FR, 2Clermont Ferrand/FR

70
CORPORATE MEMBERS,
INDUSTRY & SPONSORS

71
 ULTRASOUND VILLAGE
Scientific Coordinators:
Prof. Paolo Ricci, Rome/IT and Dr. Laura Romanini, Cremona/IT

At ESGAR 2019, the “Ultrasound Village” is a new endeavour highlighting the modality of
ultrasound where exhibitors and expert tutors offer live demonstrations on models and
the opportunity of hands-on training for participants directly at the exhibitors’ booths.
The organised demonstrations and hands on-trainings will be preceded by short keynote
lectures in the dedicated theatre installed in front of the “Ultrasound Village“.

THURSDAY, JUNE 6, 2019 FRIDAY, JUNE 7, 2019 SATURDAY, JUNE 8, 2019

10:30 – 11:00 USV 1 Keynote Lectures 10:30 – 11:00 USV 5 Keynote Lectures 10:30 – 11:00 USV 9 Keynote Lectures

11:00 – 12:30  USV 2 Hands-on Training 11:00 – 12:30 USV 6 Hands-on Training 11:00 – 12:30 USV 10 Hands-on Training

14:00 – 14:30  USV 3 Keynote Lectures 14:00 – 14:30 USV 7 Keynote Lectures

14:30 – 16:00  USV 4 Hands-on Training 14:30 – 16:00 USV 8 Hands-on Training

THE ULTRASOUND VILLAGE IS KINDLY SUPPORTED BY

THE FOLLOWING COMPANIES:
ESGAR WISHES TO GRATEFULLY ACKNOWLEDGE THE SUPPORT
OF ITS CORPORATE MEMBERS

73
 From Classical Liver
Imaging to Biomarkers
in Functional Imaging
Lunch Symposium at ESGAR
June 5, 12:15 – 13:15
Room Pisa

Speakers
A. Ba-Ssalamah, Vienna/AT
A. Huppertz, Potsdam/DE
C. Zech, Basel/CH
PP-PRIM-ALL-0025-1 May 2019
PP-PRIM-IT-0005-1
 WEDNESDAY, JUNE 5, 2019

12:15 – 13:15 / Lunch Symposium

SY 1 Pisa
BAYER: From classical liver imaging to biomarkers in functional imaging
Moderator: A. Ba-Ssalamah, Vienna/AT

12:15 Introduction
A. Ba-Ssalamah, Vienna/AT

12:15 The Role of Gadoxetic Acid as a Biomarker in Hepatobiliary Diseases

A. Ba-Ssalamah, Vienna/AT

12:35 The Mechanism of Gadoxetic Acid: how its pharmacokinetics allow functional imaging
A. Huppertz, Potsdam/DE

12:55 The Role of Gadoxetic Acid in the diagnostic Workup of Colorectal Metastases
C.J. Zech, Basel/CH

75
 UNCOMPROMISED
EFFICIENCY & PATIENT SAFETY

P19 070 OPV - April 2019.

www.optivantage.com
OptiVantage® injector is a medical device (Class: II b, CE0123) intended for use by medical imaging and diagnostic health professionals, for injecting radiopaque contrast media and saline into a patient’s vascular system during
CT examinations. For complete information about precautions and optimal usage conditions for this medical device, we recommend consulting the instructions notices/user’s manuals. OptiVantage® is a trademark of Guerbet.
Patents pending and issued patents. ©Copyright 2019 Guerbet - All rights reserved. Complete SmPC available on demand. MATERIALE DESTINATO ESCLUSIVAMENTE A PROFESSIONISTI SANITARI.
 WEDNESDAY, JUNE 5, 2019

12:15 – 13:15 / Lunch Symposium

SY 2 Amalfi
GUERBET: A Tour Around Advanced Clinical Cases in Abdominal Emergency
Moderator: D. Ippolito, Monza/IT

12:15 Introduction
D. Ippolito, Monza/IT

12:20 Advanced cases

D. Tolan, Leeds/UK
M. Ronot, Clichy/FR
D. Ippolito, Monza/IT

13:05 Q&A and conclusion

77
 THURSDAY, JUNE 6, 2019

12:45 – 13:45 / Lunch Symposium

SY 3 Pisa
BRACCO: Cross-modality approach to imaging of liver lesions
Moderator: R. Manfredi, Rome/IT

12:45 Surveillance in cirrhotic patients: is there a role for contrast-enhanced ultrasound?

V. Cantisani, Rome/IT

13:05 Multiphasic CT of the liver and radiation dose reduction: the role of iodine
S. Cavalieri, Novara/IT

13:25 MRI of the liver with MultiHance: tips for workflow optimization
L. Grazioli, Brescia/IT

79
SOMATOM go. platform

Make success your

daily business
siemens-healthineers.com/somatom-go

Go for high performance

with trendsetting workflows
Built around a new mobile workflow, the SOMATOM go. platform features
a line-up of innovative solutions that bring an unparalleled level of
flexibility and mobility to daily CT routines. These solutions also help to
enhance patient comfort by allowing staff to stay with patients for longer.

• Benefit from a groundbreaking concept of mobile operation

and workflow automation

• Allows you to deliver high performance every day

• Helps you establish and run your CT business efficiently

 THURSDAY, JUNE 6, 2019

12:45 – 13:45 / Lunch Symposium

SY 4 Amalfi
SIEMENS: Exploring new Dimensions with Spectral and Perfusion Imaging
Moderator: B. Schmidt, Forchheim/DE

12:45 Thoracic and Vascular Spectral CT

M. Albrecht, Frankfurt/DE

13:05 Spectral CT of the Abdomen in Clinical Routine

P. Apfaltrer, Vienna/AT

13:25 Body CT Perfusion: Highlights on 3rd Generation Dual Source CT

A. Agostini, Ancona/IT

81
 Computed tomography
Computed tomography

Certainty lives in layers

“With the IQon CT, we get spectral results that allow us to diagnose
confidently. We can always retrospectively evaluate and research
[patient cases] using spectral results from the IQon CT.”
-Koji Takumi, Radiologist, Ichiro Semba
Source: Techvalidate.TVID: 844-18B-45F

The Philips IQon Elite Spectral CT is the only dual-energy solution that
provides layers of spectral data in every scan, without compromise —
helping to improve your diagnostic confidence and enhance the patient
experience, while lowering costs. There’s always a way to make life better.

See what others are saying at www.philips.com/iqon.

 FRIDAY, JUNE 7, 2019

12:45 – 13:45 / Lunch Symposium

SY 5 Florence
PHILIPS: Spectral CT, a game changer in GI tract imaging
Moderator: O. Lucidarme, Paris/FR

12:45 Introduction
O. Lucidarme, Paris/FR

12:55 How Spectral CT helps to diagnose patients with vague symptoms

E. Danse, Brussels/BE

13:20 Impact of spectral imaging in patients suspected for occult cancer

M. Brun Andersen, Aarhus/DK

83
 GE Healthcare
– proud to support ESGAR
Visit our booth
to find out more
Gadoteric acid GE Healthcare expertise
PRESCRIBING INFORMATION CLARISCAN™ – gadoteric acid
Please refer to full national Summary of Product Characteristics (SmPC)
before prescribing. Further information available on request.
PRESENTATION Clariscan 0.5 mmol/mL solution for injection. Solution
for injection containing 279.3 mg/ml gadoteric acid (as gadoterate
meglumine) equivalent to 0.5 mmol/mL. INDICATIONS For diagnostic
use only. Clariscan should be used only when diagnostic information
is essential and not available with unenhanced magnetic resonance
imaging (MRI). Contrast agent for contrast enhancement in MRI for
a better visualisation/delineation. Adult and paediatric population
(0-18 years): lesions of the brain, spine, and surrounding tissues. Adults
and children over 6 months Whole body MRI. Non-coronary angio-
graphy in adults only. DOSAGE AND METHOD OF ADMINISTRATION
This medicinal product should only be administered by trained health-
care professionals with technical expertise in performing and inter-
preting gadolinium enhanced MRI. The lowest dose that provides suffi-
cient enhancement for diagnostic purposes should be used. The dose
should be calculated based on the patient’s body weight, and should
not exceed the recommended dose per kilogram of body weight detailed
in this section. MRI of brain and spine: Adults: The recommended
dose is 0.1 mmol/kg BW, i.e. 0.2 mL/kg BW. In patients with brain
tumours, an additional dose of 0.2 mmol/kg BW, i.e. 0.4 mL/kg BW,
may improve tumor characterisation and facilitate therapeutic decision
making. Children (0-18 years): The recommended and maximum
dose of Clariscan is 0.1 mmol/kg body weight. Do not use more than
one dose during a scan. Careful consideration in neonates up to
4 weeks and infants up to 1 year of age. Lack of information on repeated
administration, Clariscan injections should not be repeated before
7 days. Whole body MRI (including lesions of the liver, kidneys,
pancreas, pelvis, lungs, heart, breast, and musculoskeletal
system): Adults and children over 6 months: The recommended
dose is 0.1 mmol/kg BW, i.e. 0.2 mL/kg BW. Angiography: Adults only:
The recommended dose, IV injection is 0.1 mmol/kg BW, i.e. 0.2 mL/kg
BW. Impaired renal function: Clariscan should only be used in
patients with severe renal impairment (GFR < 30 mL/min/1.73 m2) and
in patients in the perioperative liver transplantation period after care-
ful risk/benefit assessment and if the diagnostic information is essential
and not available with non-contrast enhanced MRI. If it is necessary to
use Clariscan the dose should not exceed 0.1 mmol/kg body weight.
Clariscan injections should not be repeated before 7 days. Impaired
hepatic function: The adult dose applies. Caution recommended,
especially in perioperative liver transplantation period. Elderly (aged
65 years and above): No dosage adjustment, but exercise caution.
CONTRAINDICATIONS Hypersensitivity to gadoteric acid, to meglu-
mine or to any medicinal products containing gadolinium. WARNINGS
AND PRECAUTIONS Appropriate facilities should be readily available
for any complication, as well as for emergency treatment of severe reac-
tion to the contrast agent (e.g. hypersensitivity, seizures). The usual pre-
caution for MRI examination should be taken. Regarding any metallic
object such as exclusion of patients with pacemakers, vascular clips,
infusion pumps, nerve stimulators, cochlear implants, or suspected
intracorporeal metallic foreign bodies, particularly in the eye. Not for
intrathecal use: For intravenous injection only. Clariscan must not be
administered by subarachnoid (or epidural) injections. Extravasation:
In the event of extravasation local intolerance reactions may be obser-
ved, necessitating short term local treatment. Hypersensitivity reac-
tions: Hypersensitivity reactions can occur, including life-threatening,
and may be either allergic or non-allergic. They can be either imme-
diate (less than 60 minutes), or delayed (up to 7 days). Anaphylactic
reactions can occur immediately and can be fatal. Symptoms of an
existing asthma may be aggravated. Hypersensitivity reactions can
be aggravated in patients on beta-blockers, particularly those with
bronchial asthma. These patients may be refractory to standard treat-
ment of hypersensitivity reactions with beta-agonists. Caution in
patients with a history of allergy (e.g. fish and seafood allergy, hay fever,
hives), sensitivity to contrast media and bronchial asthma and pre-
medication with antihistamines and/or glucocorticoids may be con-
sidered. Appropriate support measures should be available. Nephro-
genic Systemic Fibrosis (NSF): Reports of NSF associated with use
of some gadolinium-containing contrast agents in patients with acute
or chronic severe renal impairment (GFR < 30 mL/min/1.73 m2).
Incidence of acute renal failure is high in patients undergoing liver
transplantation. Clariscan should only be used in patients with severe
renal impairment and in patients in the perioperative liver transplanta-
tion period after careful risk/benefit assessment and if the diagnostic
information is essential and not available with non-contrast enhanced
MRI. Prior to administration of Clariscan, it is recommended that all
patients are screened for renal dysfunction. CNS disorders: Special
precaution is necessary in patients with a low threshold for seizures.
Cardiovascular disease: Clariscan should only be administered after
careful benefit assessment. Patient preparation: Nausea and vomit-
ing are known possible undesirable effects when using MRI contrast
agents. The patient should therefore refrain from eating for 2 hours
prior to the investigation. UNDESIRABLE EFFECTS NSF [see Warnings
and Precautions]. Clinical Studies Experience: Immune system dis-
orders: Uncommon: Hypersensitivity, anaphylactic reaction, anaphylac-
toid reaction. Psychiatric disorders: Very rare: Agitation, anxiety.
Eye disorders: Rare: Conjunctivitis, ocular hyperaemia, vision blurred,
lacrimation increased, eyelid oedema. Nervous system disorders:
Very common: Paraesthesia, headache. Rare: Dysgeusia. Very rare:
Coma, convulsion, syncope, presyncope, dizziness, parosmia, tremor.
Cardiac disorders: Very rare: Cardiac arrest, bradycardia, tachycardia,
arrhythmia, palpitations. Respiratory, thoracic and mediastinal
disorders: Very rare: Respiratory arrest, Rare: Pulmonary oedema,
bronchospasm, laryngospasm, pharyngeal oedema, dyspnoea, nasal
congestion, sneezing, cough, dry throat. Gastrointestinal disorders:
Common: Nausea, vomiting. Very rare: Diarrhoea, abdominal pain,
salivary hypersecretion. Skin and subcutaneous system disorders:
Common: Pruritus, erythema, rash. Rare: Urticaria, hyperhidrosis. Very
rare: Eczema, angioedema. Isolated cases of NSF have been reported
with gadoteric acid, most of which were in patients co-administered
other gadolinium-containing contrast agents. Vascular disorders:
Very rare: Hypotension, hypertension, vasodilatation, pallor. Musculo-
skeletal and connective tissue disorders: Very rare: Muscle contrac-
ture, muscular weakness, back pain. General disorders and adminis-
tration site conditions: Common: Feeling hot, feeling cold, injection
site. Very rare: Chest discomfort, fever, chills, face oedema, asthenia,
injection site discomfort, back pain, malaise, thoracic pain, superficial
phlebitis, decreased oxygen saturation. Injection site reaction, injection
site oedema, injection site extravasation, injection site inflammation
(in case of extravasation), injection site necrosis (in case of extravasa-
tion). See full SmPC for adverse reactions reported with other intra-
venous MRI contrast agents. Postmarketing experience: The most
commonly reported adverse reactions following administration are
nausea, vomiting, pruritus and hypersensitivity reactions. The most
frequently observed hypersensitivity reactions are localised, extended
or generalised skin reactions which most often occur immediately
(during the injection or within one hour after the start of injection) or
sometimes delayed (one hour to several days after injection). Immediate
reactions include one or more effects, which appear simultaneously or
sequentially, which are most often cutaneous, respiratory and/or cardio-
vascular reactions. Each sign may be a warning sign of a starting shock
and go very rarely to death. DRUG INTERACTIONS No formal studies.
No interactions with other medicinal products have been observed.
Beta-blockers, vasoactive substances, angiotensin-converting enzyme
inhibitors, angiotensin receptor antagonists: These medicinal products
induce decreased efficacy of cardiovascular compensation mechanisms
of blood pressure. Contrast media may increase the incidence of hyper-
sensitivity reactions in patients taking beta-blockers. PREGNANCY
AND LACTATION No data in pregnant women. Clariscan should not
be used during pregnancy unless the clinical condition of the woman
requires use of gadoteric acid. Nursing Mothers: At clinical doses,
no effects on the infant are anticipated due to the small amount excreted
in milk and poor absorption from the gut. Continuing or discontinuing
breast feeding for a period of 24 hours after administration, should be
at the discretion of the doctor and lactating mother. Fertility: no clinical
data. SPECIAL POPULATIONS: Neonates and infants: Clariscan
should only be used in neonates up to 4 weeks of age and infants up
to 1 year age after careful consideration. Elderly (aged 65 years and
above): Patients should be screened due to age related decline in renal
function. OVERDOSE Clariscan can be removed by haemodialysis.
However, there is no evidence that haemodialysis is suitable for
prevention of NSF. EFFECTS ON THE ABILITY TO DRIVE AND USE
MACHINES No studies. Ambulant patients while driving vehicles or
operating machinery should take into account that nausea may
incidentally occur. INSTRUCTIONS FOR USE AND HANDLING
For single use. The solution for injection should be inspected visually
prior to use. Only clear solutions free of visible particles should be used.
In neonates and infants the required dose should be administered by
hand. The peel-off tracking label on the syringes/vials/bottles should be
stuck onto the patient record. The dose used should also be recorded.
See SmPC for full instructions. MARKETING AUTHORISATION HOLDER
GE Healthcare AS, P.O. Box 4220 Nydalen, NO-0401 OSLO, NORWAY.
MARKETING AUTHORISATION NUMBER PL 00637/0065 and
PL 00637/0066. CLASSIFICATION FOR SUPPLY Subject to medical
prescription. DATE OF REVISION OF THE TEXT May 2018.
Cost 10x20ml: £759.
Adverse events should be reported. Reporting forms and
information can be found at https://yellowcard.mhra.gov.uk/.
Adverse events should also be reported to GE Healthcare
at gpv.drugsafety@ge.com.
© 2019 General Electric Company.
GE, the GE Monogram, Clariscan and Claricyclic are trademarks
of General Electric Company.
In Italy this medicinal product is registered as Claricyclic.
GE Healthcare Limited, Amersham Place, Little Chalfont,
Buckinghamshire, England HP7 9NA, www.gehealthcare.com
Dep. c/o AIFA 18/04/2019
04-2019 JB8103/OS ESGAR-19
 FRIDAY, JUNE 7, 2019

12:45 – 13:45 / Lunch Symposium

SY 6 Pisa
GE HEALTHCARE: Inflammatory bowel disease: Contrast enhanced MRI in assessment of
paediatric and adult patients
Moderator: C. Catalano, Rome/IT

12:45 Chairman’s Welcome and Introduction

C. Catalano, Rome/IT

12:50 Important updates from the literature concerning MR Imaging safety

J. Jakobsen, Oslo/NO

13:05 Optimising use of CE-MRI for inflammatory diseases of the small and large bowel in adult and paediatric patients
F. Maccioni, Rome/IT

13:20 Consistent abdominal MR on challenging patients

F. Legou, St. Denis/FR

13:35 Questions

85
SATURDAY, JUNE 8, 2019

12:45 – 13:45 / Lunch Symposium

SY 7 Meeting Room 4
CANON: The new frontiers of interventional radiology
Moderator: M. Rossi, Rome/IT

12:45 Chairman’s Welcome and Introduction

M. Rossi, Rome/IT

12:55 Expanding the boundaries of interventional oncology

F. Orsi, Milan/IT

13:20 Easier, better, faster, clearer: abdominal image-guided interventions with Infinix-i 4D CT
J. Garnon, Strasbourg/FR

86
THURSDAY, JUNE 6, 2019

14:00 – 15:00 / Industry Satellite Workshop

ISWS 1 Meeting Room 4

Alfasigma Satellite Workshop
Moderator: A. Laghi, Rome/IT

14:00 Bowel preparation for colonoscopy: ESGE Guidelines

C. Hassan, Rome/IT

14:20 Evolution of bowel preparation with intestinal endoscopy techniques

M. Kaminski, Warsaw/PL

14:40 Current use of bowel preparation in Colonography / clinical experience with Clensia
D. Bellini, Latina/IT

FRIDAY, JUNE 7, 2019

14:00 – 15:00 / Industry Satellite Workshop

ISWS 2 Meeting Room 4

SANITAS: Improving lesion detection in CT imaging of the GI tract:
the importance of patient preparation.
Moderator: D. Regge, Turin/IT

14:00 CT-Colonography
D. Campanella, Turin/IT

14:15 CT of the small bowel

L. Funicelli, Milan/IT

14:30 Presentation of clinical cases

87
 Key publications in
Gastrointestinal Cancer

Official Journal of
the Asia-Pacific Primary Liver Cancer Expert Association (APPLE)

ubm issions
S !
welcome
Scan to access the journal homepage
www.karger.com/LIC

Editors Editor-in-Chief
Jing-Yuan Fang (Shanghai) Masatoshi Kudo (Osaka)
Peter Malfertheiner (Munich)

An international platform for Causes, mechanisms and therapy

key opinions and research
Gastrointestinal Tumors is an international, peer-reviewed jour-
nal that brings together the leading opinions in all fields related
to gastrointestinal cancer research. Ranging from the identifica-
tion of new therapeutic targets to epidemiology, disease preven-
tion, treatment and patient management, the journal provides
a platform for the dissemination of key opinions from thought
leaders in the field. By publishing timely reviews and original
papers covering the latest developments, the journal will help
readers gain insight into the evolving body of research across the
relevant disciplines.
Listed in PubMed!
The journal Liver Cancer serves the growing need to better un-
derstand the causes, mechanisms and therapy of the malig-
nancy. It provides the international community of researchers
and clinicians with a platform for their research results, focusing
on molecular carcinogenesis, prevention, surveillance, diagno-
sis and treatment, including molecular targeted therapy, of the
disease. Liver Cancer publishes clinical and translational research
related to the field of liver cancer in both humans and experi-
mental models in the form of original and review articles.
Listed in PubMed!

www.karger.com/gat www.karger.com/lic
KI19153
DOWNLOAD THE
ESGAR 2019 APP

GET IT ON
EXHIBITORS AND SPONSORS
ALFASIGMA SPA
Via Ragazzi del ‘99, 5
IT – 40133 Bologna
Phone: +39 0516489511
E-Mail: info.it@alfasigma.com
www.alfasigma.com
BAYER AG, PHARMA
Müllerstrasse 178
DE – 13353 Berlin
Phone: +49 30 468 1111
www.radiology.bayer.com
BRACCO
Via Caduti di Marcinelle 13
IT – 20134 Milan
Phone: +39 0221 771
E-Mail:
mediarelations.imaging@bracco.com
www.braccoimaging.com
CANON MEDICAL SYSTEMS
Via Canton, 115
IT – 00144 Rome
Phone: +39 0652 0771
Fax: +39 0652 958 79
E-Mail: info.it@eu.medical.canon
https://eu.medical.canon/
COOK MEDICAL
O’Halloran Road
National Technology Park
IE – Limerick
Phone: +353 61 334 440
Fax: +353 61 334 441
www.cookmedical.eu
ESAOTE SPA
Via Melen 77
IT – 16152 Genoa
Phone: +39 010 65471
www.esaote.com
90
GE HEALTHCARE PHILIPS SPA
Pollards Wood Viale Sarca 235
Nightingales lane IT – 20126 Milan
Chalfont Phone: +39 0238 5933 60
UK – HP8 4SP St. Giles E-Mail: Reception1_Milano@philips.com
Phone: +44 1494 5440 00 www.philips.it
www.gehealthcare.com
RESOUNDANT INC.
GENERAL MEDICAL 421 1st Ave. SW
Suite 204W
MERATE SPA
US – Rochester MN 55902
Via Partigiani, 25 Phone: +1 507 322 0011
IT – 24068 Seriate E-Mail: mreinfo@resoundant.com
Phone: +39 035 45 25 311 www.resoundant.com
E-Mail: comm.italia@gmmspa.com
www.gmmspa.com
SANITAS FARMACEUTICI SRL
GUERBET Via Emilia 168
BP 57400 IT – 15057 Tortona (AL)
FR – 95943 Roissy CDG Cedex Phone: +39 0131 8223 40
Phone: +33 1 45 91 50 00 Fax: +39 0131 8907 85
Fax: +33 1 45 91 51 99 E-Mail: info@sanitas1931.it
E-Mail: joana.borges@guerbet.com www.sanitas1931.it
www.guerbet.com
SIEMENS HEALTHCARE SRL
HITACHI MEDICAL Via Vipiteno 4
IT – 20128 Milan
SYSTEMS SPA
Phone: +39 02 243 1
Via Tommaso Gulli 39 www.siemens-healthineers.com/it
IT – 20147 Milan
Phone: +39 02 97166 SUPERSONIC IMAGINE
Fax: +39 02 97166127 Les Jardins de la Duranne
E-Mail: Bât E & F – 510 Rue René Descartes
welcome.it@hitachi-medical-systems.com FR – 13857 Aix-en-Provence
www.hitachi-medical-systems.it Phone: +39 3288 9862 76
Fax: +33 442 525 921
MINT MEDICAL GMBH E-Mail:
Burgstrasse 61 giuseppe.licata@supersonicimagine.com
DE – 69121 Heidelberg www.supersonicimagine.com
Phone: +49 6221 6479 760
E-Mail: info@mint-medical.com TELEMEDICINE CLINIC
www.mint-medical.com Calle Marina 16-18
Torre Mapfre Pl. 21
ES – 08005 Barcelona
Phone: +34 93 550 0750
E-Mail: info@telemedicineclinic.com
www.telemedicineclinic.com
 EXHIBITION AREA

Café
Roma

Coffee Stations

Sanitas Guerbet
Bayer Lounge Area
BRACCO
Tele-
medicine

Mint
Siemens

Hitachi

Esaote
Philips

Resoundant
GE
Cook

Poster Terminals Ultrasound

Canon Village e-Poster
Area
Supersonic

91
FLOORPLAN – MEETING HALLS

AMALFI FLORENCE

BOLOGNA CAPRI

ESGAR
Office
Preview
5

Meeting Rooms
PISA MILAN
Centre &
Scientific
Office
4

e-Poster
Area

Ultrasound
EXHIBITION Village
AREA

Poster
Terminals

to the Auditorium

i
Registration Fast Lane

Entrance

92
driving scientific advancements in digestive health
October 19-23, 2019
Venue: Fira Gran Via, Barcelona
Ahead of UEG Week Barcelona 2019, UEG
President Professor Paul Fockens discusses
why he is looking forward to one of the
world’s premier digestive health meetings.ngs.
UEG Week is the largest
and most prestigious
gastroenterology meeting
of its kind, with more than 14,000
delegates from over 110 countries
worldwide.
The UEG Scientific Committee is
developing a state-of-the-art
scientific programme, featuring the
latest advancements and most exciting
research in digestive health.
This will ensure the delivery of
world-class presentations across a
range of specialties, covering clinical,
translational and basic science. An
inclusive offering is provided for all
attendees, whatever their level of
expertise, featuring a broad variety
of sessions that include symposia,
live endoscopy and abstract-based
sessions. Different interactive formats
allow lively interaction between the
audience, chairs and speakers.
The two-day Postgraduate Teaching
Programme will provide profound
updates on a wide range of
gastrointestinal and hepatology topics
that suit both gastroenterologists
in training as well as established
physicians and general practitioners.
The programme focuses on the
relevance for the clinical day-to-day
business and enables participants
to get perfectly prepared for their
professional career. 2019 marks year 3
of our rolling 3-year curriculum.
UEG Week will once again host the
hugely successful ‘Today’s Science,
Tomorrow’s Medicine’ initiative and
this year’s theme will be ‘Microbiota:
Moving towards clinics’. Here, top-
class scientists will be invited to
discuss how current knowledge and
thinking is ready to be used in clinical
practice and establish strategies to
foster further progression in this area.
UEG Week provides an exceptional
opportunity for investigators from
around the globe to submit and
present their latest findings. UEG will
present a number of awards at the
congress, including the Top Abstract
Prizes, the UEG Research Prize and the
UEG Rising Star Awards.
I am anticipating a very exciting
week of scientific advances and
updates from leading digestive health
experts and thoroughly look forward
to welcoming new and returning
delegates to UEG Week Barcelona
2019.
To find out more,
visit ueg.eu/week
ESGAR
Annual Meeting and Postgraduate Course

2020 AC
T SUBM
NOV

ABSTR

ISS
22

ION
2019

May 19-22
DE
A D L I NE

TE RD AM ANDS
AMS NE THERL
THE